3e8d:A (ASP151) to (ALA173) CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS | AKT2, KINASE, GSK3 BETA, ATP-BINDING, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, WNT SIGNALING PATHWAY
3e8d:B (ASP151) to (ALA173) CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP- COMPETITIVE INHIBITORS | AKT2, KINASE, GSK3 BETA, ATP-BINDING, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, WNT SIGNALING PATHWAY
3e8l:C (ILE88) to (TYR114) THE CRYSTAL STRUCTURE OF THE DOUBLE-HEADED ARROWHEAD PROTEASE INHIBITOR A IN COMPLEX WITH TWO TRYPSINS | BETA-TREFOIL FOLD, PROTEASE INHIBITOR, TRYPSIN, COMPLEX, DIGESTION, HYDROLASE, METAL-BINDING, PROTEASE, SECRETED, SERINE PROTEASE, ZYMOGEN, HYDROLASE INHIBITOR-HYDROLASE COMPLEX
4gu8:H (ASN10) to (GLY34) CRYSTAL STRUCTURE OF BURKHOLDERIA OKLAHOMENSIS AGGLUTININ (BOA) | LECTIN, SUGAR BINDING, BETA BARREL, ANTI-HIV, MAN9, GLYCAN, GP120, SUGAR BINDING PROTEIN
1a7x:B (GLN20) to (PHE48) FKBP12-FK1012 COMPLEX | ISOMERASE, IMMUNOPHILIN
3ro4:A (GLY10) to (ASN42) X-RAY STRUCTURE OF KETOHEXOKINASE IN COMPLEX WITH AN INDAZOLE COMPOUND DERIVATIVE | KINASE, ATP BINDING, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
2aoh:A (ARG57) to (GLY78) CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A SUBSTRATE ANALOG P6-PR | HIV-1 PROTEASE, MUTANT, DIMER, SUBSTRATE ANALOG, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4whb:B (THR3) to (GLY29) CRYSTAL STRUCTURE OF PHENYLUREA HYDROLASE B | AMIDOHYDROLASE, DIURON HYDROLASE, HYDROLASE
3ebz:B (LYS157) to (GLY178) HIGH RESOLUTION HIV-2 PROTEASE STRUCTURE IN COMPLEX WITH CLINICAL DRUG DARUNAVIR | HIV-2, ASPARTIC PROTEASE, INHIBITOR,PROTEASE-DRUG COMPLEX, HYDROLASE
3ec0:B (LYS157) to (GLY178) HIGH RESOLUTION HIV-2 PROTEASE STRUCTURE IN COMPLEX WITH ANTIVIRAL INHIBITOR GRL-06579A | HIV-2, ASPARTIC PROTEASE, INHIBITOR, PROTEASE-INHIBITOR COMPLEX, HYDROLASE
3ecg:B (LYS157) to (GLY178) HIGH RESOLUTION HIV-2 PROTEASE STRUCTURE IN COMPLEX WITH ANTIVIRAL INHIBITOR GRL-98065 | HIV-2, ASPARTIC PROTEASE, INHIBITOR, PROTEASE-INHIBITOR COMPLEX, HYDROLASE
2oj9:A (GLY981) to (VAL1005) STRUCTURE OF IGF-1R KINASE DOMAIN COMPLEXED WITH A BENZIMIDAZOLE INHIBITOR | HORMONE/GROWTH FACTOR, IGF-1R, KINASE DOMAIN, TRANSFERASE
4wjk:A (LEU299) to (HIS330) METAL ION AND LIGAND BINDING OF INTEGRIN | CELL ADHESION-IMMUNE SYSTEM COMPLEX
1af6:A (PRO361) to (TRP421) MALTOPORIN SUCROSE COMPLEX | MEMBRANE PROTEIN, SPECIFIC PORIN, BETA BARREL, SUGAR TRANSPORT, SUCROSE
1af6:B (PRO361) to (TRP421) MALTOPORIN SUCROSE COMPLEX | MEMBRANE PROTEIN, SPECIFIC PORIN, BETA BARREL, SUGAR TRANSPORT, SUCROSE
1af6:C (PRO361) to (TRP421) MALTOPORIN SUCROSE COMPLEX | MEMBRANE PROTEIN, SPECIFIC PORIN, BETA BARREL, SUGAR TRANSPORT, SUCROSE
2axc:A (THR177) to (GLY196) CRYSTAL STRUCTURE OF COLE7 TRANSLOCATION DOMAIN | COLICIN, TRANSLOCATION DOMAIN, HYDROLASE
1ajv:A (ARG57) to (GLY78) HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC SULFAMIDE INHIBITOR AHA006 | PROTEASE, ASPARTYL PROTEASE, NON-PEPTIDE INHIBITOR, DRUG DESIGN, HIV-1
1npa:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF HIV-1 PROTEASE-HUP | PROTEASE, HIV, ASPARTYL PROTEASE, HYDROLASE
1npv:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH LDC271 | PROTEASE, HYDROLASE
1npw:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF HIV PROTEASE COMPLEXED WITH LGZ479 | PROTEASE, HYDROLASE
4h3s:A (SER696) to (GLU740) THE STRUCTURE OF GLUTAMINYL-TRNA SYNTHETASE FROM SACCHAROMYCES CEREVISIAE | ROSSMANN FOLD, LIGASE, APPENDED DOMAIN, TRNA SYNTHETASE, BETA BARREL ANTICODON BINDING DOMAIN, PSEUDO ZINC FINGER MOTIF
2oui:A (MET1) to (LYS18) D275P MUTANT OF ALCOHOL DEHYDROGENASE FROM PROTOZOA ENTAMOEBA HISTOLYTICA | TETRAMER, METAL-BINDING, NADP,OXIDOREDUCTASE, P275D MUTATION, CACODYLATE ION, THERMOSATBILITY, OXIDOREDUCTASE
2b4s:B (GLY1008) to (VAL1032) CRYSTAL STRUCTURE OF A COMPLEX BETWEEN PTP1B AND THE INSULIN RECEPTOR TYROSINE KINASE | HYDROLASE/TRANSFERASE, PHOSPHORYLATION, TYROSINE PROTEIN KINASE
2b4s:D (GLY1008) to (VAL1032) CRYSTAL STRUCTURE OF A COMPLEX BETWEEN PTP1B AND THE INSULIN RECEPTOR TYROSINE KINASE | HYDROLASE/TRANSFERASE, PHOSPHORYLATION, TYROSINE PROTEIN KINASE
4h69:B (LYS82) to (THR108) CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 2 FROM PHYSCOMITRELLA PATENS COMPLEXED WITH SUBSTRATE ANALOG | B-BARREL, OXYLIPINS, FATTY ACID, METABOLITES, ALLENE-OXIDE CYCLASE ACTIVITY, ISOMERASE
3ekv:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF THE WILD TYPE HIV-1 PROTEASE WITH THE INHIBITOR, AMPRENAVIR | PROTEASE INHIBITOR, DRUG RESISTANCE, AMPRENAVIR, HIV PROTEASE, AIDS, PROTEASE, HYDROLASE
3eky:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF WILD-TYPE HIV PROTEASE IN COMPLEX WITH THE INHIBITOR, ATAZANAVIR | HIV PROTEASE, PROTEASE INHIBITORS, DRUG RESISTANCE, ATAZANAVIR, AIDS, HYDROLASE, PROTEASE
3el1:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF WILD-TYPE HIV PROTEASE IN COMPLEX WITH THE INHIBITOR, ATAZANAVIR | HIV PROTEASE, PROTEASE INHIBITORS, DRUG RESISTANCE, ATAZANAVIR, AIDS, HYDROLASE, PROTEASE
3em3:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF AMPRENAVIR (APV) IN COMPLEX WITH A DRUG RESISTANT HIV-1 PROTEASE VARIANT (I50L/A71V). | PROTEASE INHIBITOR, HYPER SUSCEPTIBILITY, DRUG RESISTANCE, HIV, AMPRENAVIR, AIDS, HYDROLASE, PROTEASE
2oxi:A (LYS5) to (PRO30) REFINED CRYSTAL STRUCTURE OF CU-SUBSTITUTED ALCOHOL DEHYDROGENASE AT 2.1 ANGSTROMS RESOLUTION | OXIDOREDUCTASE(NAD(A)-CHOH(D))
2oxi:B (LYS5) to (ALA29) REFINED CRYSTAL STRUCTURE OF CU-SUBSTITUTED ALCOHOL DEHYDROGENASE AT 2.1 ANGSTROMS RESOLUTION | OXIDOREDUCTASE(NAD(A)-CHOH(D))
4h8s:B (GLN279) to (THR304) CRYSTAL STRUCTURE OF HUMAN APPL2BARPH DOMAIN | BAR DOMAIN, PLECKSTRIN HOMOLOGY DOMAIN, ADAPTOR PROTEIN, RAB BINDING, SIGNALING PROTEIN
1axe:B (LYS5) to (PRO30) CRYSTAL STRUCTURE OF THE ACTIVE-SITE MUTANT PHE93->TRP OF HORSE LIVER ALCOHOL DEHYDROGENASE IN COMPLEX WITH NAD AND INHIBITOR TRIFLUOROETHANOL | OXIDOREDUCTASE (NAD(A)-CHOH(D)), ALCOHOL DEHYDROGENASE
1axg:D (LYS5) to (ALA29) CRYSTAL STRUCTURE OF THE VAL203->ALA MUTANT OF LIVER ALCOHOL DEHYDROGENASE COMPLEXED WITH COFACTOR NAD AND INHIBITOR TRIFLUOROETHANOL SOLVED TO 2.5 ANGSTROM RESOLUTION | OXIDOREDUCTASE (NAD(A)-CHOH(D)), ALCOHOL DEHYDROGENASE
4wtv:A (PRO205) to (LEU258) CRYSTAL STRUCTURE OF THE PHOSPHATIDYLINOSITOL 4-KINASE IIBETA | LIPID KINASE, PHOSPHATIDYL INOSITOL, TRANSFERASE, HYDROLASE
4wtv:B (PRO205) to (GLY262) CRYSTAL STRUCTURE OF THE PHOSPHATIDYLINOSITOL 4-KINASE IIBETA | LIPID KINASE, PHOSPHATIDYL INOSITOL, TRANSFERASE, HYDROLASE
1b34:B (VAL66) to (PHE100) CRYSTAL STRUCTURE OF THE D1D2 SUB-COMPLEX FROM THE HUMAN SNRNP CORE DOMAIN | SNRNP, SPLICING, SPLICEOSOME, SM, CORE SNRNP DOMAIN, SYSTEMIC LUPUS ERYTHEMATOSUS, SLE, RNA BINDING PROTEIN
3eqp:B (GLY138) to (LEU160) CRYSTAL STRUCTURE OF ACK1 WITH COMPOUND T95 | ACK1, ALTERNATIVE SPLICING, ATP-BINDING, CELL MEMBRANE, KINASE, MAGNESIUM, MEMBRANE, METAL-BINDING, NUCLEOTIDE- BINDING, PHOSPHOPROTEIN, POLYMORPHISM, SH3 DOMAIN, TRANSFERASE, TYROSINE-PROTEIN KINASE
3eqp:A (GLY138) to (LEU160) CRYSTAL STRUCTURE OF ACK1 WITH COMPOUND T95 | ACK1, ALTERNATIVE SPLICING, ATP-BINDING, CELL MEMBRANE, KINASE, MAGNESIUM, MEMBRANE, METAL-BINDING, NUCLEOTIDE- BINDING, PHOSPHOPROTEIN, POLYMORPHISM, SH3 DOMAIN, TRANSFERASE, TYROSINE-PROTEIN KINASE
2p3b:B (ARG57) to (GLY78) CRYSTAL STRUCTURE OF THE SUBTYPE B WILD TYPE HIV PROTEASE COMPLEXED WITH TL-3 INHIBITOR | WILD TYPE SUBTYPE B HIV PROTEASE, TL-3 INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3eqr:A (GLY138) to (CYS159) CRYSTAL STRUCTURE OF ACK1 WITH COMPOUND T74 | ACK1, ALTERNATIVE SPLICING, ATP-BINDING, CELL MEMBRANE, KINASE, MAGNESIUM, MEMBRANE, METAL-BINDING, NUCLEOTIDE- BINDING, PHOSPHOPROTEIN, POLYMORPHISM, SH3 DOMAIN, TRANSFERASE, TYROSINE-PROTEIN KINASE
3er3:E (ASP83) to (ALA104) THE ACTIVE SITE OF ASPARTIC PROTEINASES | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3er5:E (ASP83) to (ALA104) THE ACTIVE SITE OF ASPARTIC PROTEINASES | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3s1s:A (THR45) to (ILE63) CHARACTERIZATION AND CRYSTAL STRUCTURE OF THE TYPE IIG RESTRICTION ENDONUCLEASE BPUSI | PD--(D/E)XK CATALYTIC MOTIF, GAMMA-N6M-ADENOSINE METHYLTRANSFERASE, S-ADENOSYL-METHIONINE BINDING, HYDROLASE, TRANSFERASE
3esg:A (ALA3) to (ASP30) CRYSTAL STRUCTURE OF HUTD FROM PSEUDOMONAS FLUORESCENS SBW25 | BETA BARREL, UNKNOWN FUNCTION
1b5f:A (PHE83) to (ILE102) NATIVE CARDOSIN A FROM CYNARA CARDUNCULUS L. | HYDROLASE, ASPARTIC PROTEINASE
1b6k:A (ARG57) to (GLY78) HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 5 | COMPLEX (ACID PROTEINASE/PEPTIDE), HYDROLASE/HYDROLASE INHIBITOR COMPLEX
1b6k:B (ARG157) to (GLY178) HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 5 | COMPLEX (ACID PROTEINASE/PEPTIDE), HYDROLASE/HYDROLASE INHIBITOR COMPLEX
1b6j:A (ARG57) to (GLY78) HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 1 | COMPLEX (ACID PROTEINASE-PEPTIDE), HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1b6l:A (ARG57) to (GLY78) HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 4 | COMPLEX (ACID PROTEINASE/PEPTIDE), HYDROLASE/HYDROLASE INHIBITOR COMPLEX
1b6l:B (ARG157) to (GLY178) HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 4 | COMPLEX (ACID PROTEINASE/PEPTIDE), HYDROLASE/HYDROLASE INHIBITOR COMPLEX
1b6m:A (ARG57) to (GLY78) HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 6 | COMPLEX (ACID PROTEINASE-PEPTIDE), HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1b6m:B (ARG157) to (GLY178) HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 6 | COMPLEX (ACID PROTEINASE-PEPTIDE), HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1b6p:A (ARG57) to (GLY78) HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 7 | COMPLEX (ACID PROTEINASE/PEPTIDE), HYDROLASE/HYDROLASE INHIBITOR COMPLEX
1b6p:B (ARG157) to (GLY178) HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 7 | COMPLEX (ACID PROTEINASE/PEPTIDE), HYDROLASE/HYDROLASE INHIBITOR COMPLEX
1bdq:B (GLY52) to (GLY78) HIV-1 (2:31-37, 47, 82) PROTEASE COMPLEXED WITH INHIBITOR SB203386 | HYDROLASE, AIDS, POLYPROTEIN, ASPARTYL PROTEASE, ACID PROTEASE, HYDROXYETHYLENE ISOSTERE INHIBITOR, SUBSTRATE ANALOGUE INHIBITOR
2biw:D (LYS314) to (ASP353) CRYSTAL STRUCTURE OF APOCAROTENOID CLEAVAGE OXYGENASE FROM SYNECHOCYSTIS, NATIVE ENZYME | OXYGENASE, NON-HEME IRON, CAROTENOID CLEAVAGE, RETINAL FORMATION, OXIDOREDUCTASE, DIOXYGENASE
3s40:B (ASN175) to (VAL195) THE CRYSTAL STRUCTURE OF A DIACYLGLYCEROL KINASES FROM BACILLUS ANTHRACIS STR. STERNE | DIACYLGLYCEROL KINASES, STRUCTURAL GENOMICS, THE CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, TRANSFERASE
2bjr:A (ASN311) to (ASP329) CRYSTAL STRUCTURE OF THE NEMATODE SPERM CELL MOTILITY PROTEIN MFP2B | MOTILITY, ASCARIS, NEMATODE, MSP
2bjr:B (ASN311) to (ASP329) CRYSTAL STRUCTURE OF THE NEMATODE SPERM CELL MOTILITY PROTEIN MFP2B | MOTILITY, ASCARIS, NEMATODE, MSP
2pd0:A (TYR78) to (PHE98) PROTEIN CGD2_2020 FROM CRYPTOSPORIDIUM PARVUM | STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, UNKNOWN FUNCTION
2pd0:C (TYR78) to (PHE98) PROTEIN CGD2_2020 FROM CRYPTOSPORIDIUM PARVUM | STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, UNKNOWN FUNCTION
1o6y:A (ARG10) to (ARG32) CATALYTIC DOMAIN OF PKNB KINASE FROM MYCOBACTERIUM TUBERCULOSIS | SERINE/THREONINE PROTEIN KINASE, TRANSFERASE, PSI, PROTEIN STRUCTURE INITIATIVE, TB STRUCTURAL GENOMICS CONSORTIUM, TB, TBSGC
2bpx:A (ARG57) to (GLY78) HIV-1 PROTEASE-INHIBITOR COMPLEX | ACID PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3s85:F (ARG57) to (GLY78) DISCOVERY OF NEW HIV PROTEASE INHIBITORS WITH POTENTIAL FOR CONVENIENT DOSING AND REDUCED SIDE EFFECTS: A-790742 AND A-792611. | BETA BARREL, ACID PROTEASE, ASPARTIC-TYPE ENDOPEPIDASE ACTIVITY, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3s85:L (ARG57) to (GLY78) DISCOVERY OF NEW HIV PROTEASE INHIBITORS WITH POTENTIAL FOR CONVENIENT DOSING AND REDUCED SIDE EFFECTS: A-790742 AND A-792611. | BETA BARREL, ACID PROTEASE, ASPARTIC-TYPE ENDOPEPIDASE ACTIVITY, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1bto:A (LYS5) to (ALA29) HORSE LIVER ALCOHOL DEHYDROGENASE COMPLEXED TO NADH AND (1S, 3R)3-BUTYLTHIOLANE 1-OXIDE | OXIDOREDUCTASE, ALCOHOL, NICOTINAMIDE COENZYME, SULFOXIDE
1bto:B (LYS5) to (ALA29) HORSE LIVER ALCOHOL DEHYDROGENASE COMPLEXED TO NADH AND (1S, 3R)3-BUTYLTHIOLANE 1-OXIDE | OXIDOREDUCTASE, ALCOHOL, NICOTINAMIDE COENZYME, SULFOXIDE
1bto:C (LYS5) to (PRO30) HORSE LIVER ALCOHOL DEHYDROGENASE COMPLEXED TO NADH AND (1S, 3R)3-BUTYLTHIOLANE 1-OXIDE | OXIDOREDUCTASE, ALCOHOL, NICOTINAMIDE COENZYME, SULFOXIDE
1bto:D (LYS5) to (PRO30) HORSE LIVER ALCOHOL DEHYDROGENASE COMPLEXED TO NADH AND (1S, 3R)3-BUTYLTHIOLANE 1-OXIDE | OXIDOREDUCTASE, ALCOHOL, NICOTINAMIDE COENZYME, SULFOXIDE
1bwb:B (ARG57) to (GLY78) HIV-1 PROTEASE (V82F/I84V) DOUBLE MUTANT COMPLEXED WITH SD146 OF DUPONT PHARMACEUTICALS | HIV-1 PROTEASE, HYDROLASE
3sa4:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH AF72 | HIV-1 PROTEASE, DRUG RESISTANCE, DRUG DESIGN, PROTEASE INHIBITORS, AIDS, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sa5:B (ARG57) to (GLY78) CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH AF69 | HIV-1 PROTEASE, DRUG RESISTANCE, DRUG DESIGN, PROTEASE INHIBITORS, AIDS, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sa6:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH AF71 | HIV-1 PROTEASE, DRUG RESISTANCE, DRUG DESIGN, PROTEASE INHIBITORS, AIDS, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sa8:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH KB83 | HIV-1 PROTEASE, DRUG RESISTANCE, DRUG DESIGN, PROTEASE INHIBITORS, AIDS, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3saa:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH AF77 | HIV-1 PROTEASE, DRUG RESISTANCE, DRUG DESIGN, PROTEASE INHIBITORS, AIDS, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sac:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH AF80 | HIV-1 PROTEASE, DRUG RESISTANCE, DRUG DESIGN, PROTEASE INHIBITORS, AIDS, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hsa:A (HIS86) to (GLY120) STRUCTURE OF INTERLEUKIN 17A IN COMPLEX WITH IL17RA RECEPTOR | CYTOKINE RECEPTOR, GLYCOSYLATION, IMMUNE SYSTEM-PROTEIN BINDING COMPLEX
4hsa:B (ILE92) to (GLY120) STRUCTURE OF INTERLEUKIN 17A IN COMPLEX WITH IL17RA RECEPTOR | CYTOKINE RECEPTOR, GLYCOSYLATION, IMMUNE SYSTEM-PROTEIN BINDING COMPLEX
4hsa:D (HIS86) to (GLY120) STRUCTURE OF INTERLEUKIN 17A IN COMPLEX WITH IL17RA RECEPTOR | CYTOKINE RECEPTOR, GLYCOSYLATION, IMMUNE SYSTEM-PROTEIN BINDING COMPLEX
4hsp:A (GLY141) to (GLN160) CRYSTAL STRUCTURE OF A DUF3299 FAMILY PROTEIN (PA4066) FROM PSEUDOMONAS AERUGINOSA PAO1 AT 2.45 A RESOLUTION | PF11736 FAMILY PROTEIN, DUF3299, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI- BIOLOGY, UNKNOWN FUNCTION, STRUCTURAL GENOMICS UNKNOWN FUNCTION
1bxo:A (ASN84) to (ALA105) ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL CYCLO[(2S)-2-[[(1R)-1-(N-(L-N-(3- METHYLBUTANOYL)VALYL-L-ASPARTYL)AMINO)-3-METHYLBUT YL] HYDROXYPHOSPHINYLOXY]-3-(3-AMINOMETHYL) PHENYLPROPANOATE | HYDROLASE, PHOSPHONATE INHIBITORS, MACROCYCLE
4xb2:B (ASN244) to (SER264) HYPERTHERMOPHILIC ARCHAEAL HOMOSERINE DEHYDROGENASE MUTANT IN COMPLEX WITH NADPH | ROSSMANN FOLD, OXIDOREDUCTASE
1odw:A (ARG57) to (GLY78) NATIVE HIV-1 PROTEINASE | PROTEINASE, RETROPEPSIN, RETROVIRUS, HIV, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1odx:A (ARG57) to (GLY78) HIV-1 PROTEINASE MUTANT A71T, V82A | PROTEINASE, RETROPEPSIN, RETROVIRUS, HIV, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hvp:A (ARG57) to (GLY78) STRUCTURE OF COMPLEX OF SYNTHETIC HIV-1 PROTEASE WITH A SUBSTRATE- BASED INHIBITOR AT 2.3 ANGSTROMS RESOLUTION | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1c0i:A (HIS1086) to (HIS1138) CRYSTAL STRUCTURE OF D-AMINO ACID OXIDASE IN COMPLEX WITH TWO ANTHRANYLATE MOLECULES | FLAVIN CONTAINING PROTEIN, ALPHA-BETA-ALPHA MOTIF, OXIDOREDUCTASE
1oew:A (ASP87) to (ALA108) ATOMIC RESOLUTION STRUCTURE OF NATIVE ENDOTHIAPEPSIN | HYDROLASE, ASPARTIC PROTEINASE MECHANISM, ATOMIC RESOLUTION, SUCCINIMIDE, ANISOTROPIC REFINEMENT
1oex:A (ASP87) to (ALA108) ATOMIC RESOLUTION STRUCTURE OF ENDOTHIAPEPSIN IN COMPLEX WITH A HYDROXYETHYLENE TRANSITION STATE ANALOGUE INHIBITOR H261 | ASPARTIC PROTEINASE MECHANISM, ATOMIC RESOLUTION, SUCCINIMIDE, ANISOTROPIC REFINEMENT, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
2pk6:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K, L33I, L63I) IN COMPLEX WITH KNI-10033 | PROTEASE COMPLEX, VIRAL PROTEIN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
2pl5:A (LYS13) to (GLY39) CRYSTAL STRUCTURE OF HOMOSERINE O-ACETYLTRANSFERASE FROM LEPTOSPIRA INTERROGANS | HOMOSERINE O-ACETYLTRANSFERASE, ALPHA/BETA HYDROLASE SUPERFAMILY, TRANSFERASE
4xfp:A (PHE17) to (ASN48) CRYSTAL STRUCTURE OF HIGHLY ACTIVE MUTANT OF BACILLUS SP. TB-90 URATE OXIDASE | ENZYME, PROTEIN ENGINEERING, FLEXIBLE LOOP, OXIDOREDUCTASE
4xfp:B (PHE17) to (ASN48) CRYSTAL STRUCTURE OF HIGHLY ACTIVE MUTANT OF BACILLUS SP. TB-90 URATE OXIDASE | ENZYME, PROTEIN ENGINEERING, FLEXIBLE LOOP, OXIDOREDUCTASE
4xfp:C (PHE17) to (ASN48) CRYSTAL STRUCTURE OF HIGHLY ACTIVE MUTANT OF BACILLUS SP. TB-90 URATE OXIDASE | ENZYME, PROTEIN ENGINEERING, FLEXIBLE LOOP, OXIDOREDUCTASE
4xfp:D (PHE17) to (ASN48) CRYSTAL STRUCTURE OF HIGHLY ACTIVE MUTANT OF BACILLUS SP. TB-90 URATE OXIDASE | ENZYME, PROTEIN ENGINEERING, FLEXIBLE LOOP, OXIDOREDUCTASE
3sez:A (VAL90) to (HIS111) CRYSTAL STRUCTURE OF C176A MUTANT OF GLUTAMINE-DEPENDENT NAD+ SYNTHETASE FROM M. TUBERCULOSIS IN COMPLEX WITH ATP AND NAAD+ | GLUTAMINE-AMIDOTRANSFERASE, GLUTAMINASE, GLUTAMINE-DEPENDENT NAD+ SYNTHETASE, LIGASE, AMMONIA TUNNELING, ATP BINDING, NAD, NUCLEOTIDE BINDING
3sez:C (VAL90) to (HIS111) CRYSTAL STRUCTURE OF C176A MUTANT OF GLUTAMINE-DEPENDENT NAD+ SYNTHETASE FROM M. TUBERCULOSIS IN COMPLEX WITH ATP AND NAAD+ | GLUTAMINE-AMIDOTRANSFERASE, GLUTAMINASE, GLUTAMINE-DEPENDENT NAD+ SYNTHETASE, LIGASE, AMMONIA TUNNELING, ATP BINDING, NAD, NUCLEOTIDE BINDING
1c9h:A (GLN20) to (PHE48) CRYSTAL STRUCTURE OF FKBP12.6 IN COMPLEX WITH RAPAMYCIN | FKBP12, RAPAMYCIN, COMPLEX, RYANODINE RECEPTOR, IMMUNE SYSTEM
2psu:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF WILD TYPE HIV-1 PROTEASE IN COMPLEX WITH CARB- AD37 | DRUG DESIGN, HIV-1 PROTEASE, PROTEASE INHIBITOR, HYDROLASE
2psv:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF WILD TYPE HIV-1 PROTEASE IN COMPLEX WITH CARB- KB45 | DRUG DESIGN, HIV-1 PROTEASE, PROTEASE INHIBITORS, HYDROLASE
2pvy:D (GLN494) to (MET518) CRYSTAL STRUCURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED CRANIOSYNOSTOSIS SYNDROME. | KINASE DOMAIN FOLD CONSISTING OF N- AND C-LOBES, TRANSFERASE
3fnu:B (TRP190) to (SER216) CRYSTAL STRUCTURE OF KNI-10006 BOUND HISTO-ASPARTIC PROTEASE (HAP) FROM PLASMODIUM FALCIPARUM | HISTO-ASPARTIC PROTEASE,HYDROLASE, PLASMEPSIN, ASPARTIC PROTEASE, KNI, KNI-10006, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1oro:A (VAL17) to (ALA37) A FLEXIBLE LOOP AT THE DIMER INTERFACE IS A PART OF THE ACTIVE SITE OF THE ADJACENT MONOMER OF ESCHERICHIA COLI OROTATE PHOSPHORIBOSYLTRANSFERASE | PYRIMIDINE NUCLEOTIDE BIOSYNTHESIS, INHIBITOR-ENZYME COMPLEX, PHOSPHORIBOSYLTRANSFERASE
4i8w:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF WILD TYPE HIV-1 PROTEASE IN COMPLEX WITH NON- PEPTIDIC INHIBITOR, GRL007 | HIV-1 PROTEASE, HIV-1 PROTEASE-INHIBITOR COMPLEX, HYDROLASE, GRL007, PROTEASE INHIBITOR, NON-PEPTIDIC PROTEASE INHIBITOR, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
2c6s:A (ASN141) to (PRO171) HUMAN ADENOVIRUS PENTON BASE 2 12 CHIMERA | VIRUS/VIRAL PROTEIN, ADENOVIRUS, CAPSID, PENTON, DODECAHEDRA, FIBER, VIRAL PROTEIN
2c6s:B (ASN141) to (PRO171) HUMAN ADENOVIRUS PENTON BASE 2 12 CHIMERA | VIRUS/VIRAL PROTEIN, ADENOVIRUS, CAPSID, PENTON, DODECAHEDRA, FIBER, VIRAL PROTEIN
2c6s:C (ASN141) to (PRO171) HUMAN ADENOVIRUS PENTON BASE 2 12 CHIMERA | VIRUS/VIRAL PROTEIN, ADENOVIRUS, CAPSID, PENTON, DODECAHEDRA, FIBER, VIRAL PROTEIN
2c6s:D (ASN141) to (PRO171) HUMAN ADENOVIRUS PENTON BASE 2 12 CHIMERA | VIRUS/VIRAL PROTEIN, ADENOVIRUS, CAPSID, PENTON, DODECAHEDRA, FIBER, VIRAL PROTEIN
2c6s:E (ASN141) to (PRO171) HUMAN ADENOVIRUS PENTON BASE 2 12 CHIMERA | VIRUS/VIRAL PROTEIN, ADENOVIRUS, CAPSID, PENTON, DODECAHEDRA, FIBER, VIRAL PROTEIN
2c6s:F (ASN141) to (PRO171) HUMAN ADENOVIRUS PENTON BASE 2 12 CHIMERA | VIRUS/VIRAL PROTEIN, ADENOVIRUS, CAPSID, PENTON, DODECAHEDRA, FIBER, VIRAL PROTEIN
2c6s:G (ASN141) to (PRO171) HUMAN ADENOVIRUS PENTON BASE 2 12 CHIMERA | VIRUS/VIRAL PROTEIN, ADENOVIRUS, CAPSID, PENTON, DODECAHEDRA, FIBER, VIRAL PROTEIN
2c6s:H (ASN141) to (PRO171) HUMAN ADENOVIRUS PENTON BASE 2 12 CHIMERA | VIRUS/VIRAL PROTEIN, ADENOVIRUS, CAPSID, PENTON, DODECAHEDRA, FIBER, VIRAL PROTEIN
2c6s:I (ASN141) to (PRO171) HUMAN ADENOVIRUS PENTON BASE 2 12 CHIMERA | VIRUS/VIRAL PROTEIN, ADENOVIRUS, CAPSID, PENTON, DODECAHEDRA, FIBER, VIRAL PROTEIN
2c6s:J (ASN141) to (PRO171) HUMAN ADENOVIRUS PENTON BASE 2 12 CHIMERA | VIRUS/VIRAL PROTEIN, ADENOVIRUS, CAPSID, PENTON, DODECAHEDRA, FIBER, VIRAL PROTEIN
2c6s:K (ASN141) to (PRO171) HUMAN ADENOVIRUS PENTON BASE 2 12 CHIMERA | VIRUS/VIRAL PROTEIN, ADENOVIRUS, CAPSID, PENTON, DODECAHEDRA, FIBER, VIRAL PROTEIN
2c6s:L (ASN141) to (PRO171) HUMAN ADENOVIRUS PENTON BASE 2 12 CHIMERA | VIRUS/VIRAL PROTEIN, ADENOVIRUS, CAPSID, PENTON, DODECAHEDRA, FIBER, VIRAL PROTEIN
2c6s:M (ASN141) to (PRO171) HUMAN ADENOVIRUS PENTON BASE 2 12 CHIMERA | VIRUS/VIRAL PROTEIN, ADENOVIRUS, CAPSID, PENTON, DODECAHEDRA, FIBER, VIRAL PROTEIN
2c6s:N (ASN141) to (PRO171) HUMAN ADENOVIRUS PENTON BASE 2 12 CHIMERA | VIRUS/VIRAL PROTEIN, ADENOVIRUS, CAPSID, PENTON, DODECAHEDRA, FIBER, VIRAL PROTEIN
2c6s:O (ASN141) to (PRO171) HUMAN ADENOVIRUS PENTON BASE 2 12 CHIMERA | VIRUS/VIRAL PROTEIN, ADENOVIRUS, CAPSID, PENTON, DODECAHEDRA, FIBER, VIRAL PROTEIN
1cpi:A (ARG57) to (GLY78) REGIOSELECTIVE STRUCTURAL AND FUNCTIONAL MIMICRY OF PEPTIDES. DESIGN OF HYDROLYTICALLY STABLE CYCLIC PEPTIDOMIMETIC INHIBITORS OF HIV-1 PROTEASE | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ibm:B (GLY1008) to (VAL1032) CRYSTAL STRUCTURE OF INSULIN RECEPTOR KINASE DOMAIN IN COMPLEX WITH AN INHIBITOR IRFIN-1 | IRK, KINASE, ATP BINDING, PHOSPHORYLATION, MEMBRANE, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX
3ftn:C (MET1) to (GLU18) Q165E/S254K DOUBLE MUTANT CHIMERA OF ALCOHOL DEHYDROGENASE BY EXCHANGE OF THE COFACTOR BINDING DOMAIN RES 153-295 OF T. BROCKII ADH BY C. BEIJERINCKII ADH | OXYDOREDUCTASE, BACTERIAL ALCOHOL DEHYDROGENASE, DOMAIN EXCHANGE, CHIMERA, METAL-BINDING, NADP, OXIDOREDUCTASE, ZINC
4ic1:A (ASN74) to (ARG103) CRYSTAL STRUCTURE OF SSO0001 | CAS4, CRISPR, MCSG, EXONUCLEASE, PSI-BIOLOGY, STRUCTURAL GENOMICS, UNKNOWN FUNCTION
4ic1:C (ASN74) to (ARG103) CRYSTAL STRUCTURE OF SSO0001 | CAS4, CRISPR, MCSG, EXONUCLEASE, PSI-BIOLOGY, STRUCTURAL GENOMICS, UNKNOWN FUNCTION
4ic1:I (ASN74) to (ASN104) CRYSTAL STRUCTURE OF SSO0001 | CAS4, CRISPR, MCSG, EXONUCLEASE, PSI-BIOLOGY, STRUCTURAL GENOMICS, UNKNOWN FUNCTION
4xlr:M (GLY18) to (PRO41) CRYSTAL STRUCTURE OF T.AQUATICUS TRANSCRIPTION INITIATION COMPLEX WITH CARD CONTAINING BUBBLE PROMOTER AND RNA | PROTEIN-DNA COMPLEX, BACTERIAL TRANSCRIPTION INITIATION COMPLEX, TRANSCRIPTION-DNA COMPLEX
4xlr:N (GLY18) to (PRO41) CRYSTAL STRUCTURE OF T.AQUATICUS TRANSCRIPTION INITIATION COMPLEX WITH CARD CONTAINING BUBBLE PROMOTER AND RNA | PROTEIN-DNA COMPLEX, BACTERIAL TRANSCRIPTION INITIATION COMPLEX, TRANSCRIPTION-DNA COMPLEX
2c9f:A (ASN141) to (PRO171) THE QUASI-ATOMIC MODEL OF THE ADENOVIRUS TYPE 3 PENTON DODECAHEDRON | VIRUS-VIRAL PROTEIN COMPLEX, DODECAHEDRON, PENTON, FIBRE
2c9f:B (ASN141) to (PRO171) THE QUASI-ATOMIC MODEL OF THE ADENOVIRUS TYPE 3 PENTON DODECAHEDRON | VIRUS-VIRAL PROTEIN COMPLEX, DODECAHEDRON, PENTON, FIBRE
2c9f:C (ASN141) to (PRO171) THE QUASI-ATOMIC MODEL OF THE ADENOVIRUS TYPE 3 PENTON DODECAHEDRON | VIRUS-VIRAL PROTEIN COMPLEX, DODECAHEDRON, PENTON, FIBRE
2c9f:D (ASN141) to (PRO171) THE QUASI-ATOMIC MODEL OF THE ADENOVIRUS TYPE 3 PENTON DODECAHEDRON | VIRUS-VIRAL PROTEIN COMPLEX, DODECAHEDRON, PENTON, FIBRE
2c9f:E (ASN141) to (PRO171) THE QUASI-ATOMIC MODEL OF THE ADENOVIRUS TYPE 3 PENTON DODECAHEDRON | VIRUS-VIRAL PROTEIN COMPLEX, DODECAHEDRON, PENTON, FIBRE
4xme:A (ALA82) to (THR110) CRYSTAL STRUCTURE OF NITROPHORIN 7 FROM RHODNIUS PROLIXUS AT PH 7.8 COMPLEXED WITH NO | HEME, NO TRANSPORTER, OXIDOREDUCTASE, TRANSPORT PROTEIN
4xmg:A (ALA82) to (VAL111) CRYSTAL STRUCTURE OF NITROPHORIN 7 FROM RHODNIUS PROLIXUS AT PH 7.8 COMPLEXED WITH IMIDAZOLE | HEME, NO TRANSPORTER, OXIDOREDUCTASE, TRANSPORT PROTEIN
4xmh:A (ALA82) to (VAL111) CRYSTAL STRUCTURE OF NITROPHORIN 7 FROM RHODNIUS PROLIXUS AT PH 7.8 COMPLEXED WITH GLY-GLY-GLY | HEME, NO TRANSPORTER, OXIDOREDUCTASE, TRANSPORT PROTEIN
1p12:E (THR163) to (ASN184) CRYSTAL STRUCTURES OF ALPHA-LYTIC PROTEASE COMPLEXES WITH IRREVERSIBLY BOUND PHOSPHONATE ESTERS | SERINE PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1p1r:B (LYS5) to (PRO30) HORSE LIVER ALCOHOL DEHYDROGENASE COMPLEXED WITH NADH AND R- N-1-METHYLHEXYLFORMAMIDE | PUCKERED REDUCED NICOTINAMIDE RING, MICHAELIS COMPLEX ANALOGUE, FORMAMIDE, OXIDOREDUCTASE
1p1r:D (LYS5) to (PRO30) HORSE LIVER ALCOHOL DEHYDROGENASE COMPLEXED WITH NADH AND R- N-1-METHYLHEXYLFORMAMIDE | PUCKERED REDUCED NICOTINAMIDE RING, MICHAELIS COMPLEX ANALOGUE, FORMAMIDE, OXIDOREDUCTASE
3g0f:B (GLY601) to (MET624) KIT KINASE DOMAIN MUTANT D816H IN COMPLEX WITH SUNITINIB | KIT KINASE DOMAIN, SUTENT BINDING, DRUG RESISTANCE, ATP- BINDING, DISEASE MUTATION, GLYCOPROTEIN, IMMUNOGLOBULIN DOMAIN, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, PROTO-ONCOGENE, RECEPTOR, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE, TRANSFERASE
1p4o:A (GLY981) to (VAL1005) STRUCTURE OF APO UNACTIVATED IGF-1R KINASE DOMAIN AT 1.5A RESOLUTION. | IGF-1R, KINASE DOMAIN, HORMONE-GROWTH FACTOR COMPLEX
1p4o:B (GLY981) to (VAL1005) STRUCTURE OF APO UNACTIVATED IGF-1R KINASE DOMAIN AT 1.5A RESOLUTION. | IGF-1R, KINASE DOMAIN, HORMONE-GROWTH FACTOR COMPLEX
1p5q:C (ILE169) to (GLU191) CRYSTAL STRUCTURE OF FKBP52 C-TERMINAL DOMAIN | ISOMERASE
1d4k:B (ARG57) to (GLY78) HIV-1 PROTEASE COMPLEXED WITH A MACROCYCLIC PEPTIDOMIMETIC INHIBITOR | HIV, PROTEASE, INHIBITOR, ANTIVIRAL, STRUCTURE, HYDROLASE
1d4j:A (ARG57) to (GLY78) HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR MSL370 | DIMER, HYDROLASE
1d4l:A (ARG57) to (GLY78) HIV-1 PROTEASE COMPLEXED WITH A MACROCYCLIC PEPTIDOMIMETIC INHIBITOR | HIV, PROTEASE, INHIBITOR, ANTIVIRAL, STRUCTURE, HYDROLASE
3syt:A (VAL90) to (HIS111) CRYSTAL STRUCTURE OF GLUTAMINE-DEPENDENT NAD+ SYNTHETASE FROM M. TUBERCULOSIS BOUND TO AMP/PPI, NAD+, AND GLUTAMATE | GLUTAMINE-AMIDOTRANSFERASE, GLUTAMINASE, GLUTAMINE-DEPENDENT NAD+ SYNTHETASE, LIGASE, AMMONIA TUNNELING, ATP BINDING, NAD, NUCLEOTIDE BINDING
1d7f:A (ASP585) to (PRO643) CRYSTAL STRUCTURE OF ASPARAGINE 233-REPLACED CYCLODEXTRIN GLUCANOTRANSFERASE FROM ALKALOPHILIC BACILLUS SP. 1011 DETERMINED AT 1.9 A RESOLUTION | CYCLODEXTRIN GLUCANOTRANSFERASE, CGTASE, TRANSFERASE
2qhy:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-1-AC86 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE | DRUG DESIGN, HIV-1 PROTEASE, PROTEASE INHIBITORS, HYDROLASE
2qhz:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-1-AC87 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE | DRUG DESIGN, HIV-1 PROTEASE, PROTEASE INHIBITORS, HYDROLASE
2qi0:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-1-KK80 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE | DRUG DESIGN, HIV-1 PROTEASE, PROTEASE INHIBITORS, HYDROLASE
2qi1:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-1-KK81 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE | DRUG DESIGN, HIV-1 PROTEASE, PROTEASE INHIBITORS, HYDROLASE
2qi3:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-2-AD94 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE | DRUG DESIGN, HIV-1 PROTEASE, PROTEASE INHIBITORS, HYDROLASE
2qi4:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-2-AD93 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE | DRUG DESIGN, HIV-1 PROTEASE, PROTEASE INHIBITORS, HYDROLASE
2qi6:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-2-KB98 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE | DRUG DESIGN, HIV-1 PROTEASE, PROTEASE INHIBITORS, HYDROLASE
2qi7:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-2-AD86 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE | DRUG DESIGN, HIV-1 PROTEASE, PROTEASE INHIBITORS, HYDROLASE
1ded:B (ASP585) to (PRO643) CRYSTAL STRUCTURE OF ALKALOPHILIC ASPARAGINE 233-REPLACED CYCLODEXTRIN GLUCANOTRANSFERASE COMPLEXED WITH AN INHIBITOR, ACARBOSE, AT 2.0 A RESOLUTION | CYCLODEXTRIN GLUCANOTRANSFERASE, CGTASE, ACARBOSE, TRANSFERASE
3t1e:A (ARG484) to (ASN507) THE STRUCTURE OF THE NEWCASTLE DISEASE VIRUS HEMAGGLUTININ- NEURAMINIDASE (HN) ECTODOMAIN REVEALS A 4-HELIX BUNDLE STALK | BETA-PROPELLER, 4 HELIX BUNDLE, HEMAGGLUTININ, NEURAMINIDASE, MEMBRANE PROTEIN, ECTODOMAIN, HYDROLASE
3t1e:B (ARG484) to (ASN507) THE STRUCTURE OF THE NEWCASTLE DISEASE VIRUS HEMAGGLUTININ- NEURAMINIDASE (HN) ECTODOMAIN REVEALS A 4-HELIX BUNDLE STALK | BETA-PROPELLER, 4 HELIX BUNDLE, HEMAGGLUTININ, NEURAMINIDASE, MEMBRANE PROTEIN, ECTODOMAIN, HYDROLASE
2coa:A (LEU9) to (CYS33) SOLUTION STRUCTURE OF THE PH DOMAIN OF PROTEIN KINASE C, D2 TYPE FROM HUMAN | PROTEIN KINASE D2, PH DOMAIN, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, SIGNALING PROTEIN
1pfz:B (ILE14) to (THR35) PROPLASMEPSIN II FROM PLASMODIUM FALCIPARUM | ASPARTIC PROTEINASE ZYMOGEN, HEMOGLOBINASE, MALARIA, HYDROLASE, ASPARTYL PROTEASE, GLYCOPROTEIN, ASPARTIC PROTEASE ZYMOGEN
4iq2:B (GLN20) to (ARG49) P21 CRYSTAL FORM OF FKBP12.6 | FKBP12.6, ISOMERASE
1pkg:B (GLY601) to (LEU625) STRUCTURE OF A C-KIT KINASE PRODUCT COMPLEX | KINASE, AUTOPHOSPHORYLATION, TRANSACTIVATION, TRANSFERASE ACTIVATOR
4xw4:A (ASP44) to (GLU64) X-RAY STRUCTURE OF PKAC WITH AMPPNP, SP20, CALCIUM IONS | PROTEIN KINASE A, PHOSPHORYLATION, CATALYTIC SUBUNIT, REACTANT COMPLEX, TRANSFERASE
4iss:B (PRO568) to (GLU588) SEMET-SUBSTITUTED KLUYVEROMYCES LACTIS ALLOPHANATE HYDROLASE | MIXED ALPHA AND BETA STRUCTURE, ALLOPHANATE BINDING, HYDROLASE
2qr0:C (THR71) to (LYS101) STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS | VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM
2qr0:D (THR71) to (LYS101) STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS | VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM
2qr0:I (THR71) to (LYS101) STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS | VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM
2qr0:J (THR71) to (LYS101) STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS | VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM
2qr0:O (THR71) to (LYS101) STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS | VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM
2qr0:P (THR71) to (LYS101) STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS | VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM
2qr0:U (THR71) to (LYS101) STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS | VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM
2qr0:V (THR71) to (LYS101) STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS | VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM
3gga:C (ARG57) to (GLY78) HIV PROTEASE INHIBITORS WITH PSEUDO-SYMMETRIC CORES | PSEUDO-SYMMETRICAL HIV PROTEASE INHIBITORS, HYDROLASE, PROTEASE
3ggv:A (ARG57) to (GLY78) HIV PROTEASE, PSEUDO-SYMMETRIC INHIBITORS | HIV PROTEASE, PSEUDO-SYMMETRIC INHIBITORS, HYDROLASE, PROTEASE
3ggv:C (ARG57) to (GLY78) HIV PROTEASE, PSEUDO-SYMMETRIC INHIBITORS | HIV PROTEASE, PSEUDO-SYMMETRIC INHIBITORS, HYDROLASE, PROTEASE
3ggv:D (ARG57) to (GLY78) HIV PROTEASE, PSEUDO-SYMMETRIC INHIBITORS | HIV PROTEASE, PSEUDO-SYMMETRIC INHIBITORS, HYDROLASE, PROTEASE
3ggv:E (ARG57) to (GLY78) HIV PROTEASE, PSEUDO-SYMMETRIC INHIBITORS | HIV PROTEASE, PSEUDO-SYMMETRIC INHIBITORS, HYDROLASE, PROTEASE
3ggv:H (ARG57) to (GLY78) HIV PROTEASE, PSEUDO-SYMMETRIC INHIBITORS | HIV PROTEASE, PSEUDO-SYMMETRIC INHIBITORS, HYDROLASE, PROTEASE
3gi0:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF A CHEMICALLY SYNTHESIZED 203 AMINO ACID 'COVALENT DIMER' [L-ALA51,D-ALA51'] HIV-1 PROTEASE MOLECULE COMPLEXED WITH JG- 365 INHIBITOR | BETA-BARREL, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3gi0:B (ARG161) to (GLY182) CRYSTAL STRUCTURE OF A CHEMICALLY SYNTHESIZED 203 AMINO ACID 'COVALENT DIMER' [L-ALA51,D-ALA51'] HIV-1 PROTEASE MOLECULE COMPLEXED WITH JG- 365 INHIBITOR | BETA-BARREL, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3gi4:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, KB60 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE | DRUG DESIGN, PROTEASE INHIBITORS, HIV-1 PROTEASE, ASPARTYL PROTEASE, HYDROLASE, PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3gi5:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, KB62 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE | DRUG DESIGN, PROTEASE INHIBITORS, HIV-1 PROTEASE, ASPARTYL PROTEASE, HYDROLASE, PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3gi6:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, AD78 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE | DRUG DESIGN, PROTEASE INHIBITORS, HIV-1 PROTEASE, ASPARTYL PROTEASE, HYDROLASE, PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3t7p:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH A HYDRAZIDE DERIVATIVE | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3t7q:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH AN INHIBITOR BASED ON THE GEWALD REACTION | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3t7x:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH AN INHIBITOR BASED ON THE GEWALD REACTION | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
2czj:C (GLU52) to (HIS82) CRYSTAL STRUCTURE OF THE TRNA DOMAIN OF TMRNA FROM THERMUS THERMOPHILUS HB8 | SMPB, TMRNA, SSRA RNA, 10SA RNA, TRNA, TRANS-TRANSLATION, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, RNA BINDING PROTEIN-RNA COMPLEX
1dys:A (PHE263) to (LYS310) ENDOGLUCANASE CEL6B FROM HUMICOLA INSOLENS | CELLULASE, HYDROLASE, CELLULOSE DEGRADATION, GLYCOSIDE HYDROLASE FAMILY 6
1pro:A (ARG57) to (GLY78) HIV-1 PROTEASE DIMER COMPLEXED WITH A-98881 | AIDS, POLYPROTEIN, HYDROLASE, ASPARTIC PROTEASE, ENDONUCLEASE, RNA-DIRECTED DNA POLYMERASE, HYDROLASE (ASPARTIC PROTEASE)
2quy:B (ASP26) to (ASP61) TRUNCATED MUTANT ASN175ALA OF PENICILLIN V ACYLASE FROM BACILLUS SPHAERICUS | PENICILLIN, AUTOPROTEOLYSIS, NTN, OXY-ANION HOLE, ANTIBIOTIC RESISTANCE, HYDROLASE, ZYMOGEN
2quy:G (ASP26) to (ASP61) TRUNCATED MUTANT ASN175ALA OF PENICILLIN V ACYLASE FROM BACILLUS SPHAERICUS | PENICILLIN, AUTOPROTEOLYSIS, NTN, OXY-ANION HOLE, ANTIBIOTIC RESISTANCE, HYDROLASE, ZYMOGEN
2qx3:A (ASN119) to (ASN144) STRUCTURE OF PECTATE LYASE II FROM XANTHOMONAS CAMPESTRIS PV. CAMPESTRIS STR. ATCC 33913 | PARALLEL BETA HELIX, LYASE
4y36:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 4 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
4y35:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 290 | FAGMENT SCREENING, HYDROLASE, INHIBITION
4y38:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B29 | FRAGMENT SCREENING, ASPARTIC PROTEASE INHIBITION, HYDROLASE
4y3a:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 181 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
4y3d:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 321 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
4y3e:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 5 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y3h:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 189 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y3j:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B30 | FRAGMENT SCREENING, ASPARTIC PROTEASE INHIBITION, HYDROLASE
4y3l:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 205 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y3m:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 103 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y3n:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 273 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
4y3t:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 207 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
4y3p:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 17 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
4y3q:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 109 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
4y3r:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 306 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
4y3s:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 266 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
3goh:A (GLU2) to (ASP22) CRYSTAL STRUCTURE OF ALCOHOL DEHYDROGENASE SUPERFAMILY PROTEIN (NP_718042.1) FROM SHEWANELLA ONEIDENSIS AT 1.55 A RESOLUTION | NP_718042.1, ALCOHOL DEHYDROGENASE SUPERFAMILY PROTEIN, ALCOHOL DEHYDROGENASE GROES-LIKE DOMAIN, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, OXIDOREDUCTASE
4y3w:A (ALA67) to (ASP92) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 35 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
4y3x:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 171 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y3y:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B42 | FRAGMENT SCREENING, ASPARTIC PROTEASE INHIBITION, HYDROLASE
3gos:A (SER231) to (ASP257) THE CRYSTAL STRUCTURE OF 2,3,4,5-TETRAHYDROPYRIDINE-2-CARBOXYLATE N- SUCCINYLTRANSFERASE FROM YERSINIA PESTIS CO92 | 2,3,4,5-TETRAHYDROPYRIDINE-2-CARBOXYLATE N-SUCCINYLTRANSFERASE, ACYLTRANSFERASE, AMINO-ACID BIOSYNTHESIS, DIAMINOPIMELATE BIOSYNTHESIS, LYSINE BIOSYNTHESIS, TRANSFERASE, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID
3gos:B (SER231) to (ASP257) THE CRYSTAL STRUCTURE OF 2,3,4,5-TETRAHYDROPYRIDINE-2-CARBOXYLATE N- SUCCINYLTRANSFERASE FROM YERSINIA PESTIS CO92 | 2,3,4,5-TETRAHYDROPYRIDINE-2-CARBOXYLATE N-SUCCINYLTRANSFERASE, ACYLTRANSFERASE, AMINO-ACID BIOSYNTHESIS, DIAMINOPIMELATE BIOSYNTHESIS, LYSINE BIOSYNTHESIS, TRANSFERASE, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID
3gos:C (SER231) to (ASP257) THE CRYSTAL STRUCTURE OF 2,3,4,5-TETRAHYDROPYRIDINE-2-CARBOXYLATE N- SUCCINYLTRANSFERASE FROM YERSINIA PESTIS CO92 | 2,3,4,5-TETRAHYDROPYRIDINE-2-CARBOXYLATE N-SUCCINYLTRANSFERASE, ACYLTRANSFERASE, AMINO-ACID BIOSYNTHESIS, DIAMINOPIMELATE BIOSYNTHESIS, LYSINE BIOSYNTHESIS, TRANSFERASE, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID
4y43:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 42 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y44:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 164 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y45:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 291 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y48:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B50 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y47:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 162 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y4b:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 323 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y4a:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 286 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y4c:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 158 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y4d:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B51 | FRAGMENT SCREENING, ASPARTIC PROTEASE INHIBITION, HYDROLASE
4y4e:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 131 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y4j:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B97 | FRAGMENT SCREENING, ASPARTIC PROTEASE INHIBITION, HYDROLASE
4y4t:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 114 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y4w:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 125 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
1e3x:A (ASP159) to (GLY177) NATIVE STRUCTURE OF CHIMAERIC AMYLASE FROM B. AMYLOLIQUEFACIENS AND B. LICHENIFORMIS AT 1.92A | HYDROLASE, AMYLASE, FAMILY 13
4y4z:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 73 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y51:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 52 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y53:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 54 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y54:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 56 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y56:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 58 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y57:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 63 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y58:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 260 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
3gql:B (GLY490) to (LEU516) CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE IN COMPLEX WITH SUBSTRATES | PHOSPHORYLATED KINASE, ACTIVATION, ATP ANALOG, ATP-BINDING, CRANIOSYNOSTOSIS, DISEASE MUTATION, DISULFIDE BOND, DWARFISM, GLYCOPROTEIN, HEPARIN-BINDING, HYPOGONADOTROPIC HYPOGONADISM, IMMUNOGLOBULIN DOMAIN, KALLMANN SYNDROME, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, RECEPTOR, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
3gql:C (ARG477) to (GLY499) CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE IN COMPLEX WITH SUBSTRATES | PHOSPHORYLATED KINASE, ACTIVATION, ATP ANALOG, ATP-BINDING, CRANIOSYNOSTOSIS, DISEASE MUTATION, DISULFIDE BOND, DWARFISM, GLYCOPROTEIN, HEPARIN-BINDING, HYPOGONADOTROPIC HYPOGONADISM, IMMUNOGLOBULIN DOMAIN, KALLMANN SYNDROME, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, RECEPTOR, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
4y5a:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 206 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
4y5b:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 261 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
4y5c:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 267 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y5e:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 268 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
4y5g:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 272 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
4y5k:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 274 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
4y5m:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 328 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y5n:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 337 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y5p:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 338 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
3gri:B (MSE1) to (GLY24) THE CRYSTAL STRUCTURE OF A DIHYDROOROTASE FROM STAPHYLOCOCCUS AUREUS | HYDROLASE, IDP00795, METAL-BINDING, PYRIMIDINE BIOSYNTHESIS, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID
1e6a:A (TRP52) to (VAL80) FLUORIDE-INHIBITED SUBSTRATE COMPLEX OF SACCHAROMYCES CEREVISIAE INORGANIC PYROPHOSPHATASE | PHOSPHORYL TRANSFER, HYDROLYSIS
4y6m:C (TRP193) to (SER215) STRUCTURE OF PLASMEPSIN II FROM PLASMODIUM FALCIPARUM COMPLEXED WITH INHIBITOR PG418 | PLASMEPSIN II HYDROXYETHYLAMINE-BASD INHIBITOR, HYDROLASE
3tdt:A (SER231) to (LYS254) COMPLEX OF TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE WITH 2-AMINO- 6-OXOPIMELATE AND COENZYME A | ACYLTRANSFERASE, LYSINE BIOSYNTHESIS
2r5p:A (ARG57) to (GLY78) CRYSTAL STRUCTURE ANALYSIS OF HIV-1 SUBTYPE C PROTEASE COMPLEXED WITH INDINAVIR | HIV-1 SUBTYPE C, ASPARTYL PROTEASE, HYDROLASE, PROTEASE, VIRAL PROTEIN
2r5p:C (ARG57) to (GLY78) CRYSTAL STRUCTURE ANALYSIS OF HIV-1 SUBTYPE C PROTEASE COMPLEXED WITH INDINAVIR | HIV-1 SUBTYPE C, ASPARTYL PROTEASE, HYDROLASE, PROTEASE, VIRAL PROTEIN
2r5q:A (ARG57) to (GLY78) CRYSTAL STRUCTURE ANALYSIS OF HIV-1 SUBTYPE C PROTEASE COMPLEXED WITH NELFINAVIR | HIV-1 SUBTYPE C, ASPARTYL PROTEASE, HYDROLASE, PROTEASE, VIRAL PROTEIN
2r5q:B (ARG57) to (GLY78) CRYSTAL STRUCTURE ANALYSIS OF HIV-1 SUBTYPE C PROTEASE COMPLEXED WITH NELFINAVIR | HIV-1 SUBTYPE C, ASPARTYL PROTEASE, HYDROLASE, PROTEASE, VIRAL PROTEIN
2r5q:C (ARG57) to (GLY78) CRYSTAL STRUCTURE ANALYSIS OF HIV-1 SUBTYPE C PROTEASE COMPLEXED WITH NELFINAVIR | HIV-1 SUBTYPE C, ASPARTYL PROTEASE, HYDROLASE, PROTEASE, VIRAL PROTEIN
2r5q:D (ARG57) to (GLY78) CRYSTAL STRUCTURE ANALYSIS OF HIV-1 SUBTYPE C PROTEASE COMPLEXED WITH NELFINAVIR | HIV-1 SUBTYPE C, ASPARTYL PROTEASE, HYDROLASE, PROTEASE, VIRAL PROTEIN
1e80:E (ASP83) to (ALA104) ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA-EMD56133 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ACID PROTEINASE
1e82:E (ASP83) to (ALA104) ENDOTHIAPEPSIN COMPLEX WITH RENIN INHIBITOR MERCK-KGAA-EMD59601 | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
2dg9:A (GLN20) to (PHE48) FK506-BINDING PROTEIN MUTANT WL59 COMPLEXED WITH RAPAMYCIN | IMMUNOPHILIN, ISOMERASE, ROTAMASE
1e8v:B (ARG485) to (SER508) STRUCTURE OF THE MULTIFUNCTIONAL PARAMYXOVIRUS HEMAGGLUTININ-NEURAMINIDASE | SIALIDASE, NEURAMINIDASE, HEMAGGLUTININ, HYDROLASE
4j95:B (PHE492) to (MET518) CRYSTAL STRUCURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED CRANIOSYNOSTOSIS SYNDROME IN SPACE GROUP C2. | KINASE DOMAIN FOLD CONSISTING OF N- AND C-LOBES, RECEPTOR TYROSINE KINASE, ATP BINDING, TRANSFERASE
4j95:C (GLN494) to (MET518) CRYSTAL STRUCURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED CRANIOSYNOSTOSIS SYNDROME IN SPACE GROUP C2. | KINASE DOMAIN FOLD CONSISTING OF N- AND C-LOBES, RECEPTOR TYROSINE KINASE, ATP BINDING, TRANSFERASE
4j96:A (GLY493) to (MET518) CRYSTAL STRUCURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC GAIN-OF-FUNCTION K659M MUTATION IDENTIFIED IN CERVICAL CANCER. | KINASE DOMAIN FOLD CONSISTING OF N- AND C-LOBES, RECEPTOR TYROSINE KINASE, ATP BINDING, TRANSFERASE
4j97:A (GLY493) to (MET518) CRYSTAL STRUCURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC GAIN-OF-FUNCTION K659E MUTATION IDENTIFIED IN ENDOMETRIAL CANCER. | KINASE DOMAIN FOLD CONSISTING OF N- AND C-LOBES, RECEPTOR TYROSINE KINASE, ATP BINDING, TRANSFERASE
1e9g:A (TRP52) to (VAL80) STRUCTURE OF INORGANIC PYROPHOSPHATASE | PYROPHOSPHATE PHOSPHOHYDROLASE, HYDROLASE, MANGANESE
2dph:B (ALA1) to (PRO20) CRYSTAL STRUCTURE OF FORMALDEHYDE DISMUTASE | DISMUTATION OF ALDEHYDES, OXIDOREDUCTASE
3tk8:A (SER270) to (ALA297) STRUCTURE OF A 2,3,4,5-TETRAHYDROPYRIDINE-2,6-DICARBOXYLATE N- SUCCINYLTRANSFERASE FROM BURKHOLDERIA PSEUDOMALLEI | SSGCID, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, TRANSFERASE
3tk8:B (SER270) to (LYS293) STRUCTURE OF A 2,3,4,5-TETRAHYDROPYRIDINE-2,6-DICARBOXYLATE N- SUCCINYLTRANSFERASE FROM BURKHOLDERIA PSEUDOMALLEI | SSGCID, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, TRANSFERASE
3tk8:C (SER270) to (ASP296) STRUCTURE OF A 2,3,4,5-TETRAHYDROPYRIDINE-2,6-DICARBOXYLATE N- SUCCINYLTRANSFERASE FROM BURKHOLDERIA PSEUDOMALLEI | SSGCID, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, TRANSFERASE
3tkw:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF HIV PROTEASE MODEL PRECURSOR/DARUNAVIR COMPLEX | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1ee2:A (LYS5) to (ALA29) THE STRUCTURE OF STEROID-ACTIVE ALCOHOL DEHYDROGENASE AT 1.54 A RESOLUTION | DEHYDROGENASE, ALCOHOL, NICOTINAMIDE COENZYME, STEROID BINDING, OXIDOREDUCTASE
1eed:P (GLY82) to (ALA104) X-RAY CRYSTALLOGRAPHIC ANALYSIS OF INHIBITION OF ENDOTHIAPEPSIN BY CYCLOHEXYL RENIN INHIBITORS | ASPARTIC PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3tmd:A (GLN15) to (GLU40) BD1817, A HDG"Y"P PROTEIN FROM BDELLOVIBRIO BACTERIOVORUS | HD-GYP, PHOSPHODIESTERASE, UNKNOWN FUNCTION, HYDROLASE,SIGNALING PROTEIN
4ya8:A (TRP193) to (SER215) STRUCTURE OF PLASMEPSIN II FROM PLASMODIUM FALCIPARUM COMPLEXED WITH INHIBITOR PG394 | PLASMEPSIN II, MALARIA, INHIBITOR, HYDROLASE
4ya8:B (TRP193) to (SER215) STRUCTURE OF PLASMEPSIN II FROM PLASMODIUM FALCIPARUM COMPLEXED WITH INHIBITOR PG394 | PLASMEPSIN II, MALARIA, INHIBITOR, HYDROLASE
4ya8:C (TRP193) to (SER215) STRUCTURE OF PLASMEPSIN II FROM PLASMODIUM FALCIPARUM COMPLEXED WITH INHIBITOR PG394 | PLASMEPSIN II, MALARIA, INHIBITOR, HYDROLASE
2dt4:A (GLY44) to (GLU71) CRYSTAL STRUCTURE OF PYROCOCCUS HORIKOSHII A PLANT- AND PROKARYOTE- CONSERVED (PPC) PROTEIN AT 1.60 RESOLUTION | PPC DOMAIN, STRUCTURAL GENOMICS, UNKNOWN FUNCTION
1qbt:A (ARG57) to (GLY78) HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY | HYDROLASE (ACID PROTEINASE), ASPARTYL PROTEASE
4yck:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 211 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4ycg:D (LYS375) to (GLY398) PRO-BONE MORPHOGENETIC PROTEIN 9 | PRO-BMP COMPLEX, MORPHOGEN, TRANSFORMING GROWTH FACTOR-BETA FAMILY, CYTOKINE
4yci:C (LYS375) to (GLY398) NON-LATENT PRO-BONE MORPHOGENETIC PROTEIN 9 | PRO-BMP COMPLEX, MORPHOGEN, TRANSFORMING GROWTH FACTOR-BETA FAMILY, CYTOKINE
1qdm:B (TYR88) to (ALA109) CRYSTAL STRUCTURE OF PROPHYTEPSIN, A ZYMOGEN OF A BARLEY VACUOLAR ASPARTIC PROTEINASE. | ASPARTIC PROTEINASES, PHYTEPSIN, SAPOSIN-LIKE DOMAIN, ZYMOGEN STRUCTURE, HYDROLASE
2rde:A (GLU138) to (ARG165) CRYSTAL STRUCTURE OF VCA0042 COMPLEXED WITH C-DI-GMP | C-DI-GMP, VIBRIO CHOLERAE, VCA0042, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, UNKNOWN FUNCTION
2rde:B (GLU138) to (ARG165) CRYSTAL STRUCTURE OF VCA0042 COMPLEXED WITH C-DI-GMP | C-DI-GMP, VIBRIO CHOLERAE, VCA0042, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, UNKNOWN FUNCTION
4jja:A (GLN270) to (SER308) CRYSTAL STRUCTURE OF A DUF1343 FAMILY PROTEIN (BF0379) FROM BACTEROIDES FRAGILIS NCTC 9343 AT 1.30 A RESOLUTION | PF07075 FAMILY PROTEIN, DUF1343, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI- BIOLOGY, UNKNOWN FUNCTION
4yct:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 216 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4yd3:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 224 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4yd5:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 236 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4yd6:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 240 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4ydq:B (LEU380) to (LYS415) CRYSTAL STRUCTURE OF PROLYL-TRNA SYNTHETASE (PRS) FROM PLASMODIUM FALCIPARUM IN COMPLEX WITH HALOFUGINONE AND AMPPNP | PROLYL-TRNA SYNTHETASE, COMPLEX, HALOFUGINONE, MALARIA
1ent:E (ASP83) to (ALA104) X-RAY ANALYSES OF ASPARTIC PROTEINASES. THE THREE-DIMENSIONAL STRUCTURE AT 2.1 ANGSTROMS RESOLUTION OF ENDOTHIAPEPSIN | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3ttq:A (GLN2491) to (ASN2518) CRYSTAL STRUCTURE OF LEUCONOSTOC MESENTEROIDES NRRL B-1299 N- TERMINALLY TRUNCATED DEXTRANSUCRASE DSR-E IN ORTHORHOMBIC APO-FORM AT 1.9 ANGSTROM RESOLUTION | (BETA/ALPHA)8 BARREL, SUCROSE/DEXTRAN/GLUCO-OLIGOSACCHARIDE BINDING, ALPHA-1,2 BRANCHING DEXTRANSUCRASE, TRANSFERASE
1epl:E (ASP83) to (ALA104) A STRUCTURAL COMPARISON OF 21 INHIBITOR COMPLEXES OF THE ASPARTIC PROTEINASE FROM ENDOTHIA PARASITICA | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1epn:E (ASP83) to (ALA104) A STRUCTURAL COMPARISON OF 21 INHIBITOR COMPLEXES OF THE ASPARTIC PROTEINASE FROM ENDOTHIA PARASITICA | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1epp:E (ASP83) to (ALA104) ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) COMPLEXED WITH PD-130, 693 (MAS PHE LYS+MTF STA MBA) | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ACID PROTEINASE
1epq:E (ASP83) to (ALA104) ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) COMPLEXED WITH PD-133, 450 (SOT PHE GLY+SCC GCL) | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ACID PROTEINASE
1er8:E (ASP83) to (ALA104) THE ACTIVE SITE OF ASPARTIC PROTEINASES | HYDROLASE, ACID PROTEINASE
1er8:E (TRP190) to (THR216) THE ACTIVE SITE OF ASPARTIC PROTEINASES | HYDROLASE, ACID PROTEINASE
2rkg:A (ARG58) to (GLY79) HIV-1 PR RESISTANT MUTANT + LPV | RESISTENCE, INSERTION, HYDROLASE
1qlh:A (LYS5) to (PRO30) HORSE LIVER ALCOHOL DEHYDROGENASE COMPLEXED TO NAD DOUBLE MUTANT OF GLY 293 ALA AND PRO 295 THR | OXIDOREDUCTASE, DEHYDROGENASE, ALCOHOL, NICOTINAMIDE COENZYME, DOUBLE MUTANT
1qlj:A (LYS5) to (PRO30) HORSE LIVER ALCOHOL DEHYDROGENASE APO ENZYME DOUBLE MUTANT OF GLY 293 ALA AND PRO 295 THR | DEHYDROGENASE, ALCOHOL, OXIDOREDUCTASE, DOUBLE MUTANT
2rqf:A (PRO42) to (GLY69) SOLUTION STRUCTURE OF JUVENILE HORMONE BINDING PROTEIN FROM SILKWORM IN COMPLEX WITH JH III | JUVENILE HORMONE, HORMONE BINDING PROTEIN
2tdt:A (SER231) to (LYS254) COMPLEX OF TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE WITH 2- AMINOPIMELATE AND COENZYME A | ACYLTRANSFERASE, LYSINE BIOSYNTHESIS
4ygf:D (ASP103) to (ALA135) CRYSTAL STRUCTURE OF THE COMPLEX OF HELICOBACTER PYLORI ALPHA-CARBONIC ANHYDRASE WITH ACETAZOLAMIDE | PERIPLASM, ZINC METALLOENZYME, LYASE
3h4r:A (GLY726) to (GLU753) CRYSTAL STRUCTURE OF E. COLI RECE EXONUCLEASE | EXONUCLEASE, RECOMBINATION, HYDROLASE, NUCLEASE
4yix:A (VAL253) to (PRO305) STRUCTURE OF MRB1590 BOUND TO ADP | KRNA EDITING, MRB1590, ATPASE, RNA BINDING, RNA BINDING PROTEIN
4yiy:B (VAL253) to (PRO305) STRUCTURE OF MRB1590 BOUND TO AMP-PNP | KRNA EDITING, MRB1590, ATPASE, RNA BINDING, RNA BINDING PROTEIN
4yiy:A (VAL253) to (PRO305) STRUCTURE OF MRB1590 BOUND TO AMP-PNP | KRNA EDITING, MRB1590, ATPASE, RNA BINDING, RNA BINDING PROTEIN
4yj1:A (VAL253) to (PRO305) CRYSTAL STRUCTURE OF T. BRUCEI MRB1590-ADP BOUND TO POLY-U RNA | KRNA EDITING, KASP, MRB1, RNA BINDING PROTEIN
1f34:A (ILE83) to (SER104) CRYSTAL STRUCTURE OF ASCARIS PEPSIN INHIBITOR-3 BOUND TO PORCINE PEPSIN | PROTEINASE-INHIBITOR COMPLEX, HYDROLASE/HYDROLASE INHIBITOR COMPLEX
1qty:W (THR71) to (ASN100) VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH DOMAIN 2 OF THE FLT-1 RECEPTOR | COMPLEX (GROWTH FACTOR/RECEPTOR), FLT-1, VEGF RECEPTOR, RECEPTOR TYROSINE KINASE, CYSTINE KNOT, GLYCOPROTEIN, IMMUNOGLOBULIN-LIKE DOMAIN, I-SET, HORMONE/GROWTH FACTOR RECEPTOR
1qty:R (THR71) to (ASN100) VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH DOMAIN 2 OF THE FLT-1 RECEPTOR | COMPLEX (GROWTH FACTOR/RECEPTOR), FLT-1, VEGF RECEPTOR, RECEPTOR TYROSINE KINASE, CYSTINE KNOT, GLYCOPROTEIN, IMMUNOGLOBULIN-LIKE DOMAIN, I-SET, HORMONE/GROWTH FACTOR RECEPTOR
3u12:B (LEU4) to (GLU33) THE PLECKSTRIN HOMOLOGY (PH) DOMAIN OF USP37 | STRUCTURAL GENOMICS, PH-DOMAIN, HYDROLASE, STRUCTURAL GENOMICS CONSORTIUM, SGC
3u14:B (ALA332) to (PRO355) STRUCTURE OF D50A-FRUCTOFURANOSIDASE FROM SCHWANNIOMYCES OCCIDENTALIS COMPLEXED WITH INULIN | GLYCOSIDASE GH32, BETA-PROPELLER, HYDROLASE, CARBOHYDRATE/SUGAR BINDING, GLYCOSYLATIONS
1qv7:A (LYS5) to (ALA29) HORSE LIVER ALCOHOL DEHYDROGENASE HIS51GLN/LYS228ARG MUTANT COMPLEXED WITH NAD+ AND 2,3-DIFLUOROBENZYL ALCOHOL | DEHYDROGENASE, ALCOHOL, NICOTINAMIDE COENZYME, 2,3- DIFLUOROBENZYL ALCOHOL, HIS51GLN/LYS228ARG MUTANT, HORSE LIVER, OXIDOREDUCTASE
2eab:A (LEU779) to (LEU801) CRYSTAL STRUCTURE OF 1,2-A-L-FUCOSIDASE FROM BIFIDOBACTERIUM BIFIDUM (APO FORM) | FUCOSIDASE, GLYCOSIDE HYDROLASE
2eab:B (LEU779) to (LEU801) CRYSTAL STRUCTURE OF 1,2-A-L-FUCOSIDASE FROM BIFIDOBACTERIUM BIFIDUM (APO FORM) | FUCOSIDASE, GLYCOSIDE HYDROLASE
2ead:B (LEU779) to (LEU801) CRYSTAL STRUCTURE OF 1,2-A-L-FUCOSIDASE FROM BIFIDOBACTERIUM BIFIDUM IN COMPLEX WITH SUBSTRATE | FUCOSIDASE, GLYCOSIDE HYDROLASE
3hau:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF CHEMICALLY SYNTHESIZED HIV-1 PROTEASE WITH REDUCED ISOSTERE MVT-101 INHIBITOR | BETA BARREL, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3haw:B (ARG57) to (GLY78) CRYSTAL STRUCTURE OF [L-ALA51/51']HIV-1 PROTEASE WITH REDUCED ISOSTERE MVT-101 INHIBITOR | BETA BARREL, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1f7a:B (ARG57) to (GLY78) HOW DOES A SYMMETRIC DIMER RECOGNIZE AN ASYMMETRIC SUBSTRATE? A SUBSTRATE COMPLEX OF HIV-1 PROTEASE. | CAPSID, SUBSTRATE RECOGNITION, HYDROLASE
3hbo:B (ARG57) to (GLY78) CRYSTAL STRUCTURE OF CHEMICALLY SYNTHESIZED [D-ALA51/51']HIV-1 PROTEASE | BETA BARREL, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1fb7:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF AN IN VIVO HIV-1 PROTEASE MUTANT IN COMPLEX WITH SAQUINAVIR: INSIGHTS INTO THE MECHANISMS OF DRUG RESISTANCE | HIV PROTEASE, MUTANT, DRUG RESISTANCE, VIRAL PROTEIN, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
2uxw:A (ASP257) to (VAL283) CRYSTAL STRUCTURE OF HUMAN VERY LONG CHAIN ACYL-COA DEHYDROGENASE (ACADVL) | FATTY ACID METABOLISM, TRANSIT PEPTIDE, DISEASE MUTATION, LIPID METABOLISM, COENZYME A DEHYDROGENASE, VERY LONG CHAIN FATTY ACIDS, FAD, FLAVOPROTEIN, MITOCHONDRIAL FATTY ACID BETA-OXIDATION, MITOCHONDRION, OXIDOREDUCTASE, CARDIOMYOPATHY
2uz9:A (HIS11) to (SER37) HUMAN GUANINE DEAMINASE (GUAD) IN COMPLEX WITH ZINC AND ITS PRODUCT XANTHINE. | ZINC, HYDROLASE, PURINE METABOLISM, GUANINE AMINOHYDROLASE
2ejw:E (GLY233) to (PRO259) HOMOSERINE DEHYDROGENASE FROM THERMUS THERMOPHILUS HB8 | NAD-DEPENDENT, DEHYDROGENASE, OXIDOREDUCTASE
1fgk:B (GLY490) to (MET515) CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 | TRANSFERASE, TYROSINE-PROTEIN KINASE, ATP-BINDING, PHOSPHORYLATION, RECEPTOR, PHOSPHOTRANSFERASE
4k22:A (ARG74) to (GLU109) STRUCTURE OF THE C-TERMINAL TRUNCATED FORM OF E.COLI C5-HYDROXYLASE UBII INVOLVED IN UBIQUINONE (Q8) BIOSYNTHESIS | ROSSMANN FOLD, HYDROXYLASE, OXIDOREDUCTASE
4k22:B (ARG74) to (GLU109) STRUCTURE OF THE C-TERMINAL TRUNCATED FORM OF E.COLI C5-HYDROXYLASE UBII INVOLVED IN UBIQUINONE (Q8) BIOSYNTHESIS | ROSSMANN FOLD, HYDROXYLASE, OXIDOREDUCTASE
2er0:E (ASP83) to (ALA104) X-RAY STUDIES OF ASPARTIC PROTEINASE-STATINE INHIBITOR COMPLEXES | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
2er0:E (TRP190) to (THR216) X-RAY STUDIES OF ASPARTIC PROTEINASE-STATINE INHIBITOR COMPLEXES | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
2er7:E (ASP83) to (ALA104) X-RAY ANALYSES OF ASPARTIC PROTEINASES.III. THREE-DIMENSIONAL STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH A TRANSITION-STATE ISOSTERE INHIBITOR OF RENIN AT 1.6 ANGSTROMS RESOLUTION | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ACID PROTEINASE
1fki:A (GLN20) to (MET49) DESIGN, SYNTHESIS, AND KINETIC EVALUATION OF HIGH-AFFINITY FKBP LIGANDS, AND THE X-RAY CRYSTAL STRUCTURES OF THEIR COMPLEXES WITH FKBP12 | CIS-TRANS ISOMERASE
1flg:A (GLU322) to (ALA342) CRYSTAL STRUCTURE OF THE QUINOPROTEIN ETHANOL DEHYDROGENASE FROM PSEUDOMONAS AERUGINOSA | QUINOPROTEIN, SUPERBARREL, DEHYDROGENASE, OXIDOREDUCTASE
1fmb:A (GLY58) to (ALA83) EIAV PROTEASE COMPLEXED WITH THE INHIBITOR HBY-793 | HYDROLASE (ACID PROTEINASE), RNA-DIRECTED DNA POLYMERASE, ASPARTYL PROTEASE, ENDONUCLEASE, POLYPROTEIN
1fmu:A (TYR83) to (ALA102) STRUCTURE OF NATIVE PROTEINASE A IN P3221 SPACE GROUP. | PROTEINASE A, HYDROLASE
1fmx:B (TYR84) to (THR106) STRUCTURE OF NATIVE PROTEINASE A IN THE SPACE GROUP P21 | PROTEINASE A, HYDROLASE
3uf8:A (THR28) to (PHE55) CRYSTAL STRUCTURE OF A SMT FUSION PEPTIDYL-PROLYL CIS-TRANS ISOMERASE WITH A G95A SURFACE MUTATION FROM BURKHOLDERIA PSEUDOMALLEI COMPLEXED WITH FK506 | SSGCID, ISOMERASE, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, PROTEIN BINDING
4k4p:B (ARG57) to (GLY78) TL-3 INHIBITED TRP6ALA HIV PROTEASE | FRAGMENT BINDING, EXOSITE, PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1fo6:A (GLY89) to (ASP116) CRYSTAL STRUCTURE ANALYSIS OF N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLASE | FOUR LAYER A/B FOLD, HYDROLASE
1foc:B (GLY53) to (SER70) CYTOCHROME C557: IMPROPERLY FOLDED THERMUS THERMOPHILUS C552 | CYTOCHROME C, THERMUS THERMOPHILUS, HEME INVERSION, ELECTRON TRANSPORT
3ugg:B (SER29) to (ASP53) CRYSTAL STRUCTURE OF A 6-SST/6-SFT FROM PACHYSANDRA TERMINALIS IN COMPLEX WITH 1-KESTOSE | FRUCTOSYLTRANSFERASE, GLYCOSIDE HYDROLASE FAMILY 32, TRANSFERASE
3hlo:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF CHEMICALLY SYNTHESIZED 'COVALENT DIMER' [GLY51/D- ALA51']HIV-1 PROTEASE | BETA BARREL, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1fq4:A (TYR83) to (GLY109) CRYSTAL STRUCTURE OF A COMPLEX BETWEEN HYDROXYETHYLENE INHIBITOR CP- 108,420 AND YEAST ASPARTIC PROTEINASE A | ASPARTIC PROTEINASE-INHIBITOR COMPLEX, EXTENDED BETA-STRAND (INHIBITOR), HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1fq6:A (TYR83) to (GLY109) X-RAY STRUCTURE OF GLYCOL INHIBITOR PD-133,450 BOUND TO SACCHAROPEPSIN | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1fq8:A (TYR83) to (GLY109) X-RAY STRUCTURE OF DIFLUOROSTATINE INHIBITOR CP81,198 BOUND TO SACCHAROPEPSIN | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
2f17:A (GLN190) to (PHE211) MOUSE THIAMIN PYROPHOSPHOKINASE IN A TERNARY COMPLEX WITH PYRITHIAMIN PYROPHOSPHATE AND AMP AT 2.5 ANGSTROM | BETA BARREL, ALPHA/BETA/ALPHA SANDWICH, PYROPHOSPHOKINASE, AMP, TRANSFERASE
4yu8:A (ALA88) to (HIS117) CRYSTAL STRUCTURE OF NEUROBLASTOMA SUPPRESSOR OF TUMORIGENICITY 1 | BMP BINDING PROTEIN, NBL1 DAN DOMAIN FAMILY MEMBER 1 BMP-BINDING, STRUCTURAL GENOMICS, OXFORD PROTEIN PRODUCTION FACILITY, OPPF, ANTITUMOR PROTEIN
2vat:B (ASP17) to (GLY43) CRYSTAL STRUCTURE OF DEACETYLCEPHALOSPORIN C ACETYLTRANSFERASE IN COMPLEX WITH COENZYME A | ACETYL TRANSFERASE, A/B- HYDROLASE FOLD, TRANSFERASE, ACYLTRANSFERASE, ACETYL COENZYME A, ANTIBIOTIC BIOSYNTHESIS, CEPHALOSPORIN BIOSYNTHESIS
2vat:F (ASP17) to (GLY43) CRYSTAL STRUCTURE OF DEACETYLCEPHALOSPORIN C ACETYLTRANSFERASE IN COMPLEX WITH COENZYME A | ACETYL TRANSFERASE, A/B- HYDROLASE FOLD, TRANSFERASE, ACYLTRANSFERASE, ACETYL COENZYME A, ANTIBIOTIC BIOSYNTHESIS, CEPHALOSPORIN BIOSYNTHESIS
2vat:I (ASP17) to (GLY43) CRYSTAL STRUCTURE OF DEACETYLCEPHALOSPORIN C ACETYLTRANSFERASE IN COMPLEX WITH COENZYME A | ACETYL TRANSFERASE, A/B- HYDROLASE FOLD, TRANSFERASE, ACYLTRANSFERASE, ACETYL COENZYME A, ANTIBIOTIC BIOSYNTHESIS, CEPHALOSPORIN BIOSYNTHESIS
2vav:B (ASP17) to (GLY43) CRYSTAL STRUCTURE OF DEACETYLCEPHALOSPORIN C ACETYLTRANSFERASE (DAC-SOAK) | ACETYL TRANSFERASE, A/B- HYDROLASE FOLD, TRANSFERASE, ACYLTRANSFERASE, ACETYL COENZYME A, ANTIBIOTIC BIOSYNTHESIS, CEPHALOSPORIN BIOSYNTHESIS
2vav:F (ASP17) to (GLY43) CRYSTAL STRUCTURE OF DEACETYLCEPHALOSPORIN C ACETYLTRANSFERASE (DAC-SOAK) | ACETYL TRANSFERASE, A/B- HYDROLASE FOLD, TRANSFERASE, ACYLTRANSFERASE, ACETYL COENZYME A, ANTIBIOTIC BIOSYNTHESIS, CEPHALOSPORIN BIOSYNTHESIS
2vav:I (ASP17) to (GLY43) CRYSTAL STRUCTURE OF DEACETYLCEPHALOSPORIN C ACETYLTRANSFERASE (DAC-SOAK) | ACETYL TRANSFERASE, A/B- HYDROLASE FOLD, TRANSFERASE, ACYLTRANSFERASE, ACETYL COENZYME A, ANTIBIOTIC BIOSYNTHESIS, CEPHALOSPORIN BIOSYNTHESIS
2vav:J (ASP17) to (GLY43) CRYSTAL STRUCTURE OF DEACETYLCEPHALOSPORIN C ACETYLTRANSFERASE (DAC-SOAK) | ACETYL TRANSFERASE, A/B- HYDROLASE FOLD, TRANSFERASE, ACYLTRANSFERASE, ACETYL COENZYME A, ANTIBIOTIC BIOSYNTHESIS, CEPHALOSPORIN BIOSYNTHESIS
2vax:B (ASP17) to (GLY43) CRYSTAL STRUCTURE OF DEACETYLCEPHALOSPORIN C ACETYLTRANSFERASE (CEPHALOSPORIN C-SOAK) | DEACETYLCEPHALOSPORIN C, CEPHALOSPORIN BIOSYNTHESIS, A/B- HYDROLASE FOLD, ANTIBIOTIC BIOSYNTHESIS, TRANSFERASE, ACYLTRANSFERASE, ACETYL TRANSFERASE
2vax:C (ASP17) to (GLY43) CRYSTAL STRUCTURE OF DEACETYLCEPHALOSPORIN C ACETYLTRANSFERASE (CEPHALOSPORIN C-SOAK) | DEACETYLCEPHALOSPORIN C, CEPHALOSPORIN BIOSYNTHESIS, A/B- HYDROLASE FOLD, ANTIBIOTIC BIOSYNTHESIS, TRANSFERASE, ACYLTRANSFERASE, ACETYL TRANSFERASE
2vax:F (ASP17) to (GLY43) CRYSTAL STRUCTURE OF DEACETYLCEPHALOSPORIN C ACETYLTRANSFERASE (CEPHALOSPORIN C-SOAK) | DEACETYLCEPHALOSPORIN C, CEPHALOSPORIN BIOSYNTHESIS, A/B- HYDROLASE FOLD, ANTIBIOTIC BIOSYNTHESIS, TRANSFERASE, ACYLTRANSFERASE, ACETYL TRANSFERASE
2vax:I (ASP17) to (GLY43) CRYSTAL STRUCTURE OF DEACETYLCEPHALOSPORIN C ACETYLTRANSFERASE (CEPHALOSPORIN C-SOAK) | DEACETYLCEPHALOSPORIN C, CEPHALOSPORIN BIOSYNTHESIS, A/B- HYDROLASE FOLD, ANTIBIOTIC BIOSYNTHESIS, TRANSFERASE, ACYLTRANSFERASE, ACETYL TRANSFERASE
2vax:J (ASP17) to (GLY43) CRYSTAL STRUCTURE OF DEACETYLCEPHALOSPORIN C ACETYLTRANSFERASE (CEPHALOSPORIN C-SOAK) | DEACETYLCEPHALOSPORIN C, CEPHALOSPORIN BIOSYNTHESIS, A/B- HYDROLASE FOLD, ANTIBIOTIC BIOSYNTHESIS, TRANSFERASE, ACYLTRANSFERASE, ACETYL TRANSFERASE
2vax:K (ASP17) to (GLY43) CRYSTAL STRUCTURE OF DEACETYLCEPHALOSPORIN C ACETYLTRANSFERASE (CEPHALOSPORIN C-SOAK) | DEACETYLCEPHALOSPORIN C, CEPHALOSPORIN BIOSYNTHESIS, A/B- HYDROLASE FOLD, ANTIBIOTIC BIOSYNTHESIS, TRANSFERASE, ACYLTRANSFERASE, ACETYL TRANSFERASE
2vax:L (ASP17) to (GLY43) CRYSTAL STRUCTURE OF DEACETYLCEPHALOSPORIN C ACETYLTRANSFERASE (CEPHALOSPORIN C-SOAK) | DEACETYLCEPHALOSPORIN C, CEPHALOSPORIN BIOSYNTHESIS, A/B- HYDROLASE FOLD, ANTIBIOTIC BIOSYNTHESIS, TRANSFERASE, ACYLTRANSFERASE, ACETYL TRANSFERASE
4yz4:A (ASN459) to (HIS485) CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC, IN COMPLEX WITH N- ACETYLNEURAMINIC ACID. | SIALIDASE, NEURAMINIDASE, BETA-PROPELLER, CBM40, HYDROLASE
1rqq:A (PHE1007) to (VAL1032) CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH THE SH2 DOMAIN OF APS | PROTEIN TYROSINE KINASE, ADAPTOR PROTEIN, SH2 DOMAIN, TRANSFERASE/SIGNALING PROTEIN COMPLEX
1rqq:B (GLY1008) to (VAL1032) CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH THE SH2 DOMAIN OF APS | PROTEIN TYROSINE KINASE, ADAPTOR PROTEIN, SH2 DOMAIN, TRANSFERASE/SIGNALING PROTEIN COMPLEX
3uod:A (ASP132) to (GLN154) AURORA A IN COMPLEX WITH RPM1693 | PROTEIN KINASE, AURORA A, INHIBITOR, DFG-IN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
3uog:A (LYS3) to (PRO24) CRYSTAL STRUCTURE OF PUTATIVE ALCOHOL DEHYDROGENASE FROM SINORHIZOBIUM MELILOTI 1021 | STRUCTURAL GENOMICS, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, NEW YORK STRUCTURAL GENOMICS RESEARCH CONSORTIUM, NYSGRC, OXIDOREDUCTASE
3uog:B (LYS3) to (PRO24) CRYSTAL STRUCTURE OF PUTATIVE ALCOHOL DEHYDROGENASE FROM SINORHIZOBIUM MELILOTI 1021 | STRUCTURAL GENOMICS, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, NEW YORK STRUCTURAL GENOMICS RESEARCH CONSORTIUM, NYSGRC, OXIDOREDUCTASE
3uoh:A (GLU134) to (GLU152) AURORA A IN COMPLEX WITH RPM1722 | PROTEIN KINASE, AURORA A, INHIBITOR, DFG-OUT, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
3uoh:B (GLU134) to (GLU152) AURORA A IN COMPLEX WITH RPM1722 | PROTEIN KINASE, AURORA A, INHIBITOR, DFG-OUT, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
4z2z:A (GLY260) to (ASP282) NEW CRYSTAL STRUCTURE OF YEAST DDI1 ASPARTYL PROTEASE REVEALS SUBSTRATE ENGAGEMENT MODE | PROTEASE, DDI1, HYDROLASE
3up6:A (GLN51) to (THR85) CRYSTAL STRUCTURE OF A PUTATIVE CELL ADHESION PROTEIN (BACOVA_04078) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.80 A RESOLUTION | CELL ADHESION, MAJOR FIMBRIAL SUBUNIT PROTEIN (FIMA), STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY
1g6l:A (ARG57) to (GLY78) 1.9A CRYSTAL STRUCTURE OF TETHERED HIV-1 PROTEASE | HYDROLASE
3upu:B (ILE300) to (GLY331) CRYSTAL STRUCTURE OF THE T4 PHAGE SF1B HELICASE DDA | RECA-LIKE DOMAIN, SH3 DOMAIN, PIN-TOWER INTERFACE, COUPLING ATP HYDROLYSIS TO DNA UNWINDING, SSDNA, HYDROLASE-DNA COMPLEX
3upu:C (ILE300) to (GLY331) CRYSTAL STRUCTURE OF THE T4 PHAGE SF1B HELICASE DDA | RECA-LIKE DOMAIN, SH3 DOMAIN, PIN-TOWER INTERFACE, COUPLING ATP HYDROLYSIS TO DNA UNWINDING, SSDNA, HYDROLASE-DNA COMPLEX
2fgu:A (ARG57) to (GLY78) X-RAY CRYSTAL STRUCTURE OF HIV-1 PROTEASE T80S VARIANT IN COMPLEX WITH THE INHIBITOR SAQUINAVIR USED TO EXPLORE THE ROLE OF INVARIANT THR80 IN HIV-1 PROTEASE STRUCTURE, FUNCTION, AND VIRAL INFECTIVITY. | HIV PROTEASE, DRUG RESISTANCE, ENZYME KINETICS, SEQUENCE CONSERVATION, PROTEIN STRUCTURE, HYDROLASE
2fgv:B (ARG57) to (GLY78) X-RAY CRYSTAL STRUCTURE OF HIV-1 PROTEASE T80N VARIANT IN COMPLEX WITH THE INHIBITOR SAQUINAVIR USED TO EXPLORE THE ROLE OF INVARIANT THR80 IN HIV-1 PROTEASE STRUCTURE, FUNCTION, AND VIRAL INFECTIVITY. | HIV PROTEASE, DRUG RESISTANCE, ENZYME KINETICS, SEQUENCE CONSERVATION, PROTEIN STRUCTURE, HYDROLASE
3ure:A (THR163) to (ASN184) REPACK MUTANT (T181I, W199L, Q210I) OF ALPHA-LYTIC PROTEASE | SERINE PROTEASE, HYDROLASE
3ure:B (THR163) to (ASN184) REPACK MUTANT (T181I, W199L, Q210I) OF ALPHA-LYTIC PROTEASE | SERINE PROTEASE, HYDROLASE
3uri:A (ASP87) to (ALA108) ENDOTHIAPEPSIN-DB5 COMPLEX. | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ASPARTIC PROTEINASE MECHANISM, TRANSITION STATE ANALOGUE.
3urj:A (ASP87) to (ALA108) TYPE IV NATIVE ENDOTHIAPEPSIN | ASPARTIC PROTEINASE, PROTEOLYSIS, SECRETED., HYDROLASE
3url:A (ASP87) to (ALA108) ENDOTHIAPEPSIN-DB6 COMPLEX. | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ASPARTIC PROTEINASE MECHANISM, TRANSITION STATE ANALOGUE.
2fiv:A (GLY61) to (ASP94) CRYSTAL STRUCTURE OF FELINE IMMUNODEFICIENCY VIRUS PROTEASE COMPLEXED WITH A SUBSTRATE | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ACID PROTEINASE-SUBSTRATE, ASPARTIC PROTEASE, RETROVIRAL PROTEASE
2fiv:B (GLY61) to (ASP94) CRYSTAL STRUCTURE OF FELINE IMMUNODEFICIENCY VIRUS PROTEASE COMPLEXED WITH A SUBSTRATE | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ACID PROTEINASE-SUBSTRATE, ASPARTIC PROTEASE, RETROVIRAL PROTEASE
4z7n:C (ARG303) to (GLN333) INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE | CELL ADHESION, PLATELET AGGREGATION, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX
2fle:A (ARG57) to (GLY78) STRUCTURAL ANALYSIS OF ASYMMETRIC INHIBITOR BOUND TO THE HIV-1 PROTEASE V82A MUTANT | HIV-1 PROTEASE, INHIBITOR, RESISTANCE, INDUCED FIT, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
2fmb:A (GLY58) to (ALA83) EIAV PROTEASE COMPLEXED WITH AN INHIBITOR LP-130 | ASPARTIC PROTEASE, RETROPEPSIN, RETROVIRUS, EIAV, HORSE
3hrl:A (TYR45) to (THR64) CRYSTAL STRUCTURE OF A PUTATIVE ENDONUCLEASE-LIKE PROTEIN (NGO0050) FROM NEISSERIA GONORRHOEAE | STRUCTURAL GENOMICS; ENDONUCLEASE; NEISSERIA GONORRHOEAE, PSI-2, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, STRUCTURAL GENOMICS, UNKNOWN FUNCTION
2fnt:B (GLY52) to (GLY78) CRYSTAL STRUCTURE OF A DRUG-RESISTANT (V82A) INACTIVE (D25N) HIV-1 PROTEASE COMPLEXED WITH AP2V VARIANT OF HIV-1 NC-P1 SUBSTRATE. | STRUCTURAL INTERMEDIATE, SUBSTRATE RECOGNITION, HIV-1 PROTEASE, NC-P1 SUBSTRATE, DRUG RESISTANCE, FLAP CONFORMATION, HYDROLASE
3hud:B (LYS5) to (ALA29) THE STRUCTURE OF HUMAN BETA 1 BETA 1 ALCOHOL DEHYDROGENASE: CATALYTIC EFFECTS OF NON-ACTIVE-SITE SUBSTITUTIONS | OXIDOREDUCTASE(NAD(A)-CHOH(D))
3v2a:A (THR71) to (LEU97) VEGFR-2/VEGF-A COMPLEX STRUCTURE | IG-HOMOLOGY DOMAIN, VEGFR-2, GROWTH FACTOR RECEPTOR, VEGF LIGAND, HORMONE-SIGNALING PROTEIN COMPLEX, ANGIOGENESIS, MEMBRANE, VEGF-A
4zea:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B91 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
1sbg:B (ARG57) to (GLY78) AN ORALLY-BIOAVAILABLE HIV-1 PROTEASE INHIBITOR CONTAINING AN IMIDAZOLE-DERIVED PEPTIDE BOND REPLACEMENT. CRYSTALLOGRAPHIC AND PHARMACOKINETIC ANALYSIS | HYDROLASE(ACID PROTEASE)
1sdt:A (ARG57) to (GLY78) CRYSTAL STRUCTURES OF HIV PROTEASE V82A AND L90M MUTANTS REVEAL CHANGES IN INDINAVIR BINDING SITE. | DRUG RESISTANCE; HIV-1, HYDROLASE
1sdv:A (ARG57) to (GLY78) CRYSTAL STRUCTURES OF HIV PROTEASE V82A AND L90M MUTANTS REVEAL CHANGES IN INDINAVIR BINDING SITE. | DRUG RESISTANCE; HIV-1 PROTEASE, HYDROLASE
2fwl:A (LEU51) to (SER71) THE CYTOCHROME C552/CUA COMPLEX FROM THERMUS THERMOPHILUS | DOCKING CALCULATIONS, REDOX PROTEIN COMPLEX, ELECTRON TRANSFER PATHWAY, ELECTRON TRANSPORT-OXIDOREDUCTASE COMPLEX
4kpf:B (VAL236) to (PRO260) NOVEL FLUOROQUINOLONES IN COMPLEX WITH TOPOISOMERASE IV FROM S. PNEUMONIAE AND E-SITE G-GATE | PROTEIN-DNA CLEAVAGE COMPLEX, ISOMERASE-DNA-INHIBITOR COMPLEX, TOPOISOMERASE IIA, QUINOLONE, ACHN-454
2vm8:C (ASP408) to (PRO443) HUMAN CRMP-2 CRYSTALLISED IN THE PRESENCE OF MG | NEUROGENESIS, PHOSPHOPROTEIN, DIFFERENTIATION, CRMP, CYTOPLASM, TIM BARREL, POLYMORPHISM, AXONAL PATHFINDING, DEVELOPMENTAL PROTEIN, SIGNALING PROTEIN
1gnn:B (ARG57) to (GLY78) HIV-1 PROTEASE MUTANT WITH VAL 82 REPLACED BY ASN (V82N) COMPLEXED WITH U89360E (INHIBITOR) | ASPARTIC PROTEASE, HIV, MUTANT, INHIBITOR, U-89360E, HYDROLASE (ACID PROTEASE)
1gno:B (ARG57) to (GLY78) HIV-1 PROTEASE (WILD TYPE) COMPLEXED WITH U89360E (INHIBITOR) | ASPARTIC PROTEASE, HIV, MUTANT, INHIBITOR, U-89360E, HYDROLASE (ACID PROTEASE)
3v76:A (GLY211) to (THR232) THE CRYSTAL STRUCTURE OF A FLAVOPROTEIN FROM SINORHIZOBIUM MELILOTI | STRUCTURAL GENOMICS, PSI-BIOLOGY, NEW YORK STRUCTURAL GENOMICS RESEARCH CONSORTIUM, NYSGRC, FLAVOPROTEIN
2vpf:C (THR71) to (LEU97) VASCULAR ENDOTHELIAL GROWTH FACTOR REFINED TO 1.93 ANGSTROMS RESOLUTION | GROWTH FACTOR, CYSTINE KNOT, ANGIOGENESIS, VASCULOGENESIS
2vpf:D (THR71) to (LEU97) VASCULAR ENDOTHELIAL GROWTH FACTOR REFINED TO 1.93 ANGSTROMS RESOLUTION | GROWTH FACTOR, CYSTINE KNOT, ANGIOGENESIS, VASCULOGENESIS
3i1i:A (ILE3) to (GLY32) X-RAY CRYSTAL STRUCTURE OF HOMOSERINE O-ACETYLTRANSFERASE FROM BACILLUS ANTHRACIS | STRUCTURAL GENOMICS, IDP01610, HOMOSERINE, O-ACETYLTRANSFERASE, BACILLUS ANTHRACIS, TRANSFERASE, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID
3i1i:B (ILE3) to (GLY32) X-RAY CRYSTAL STRUCTURE OF HOMOSERINE O-ACETYLTRANSFERASE FROM BACILLUS ANTHRACIS | STRUCTURAL GENOMICS, IDP01610, HOMOSERINE, O-ACETYLTRANSFERASE, BACILLUS ANTHRACIS, TRANSFERASE, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID
1sme:B (TRP193) to (SER215) PLASMEPSIN II, A HEMOGLOBIN-DEGRADING ENZYME FROM PLASMODIUM FALCIPARUM, IN COMPLEX WITH PEPSTATIN A | ASPARTYL PROTEINASE, ASPARTIC PROTEINASE, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
2vs2:A (ASP88) to (ALA109) NEUTRON DIFFRACTION STRUCTURE OF ENDOTHIAPEPSIN IN COMPLEX WITH A GEM-DIOL INHIBITOR. | ACID PROTEINASE, ASPARTYL PROTEASE, ZYMOGEN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4kup:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH 20MM ACYLHYDRAZONE INHIBITOR | HYDROLASE, ASPARTIC PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3i6o:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF WILD TYPE HIV-1 PROTEASE WITH MACROCYCLIC INHIBITOR GRL-0216A | HIV-1, WILD TYPE PROTEASE, PROTEASE INHIBITOR, MACROCYCLIC LIGAND, AIDS, ASPARTYL PROTEASE, HYDROLASE
2vvl:E (MET1) to (PRO20) THE STRUCTURE OF MAO-N-D3, A VARIANT OF MONOAMINE OXIDASE FROM ASPERGILLUS NIGER. | MONOAMINE OXIDASE, ASPERGILLUS NIGER, FAD, PEROXISOME, FLAVOPROTEIN, OXIDOREDUCTASE, ENANTIOSELECTIVITY, DIRECTED EVOLUTION VARIANT
1gvt:A (ASP88) to (ALA109) ENDOTHIAPEPSIN COMPLEX WITH CP-80,794 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ASPARTIC PROTEINASE MECHANISM, TETRAHEDRAL INTERMEDIATE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1gvu:A (ASP88) to (ALA109) ENDOTHIAPEPSIN COMPLEX WITH H189 | HYDROLASE, ASPARTIC PROTEINASE MECHANISM, ATOMIC RESOLUTION, Z TETRAHEDRAL INTERMEDIATE, ANISOTROPIC REFINEMENT, ASPARTYL P, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1gvv:A (ASP88) to (ALA109) FIVE ATOMIC RESOLUTION STRUCTURES OF ENDOTHIAPEPSIN INHIBITOR COMPLEXES; IMPLICATIONS FOR THE ASPARTIC PROTEINASE MECHANISM | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ASPARTIC PROTEINASE MECHANISM, Z TETRAHEDRAL INTERMEDIATE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1gvw:A (ASP88) to (ALA109) ENDOTHIAPEPSIN COMPLEX WITH PD-130,328 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ASPARTIC PROTEINASE MECHANISM, TETRAHEDRAL INTERMEDIATE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1gvx:A (ASP88) to (ALA109) ENDOTHIAPEPSIN COMPLEXED WITH H256 | HYDROLASE, ASPARTIC PROTEINASE MECHANISM, TETRAHEDRAL INTERMEDIATE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4kzn:A (THR71) to (LEU97) CRYSTAL STRUCTURE OF HUMAN VEGF-A RECEPTOR BINDING DOMAIN | VEGF A, PDGF FAMILY, RECEPTOR BINDING, HORMONE
3ia9:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF A CHEMICALLY SYNTHESIZED [D25N]HIV-1 PROTEASE MOLECULE COMPLEXED WITH MVT-101 REDUCED ISOSTERE INHIBITOR | BETA-SHEET, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3vf1:A (LEU76) to (ILE109) STRUCTURE OF A CALCIUM-DEPENDENT 11R-LIPOXYGENASE SUGGESTS A MECHANISM FOR CA-REGULATION | LOX, PLAT, BETA SANDWICH, C2-LIKE DOMAIN, NON-HEME IRON, CONFORMATIONAL CHANGE, DIOXYGENASE, OXIDOREDUCTASE
3vf1:B (LEU76) to (ILE109) STRUCTURE OF A CALCIUM-DEPENDENT 11R-LIPOXYGENASE SUGGESTS A MECHANISM FOR CA-REGULATION | LOX, PLAT, BETA SANDWICH, C2-LIKE DOMAIN, NON-HEME IRON, CONFORMATIONAL CHANGE, DIOXYGENASE, OXIDOREDUCTASE
3vfa:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF HIV-1 PROTEASE MUTANT V82A WITH NOVEL P1'-LIGANDS GRL-02031 | PROTEASE INHIBITOR,P1'-LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3ial:B (LEU167) to (CYS200) GIARDIA LAMBLIA PROLYL-TRNA SYNTHETASE IN COMPLEX WITH PROLYL- ADENYLATE | AMINOACYL-TRNA SYNTHETASE, TRNA LIGASE, AARS, PRORS, CYSRS, PRO(CYS) RS, TRANSLATION, ATP-BINDING, NUCLEOTIDE-BINDING, STRUCTURAL GENOMICS, MEDICAL STRUCTURAL GENOMICS OF PATHOGENIC PROTAZOA, MSGPP, LIGASE, MEDICAL STRUCTURAL GENOMICS OF PATHOGENIC PROTOZOA
3vhe:A (GLY846) to (MET869) CRYSTAL STRUCTURE OF HUMAN VEGFR2 KINASE DOMAIN WITH A NOVEL PYRROLOPYRIMIDINE INHIBITOR. | KINASE DOMAIN, KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
4l1p:B (GLY407) to (HIS430) CRYSTAL STRUCTURE OF HUMAN RTF1 PLUS3 DOMAIN | TUTOR, PLUS3, PEPTIDE BINDING PROTEIN, SPT5 CTR BINDING, TRANSCRIPTION, PAF1 COMPLEX, RTF1, ORF ASSOCIATION REGION, CHROMATIN
4zk7:U (ALA29) to (LYS58) CRYSTAL STRUCTURE OF RESCUED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T33-31 | TETRAHEDRAL, COMPUTATIONAL DESIGN, ROSETTA, SELF-ASSEMBLY, SYMMETRIC, NANOMATERIAL, SOLUBILITY, PROTEIN BINDING
2gk3:C (ASP154) to (ALA189) CYTOPLASMIC PROTEIN STM3548 FROM SALMONELLA TYPHIMURIUM | SALMONELLA TYPHIMURIUM, STM3548, STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, UNKNOWN FUNCTION
3ibj:B (GLN273) to (PRO291) X-RAY STRUCTURE OF PDE2A | PHOSPHODIESTERASE, PDE2A, GAF-DOMAINS, ALLOSTERIC REGULATION, CGMP, HYDROLASE, MEMBRANE
4l3l:A (GLU69) to (THR89) CRYSTAL STRUCTURES OF HUMAN P70S6K1 KINASE DOMAIN (ZINC ANOMALOUS) | PROTEIN KINASE, TRANSFERASE
1t3r:A (ARG57) to (GLY78) HIV PROTEASE WILD-TYPE IN COMPLEX WITH TMC114 INHIBITOR | HIV-1 PROTEASE; DRUG RESISTANCE; THERMODYNAMICS; SUBSTRATE ENVELOPE, HYDROLASE
4l42:A (GLU69) to (THR89) CRYSTAL STRUCTURES OF HUMAN P70S6K1-PIF | PROTEIN KINASE, TRANSFERASE
4l43:A (CYS67) to (THR89) CRYSTAL STRUCTURES OF HUMAN P70S6K1-T389A (FORM I) | PROTEIN KINASE, TRANSFERASE
3icj:A (CYS34) to (SER59) CRYSTAL STRUCTURE OF AN UNCHARACTERIZED METAL-DEPENDENT HYDROLASE FROM PYROCOCCUS FURIOSUS | STRUCTURAL GENOMICS, AMIDOHYDROLASE, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC, HYDROLASE
1t45:A (GLY601) to (LEU625) STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C- KIT TYROSINE KINASE | KINASE, AUTOINHIBITION,, TRANSFERASE ACTIVATOR
4zls:A (ARG57) to (GLY78) HIV-1 WILD TYPE PROTEASE WITH GRL-096-13A (A BOC-DERIVATIVE P2-LIGAND, 3,-5-DIMETHYLBIPHENYL P1-LIGAND) | MULTIDRUG-RESISTANT STRAINS, HYDROLASE INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1h4s:A (LEU133) to (ALA166) PROLYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS COMPLEXED WITH TRNAPRO(CGG) AND A PROLYL-ADENYLATE ANALOGUE | AMINOACYL-TRNA SYNTHETASE, ATP + L-PROLINE + TRNA(PRO) AMP + PPI + L-PROLYL-TRNA(PRO), CLASS II AMINOACYL-TRNA SYNTHETASE
1h4s:B (LEU133) to (ALA166) PROLYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS COMPLEXED WITH TRNAPRO(CGG) AND A PROLYL-ADENYLATE ANALOGUE | AMINOACYL-TRNA SYNTHETASE, ATP + L-PROLINE + TRNA(PRO) AMP + PPI + L-PROLYL-TRNA(PRO), CLASS II AMINOACYL-TRNA SYNTHETASE
1h4t:B (LEU133) to (ALA166) PROLYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS COMPLEXED WITH L-PROLINE | AMINOACYL-TRNA SYNTHETASE, ATP + L-PROLINE + TRNA(PRO) AMP + PPI + L-PROLYL-TRNA(PRO), CLASS II AMINOACYL-TRNA SYNTHETASE
1h4t:C (LEU133) to (ALA166) PROLYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS COMPLEXED WITH L-PROLINE | AMINOACYL-TRNA SYNTHETASE, ATP + L-PROLINE + TRNA(PRO) AMP + PPI + L-PROLYL-TRNA(PRO), CLASS II AMINOACYL-TRNA SYNTHETASE
1h4t:D (LEU133) to (ALA166) PROLYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS COMPLEXED WITH L-PROLINE | AMINOACYL-TRNA SYNTHETASE, ATP + L-PROLINE + TRNA(PRO) AMP + PPI + L-PROLYL-TRNA(PRO), CLASS II AMINOACYL-TRNA SYNTHETASE
4l6b:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH THIOPHEN-BASED INHIBITOR SAP128 | ASPARTATE PROTEASE, INHIBITOR COMPLEX, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1t6e:X (ALA94) to (PRO126) CRYSTAL STRUCTURE OF THE TRITICUM AESTIVUM XYLANASE INHIBITOR I | TWO BETA-BARREL DOMAIN STRUCTURE, HYDROLASE INHIBITOR
1t7i:A (ARG57) to (GLY78) THE STRUCTURAL AND THERMODYNAMIC BASIS FOR THE BINDING OF TMC114, A NEXT-GENERATION HIV-1 PROTEASE INHIBITOR. | HIV-1 PROTEASE, DRUG RESITANCE, THERMODYNAMICS, SUBSTRATE ENVELOPE, HYDROLASE
1t7i:B (GLY52) to (GLY78) THE STRUCTURAL AND THERMODYNAMIC BASIS FOR THE BINDING OF TMC114, A NEXT-GENERATION HIV-1 PROTEASE INHIBITOR. | HIV-1 PROTEASE, DRUG RESITANCE, THERMODYNAMICS, SUBSTRATE ENVELOPE, HYDROLASE
1t7k:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF HIV PROTEASE COMPLEXED WITH ARYLSULFONAMIDE AZACYCLIC UREA | HIV PROTEASE, ARYLSULFONAMIDE AZACYCLIC UREA, HYDROLASE
2gqf:A (GLY213) to (PHE234) CRYSTAL STRUCTURE OF FLAVOPROTEIN HI0933 FROM HAEMOPHILUS INFLUENZAE RD | STRUCTURAL GENOMICS, FAD-UTILIZING PROTEIN, FLAVOPROTEIN, PSI, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC, UNKNOWN FUNCTION
2gs7:A (PHE699) to (LEU723) CRYSTAL STRUCTURE OF THE INACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP | EGFR, KINASE, INACTIVE, AMP-PNP, TRANSFERASE
2gse:A (ASP408) to (GLN449) CRYSTAL STRUCTURE OF HUMAN DIHYDROPYRIMIDINEASE-LIKE 2 | ALPHA/BETA BARREL, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, DIHYDROPYRIMIDINASE-RELATED PROTEIN 2, DRP2, COLLAPSIN RESPONSE MEDIATOR PROTEIN 2, CRMP2, HYDROLASE
3ije:A (TYR290) to (ALA322) CRYSTAL STRUCTURE OF THE COMPLETE INTEGRIN ALHAVBETA3 ECTODOMAIN PLUS AN ALPHA/BETA TRANSMEMBRANE FRAGMENT | INTEGRIN STRUCTURE, ACTIVATION, EGF DOMAINS, FLIM, CELL SIGNALING, CELL ADHESION, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, INTEGRIN, MEMBRANE, RECEPTOR, TRANSMEMBRANE, DISEASE MUTATION, PHOSPHOPROTEIN, PROTEIN BINDING
4lap:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH THIOPHEN-BASED INHIBITOR SAP114 | ASPARTATE PROTEASE, INHIBITOR COMPLEX, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4lbt:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH 100MM ACYLHYDRAZONE INHIBITOR | HYDROLASE, ASPARTIC PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4zrx:A (GLY417) to (GLY443) CRYSTAL STRUCTURE OF A PUTATIVE ALPHA-L-FUCOSIDASE (BACOVA_04357) FROM BACTEROIDES OVATUS ATCC 8483 AT 1.59 A RESOLUTION | SUGAR BINDING PROTEIN, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI- BIOLOGY, HYDROLASE
1tdt:A (SER231) to (LYS254) THREE-DIMENSIONAL STRUCTURE OF TETRAHYDRODIPICOLINATE-N- SUCCINLYTRANSFERASE | TRANSFERASE, SUCCINYLTRANSFERASE, LYSINE METABOLISM, HEXAPEPTIDE TRANSFERASE, CELL WALL BIOSYNTHESIS
1tdt:B (SER231) to (LYS254) THREE-DIMENSIONAL STRUCTURE OF TETRAHYDRODIPICOLINATE-N- SUCCINLYTRANSFERASE | TRANSFERASE, SUCCINYLTRANSFERASE, LYSINE METABOLISM, HEXAPEPTIDE TRANSFERASE, CELL WALL BIOSYNTHESIS
1tdt:C (SER231) to (LYS254) THREE-DIMENSIONAL STRUCTURE OF TETRAHYDRODIPICOLINATE-N- SUCCINLYTRANSFERASE | TRANSFERASE, SUCCINYLTRANSFERASE, LYSINE METABOLISM, HEXAPEPTIDE TRANSFERASE, CELL WALL BIOSYNTHESIS
1hbv:A (ARG57) to (GLY78) A CHECK ON RATIONAL DRUG DESIGN. CRYSTAL STRUCTURE OF A COMPLEX OF HIV-1 PROTEASE WITH A NOVEL GAMMA-TURN MIMETIC | HYDROLASE (ACID PROTEASE)
1hbv:B (ARG57) to (GLY78) A CHECK ON RATIONAL DRUG DESIGN. CRYSTAL STRUCTURE OF A COMPLEX OF HIV-1 PROTEASE WITH A NOVEL GAMMA-TURN MIMETIC | HYDROLASE (ACID PROTEASE)
1hc7:B (LEU133) to (ALA166) PROLYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS | AMINOACYL-TRNA SYNTHETASE, ATP + L-PROLINE + TRNA(PRO) AMP + PPI + L-PROLYL-TRNA(PRO), CLASS II AMINOACYL-TRNA SYNTHETASE
1hdy:B (LYS5) to (PRO30) THREE-DIMENSIONAL STRUCTURES OF THREE HUMAN ALCOHOL DEHYDROGENASE VARIANTS: CORRELATIONS WITH THEIR FUNCTIONAL DIFFERENCES | OXIDOREDUCTASE(NAD(A)-CHOH(D))
1hef:E (ARG57) to (GLY78) THE CRYSTAL STRUCTURES AT 2.2 ANGSTROMS RESOLUTION OF HYDROXYETHYLENE- BASED INHIBITORS BOUND TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE SHOW THAT THE INHIBITORS ARE PRESENT IN TWO DISTINCT ORIENTATIONS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4lhh:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH 2MM ACYLHYDRAZONE INHIBITOR | HYDROLASE, ASPARTIC PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
2h5d:A (THR163) to (ASN184) 0.9A RESOLUTION CRYSTAL STRUCTURE OF ALPHA-LYTIC PROTEASE COMPLEXED WITH A TRANSITION STATE ANALOGUE, MEOSUC-ALA-ALA-PRO-VAL BORONIC ACID | A-LYTIC PROTEASE, SERINE PROTEASE, ACYLATION TRANSITION STATE, CATALYSIS, PROTEIN FOLDING, PROTEIN STABILITY, PACKING DISTORTION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
2hak:E (ASN52) to (LEU74) CATALYTIC AND UBIQUTIN-ASSOCIATED DOMAINS OF MARK1/PAR-1 | SERINE/THREONINE PROTEIN KINASE; MARK; PAR-1; KIN1; UBA DOMAIN, SIGNALING PROTEIN,TRANSFERASE
3iuu:A (ASN346) to (LYS372) CRYSTAL STRUCTURE OF PUTATIVE METALLOPEPTIDASE (YP_676511.1) FROM MESORHIZOBIUM SP. BNC1 AT 2.13 A RESOLUTION | YP_676511.1, PUTATIVE METALLOPEPTIDASE, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, HYDROLASE
2hc0:B (ARG2157) to (GLY2178) STRUCTURE OF HIV PROTEASE 6X MUTANT IN COMPLEX WITH AB-2. | HIV, PROTEASE, MUTANT, ASPARTYL, HYDROLASE
1hps:B (ARG57) to (GLY78) RATIONAL DESIGN, SYNTHESIS AND CRYSTALLOGRAPHIC ANALYSIS OF A HYDROXYETHYLENE-BASED HIV-1 PROTEASE INHIBITOR CONTAINING A HETEROCYCLIC P1'-P2' AMIDE BOND ISOSTERE | HYDROLASE(ACID PROTEINASE)
1hpv:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF HIV-1 PROTEASE IN COMPLEX WITH VX-478, A POTENT AND ORALLY BIOAVAILABLE INHIBITOR OF THE ENZYME | HYDROLASE (ACID PROTEINASE)
1hpx:B (ARG57) to (GLY78) HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR KNI-272 | ACID PROTEASE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3vo3:A (GLY846) to (MET869) CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN VEGFR2 WITH IMIDAZO[1, 2-B]PYRIDAZINE DERIVATIVE | VEGFR2, KINASE DOMAIN, TYROSIN-PROTEIN KINASE, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX
2wea:A (ASN84) to (ALA105) ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL[CYCLO-7[(2R)-((N-VALYL) AMINO)-2-(HYDROXYL-(1S)-1-METHYOXYCARBONYL-2-PHENYLETHOXY) PHOSPHINYLOXY-ETHYL]-1-NAPHTHALENEACETAMIDE], SODIUM SALT | PENICILLOPEPSIN, PHOSPHONATE INHIBITOR, HYDROLASE
2web:A (ASN84) to (ALA105) ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL(2S)-[1-(((N-FORMYL)-L- VALYL)AMINO-2-(2-NAPHTHYL)ETHYL)HYDROXYPHOSPHINYLOXY]-3- PHENYLPROPANOATE, SODIUM SALT | PENICILLOPEPSIN, PHOSPHONATE INHIBITOR, HYDROLASE
2hen:A (GLU642) to (LEU663) CRYSTAL STRUCTURE OF THE EPHB2 RECEPTOR KINASE DOMAIN IN COMPLEX WITH ADP | EPH KINASE DOMAIN, ACTIVATION, TRANSFERASE
2hen:C (GLU642) to (LEU663) CRYSTAL STRUCTURE OF THE EPHB2 RECEPTOR KINASE DOMAIN IN COMPLEX WITH ADP | EPH KINASE DOMAIN, ACTIVATION, TRANSFERASE
1hsg:A (ARG57) to (GLY78) CRYSTAL STRUCTURE AT 1.9 ANGSTROMS RESOLUTION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) II PROTEASE COMPLEXED WITH L- 735,524, AN ORALLY BIOAVAILABLE INHIBITOR OF THE HIV PROTEASES | HYDROLASE (ACID PROTEINASE)
1tve:A (ASN282) to (ASP306) HOMOSERINE DEHYDROGENASE IN COMPLEX WITH 4-(4-HYDROXY-3- ISOPROPYLPHENYLTHIO)-2-ISOPROPYLPHENOL | ANTIFUNGAL; SMALL MOLECULE SCREENING; AMINO ACID BIOSYNTHESIS, OXIDOREDUCTASE
1hsz:A (LYS5) to (ALA29) HUMAN BETA-1 ALCOHOL DEHYDROGENASE (ADH1B*1) | ROSSMANN FOLD, ALCOHOL DEHYDROGENASE, ZINC, OXIDOREDUCTASE
1hso:A (LYS5) to (ALA29) HUMAN ALPHA ALCOHOL DEHYDROGENASE (ADH1A) | ROSSMANN FOLD, ALCOHOL DEHYDROGENASE, OXIDOREDUCTASE
1ht0:B (LYS5) to (ALA29) HUMAN GAMMA-2 ALCOHOL DEHYDROGENSE | ROSSMANN FOLD, ALCOHOL DEHYDROGENASE, ZINC, OXIDOREDUCTASE
1hte:A (ARG57) to (GLY78) X-RAY CRYSTALLOGRAPHIC STUDIES OF A SERIES OF PENICILLIN- DERIVED ASYMMETRIC INHIBITORS OF HIV-1 PROTEASE | HYDROLASE(ACID PROTEINASE)
1huj:A (TRP52) to (VAL80) REFINED STRUCTURE OF YEAST INORGANIC PYROPHOSPHATASE AND ITS K61R MUTANT | HYDROLASE, MAGNESIUM, 3D-STRUCTURE
1huk:A (TRP52) to (VAL80) REFINED STRUCTURE OF YEAST INORGANIC PYROPHOSPHATASE AND ITS K61R MUTANT | HYDROLASE, MAGNESIUM, 3D-STRUCTURE
1huk:B (TRP52) to (VAL80) REFINED STRUCTURE OF YEAST INORGANIC PYROPHOSPHATASE AND ITS K61R MUTANT | HYDROLASE, MAGNESIUM, 3D-STRUCTURE
1hvc:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF A TETHERED DIMER OF HIV-1 PROTEASE COMPLEXED WITH AN INHIBITOR | HYDROLASE(ACID PROTEASE)
1hvr:A (ARG57) to (GLY78) RATIONAL DESIGN OF POTENT, BIOAVAILABLE, NONPEPTIDE CYCLIC UREAS AS HIV PROTEASE INHIBITORS | HYDROLASE, ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1hvs:B (ARG57) to (GLY78) STRUCTURAL BASIS OF DRUG RESISTANCE FOR THE V82A MUTANT OF HIV-1 PROTEASE: BACKBONE FLEXIBILITY AND SUBSITE REPACKING | HYDROLASE (ACID PROTEASE)
2hma:A (PHE303) to (LYS325) THE CRYSTAL STRUCTURE OF TRNA (5-METHYLAMINOMETHYL-2-THIOURIDYLATE)- METHYLTRANSFERASE TRMU FROM STREPTOCOCCUS PNEUMONIAE | ALPHA-BETA, BETA BARREL, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, TRANSFERASE
1hvz:A (GLY1) to (ARG18) RTD-1, A CYCLIC ANTIMICROBIAL DEFENSIN FROM RHESUS MACAQUE LEUKOCYTES | CYCLIC, BETA-SHEET, DISULFIDE-RICH, ANTIMICROBIAL PROTEIN
1hwr:B (ARG57) to (GLY78) MOLECULAR RECOGNITION OF CYCLIC UREA HIV PROTEASE INHIBITORS | ASPARTYL PROTEASE, HYDROLASE, ACID PROTEINASE
1hxw:A (ARG57) to (GLY78) HIV-1 PROTEASE DIMER COMPLEXED WITH A-84538 | ASPARTYL PROTEASE, HYDROLASE, ASPARTIC PROTEINASE, HIV, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
3vu8:A (ASP116) to (ARG162) METIONYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS COMPLEXED WITH METHIONYL-ADENYLATE ANALOGUE | PROTEIN MET-AMP COMPLEX, LIGASE
4lp9:A (ASP83) to (ALA104) ENDOTHIAPEPSIN COMPLEXED WITH PHE-REDUCED-TYR PEPTIDE. | ASPARTIC PROTEINASE FOLD, PROTEOLYSIS, HYDROLASE (ACID PROTEINASE), HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4lq8:A (CYS214) to (LYS249) RICKETTSIA RICKETTSII CELL SURFACE ANTIGEN 4 (SCA4) HEAD DOMAIN (RESIDUES 21-360) | CELL ADHESION
4lq8:B (CYS214) to (LYS249) RICKETTSIA RICKETTSII CELL SURFACE ANTIGEN 4 (SCA4) HEAD DOMAIN (RESIDUES 21-360) | CELL ADHESION
3vvl:A (ARG10) to (GLY37) CRYSTAL STRUCTURE OF L-SERINE-O-ACETYLTRANSFERASE FOUND IN D- CYCLOSERINE BIOSYNTHETIC PATHWAY | D-CYCLOSERINE, ALPHA/BETA HYDROLASE DOMAIN, L-SERINE-O- ACETYLTRANSFERASE, TRANSFERASE
1tzs:A (GLY89) to (THR117) CRYSTAL STRUCTURE OF AN ACTIVATION INTERMEDIATE OF CATHEPSIN E | HYDROLASE, ASPARTIC PROTEASE, ACTIVATION INTERMEDIATE
2wns:B (ALA20) to (LEU40) HUMAN OROTATE PHOSPHORIBOSYLTRANSFERASE (OPRTASE) DOMAIN OF URIDINE 5'-MONOPHOSPHATE SYNTHASE (UMPS) IN COMPLEX WITH ITS SUBSTRATE OROTIDINE 5'-MONOPHOSPHATE (OMP) | ALTERNATIVE SPLICING, MULTIFUNCTIONAL ENZYME, LYASE, TRANSFERASE, POLYMORPHISM, DECARBOXYLASE, PHOSPHOPROTEIN, DISEASE MUTATION, GLYCOSYLTRANSFERASE, PYRIMIDINE BIOSYNTHESIS
3vys:B (PHE274) to (LEU295) CRYSTAL STRUCTURE OF THE HYPC-HYPD-HYPE COMPLEX (FORM I) | [NIFE] HYDROGENASE MATURATION, METAL BINDING PROTEIN-TRANSFERASE COMPLEX
1i44:A (GLY1008) to (VAL1032) CRYSTALLOGRAPHIC STUDIES OF AN ACTIVATION LOOP MUTANT OF THE INSULIN RECEPTOR TYROSINE KINASE | PROTEIN TYROSINE KINASE, PHOSPHOTRANSFERASE
1u3t:A (LYS5) to (ALA29) CRYSTAL STRUCTURE OF HUMAN ALCOHOL DEHYDROGENASE ALPHA- ALPHA ISOFORM COMPLEXED WITH N-CYCLOPENTYL-N- CYCLOBUTYLFORMAMIDE DETERMINED TO 2.5 ANGSTROM RESOLUTION | OXIDOREDUCTASE
1u3t:B (LYS5) to (ALA29) CRYSTAL STRUCTURE OF HUMAN ALCOHOL DEHYDROGENASE ALPHA- ALPHA ISOFORM COMPLEXED WITH N-CYCLOPENTYL-N- CYCLOBUTYLFORMAMIDE DETERMINED TO 2.5 ANGSTROM RESOLUTION | OXIDOREDUCTASE
1u3v:A (LYS5) to (ALA29) CRYSTAL STRUCTURE OF HUMAN ALCOHOL DEHYDROGENASE BETA-1- BETA-1 ISOFORM COMPLEXED WITH N-HEPTYLFORMAMIDE DETERMINED TO 1.65 ANGSTROM RESOLUTION | OXIDOREDUCTASE
1u3w:A (LYS5) to (PRO30) CRYSTAL STRUCTURE OF HUMAN ALCOHOL DEHYDROGENASE GAMMA-2- GAMMA-2 ISOFORM COMPLEXED WITH N-1-METHYLHEPTYLFORMAMIDE DETERMINED TO 1.45 ANGSTROM RESOLUTION | OXIDOREDUCTASE
1u5u:A (GLY70) to (ALA104) THE STRUCTURE OF AN ALLENE OXIDE SYNTHASE REVEALS A NOVEL USE FOR A CATALASE FOLD | ALLENE OXIDE SYNTHASE, CATALASE, HEME, EICOSANOID, FUSION PROTEIN, LYASE
3w4s:A (MET1) to (GLY27) MYO-INOSITOL KINASE FROM THERMOCOCCUS KODAKARENSIS | KINASE, TRANSFERASE
4m0l:B (GLU252) to (LYS275) GAMMA SUBUNIT OF THE TRANSLATION INITIATION FACTOR 2 FROM SULFOLOBUS SOLFATARICUS COMPLEXED WITH GDP | AIF2, AIF2 GAMMA SUBUNIT, G-PROTEIN, TRANSLATION, TRANSLATION INITIATION, PROTEIN BIOSYNTHESIS, RNA-BINDING, GTP-BINDING, NUCLEOTIDE-BINDING
2i0a:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF KB-19 COMPLEXED WITH WILD TYPE HIV-1 PROTEASE | DRUG DESIGN, HIV-1 PROTEASE, PROTEASE INHIBITORS, HYDROLASE
2i0d:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF AD-81 COMPLEXED WITH WILD TYPE HIV-1 PROTEASE | DRUG DESIGN, HIV-1 PROTEASE, PROTEASE INHIBITORS, HYDROLASE
1ida:A (LYS57) to (GLY78) CRYSTAL STRUCTURES OF HIV-2 PROTEASE IN COMPLEX WITH INHIBITORS CONTAINING THE HYDROXYETHYLAMINE DIPEPTIDE ISOSTERE | ACID PROTEINASE, AIDS, PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1ida:B (GLY52) to (GLY78) CRYSTAL STRUCTURES OF HIV-2 PROTEASE IN COMPLEX WITH INHIBITORS CONTAINING THE HYDROXYETHYLAMINE DIPEPTIDE ISOSTERE | ACID PROTEINASE, AIDS, PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1idb:B (GLY52) to (GLY78) CRYSTAL STRUCTURES OF HIV-2 PROTEASE IN COMPLEX WITH INHIBITORS CONTAINING THE HYDROXYETHYLAMINE DIPEPTIDE ISOSTERE | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1ig0:A (ALA259) to (SER278) CRYSTAL STRUCTURE OF YEAST THIAMIN PYROPHOSPHOKINASE | PROTEIN-SUBSTRATE COMPLEX, COMPOUND ACTIVE SITE, ALPHA-BETA- ALPHA, BETA SANDWICH, TRANSFERASE
1ig0:B (GLU258) to (SER278) CRYSTAL STRUCTURE OF YEAST THIAMIN PYROPHOSPHOKINASE | PROTEIN-SUBSTRATE COMPLEX, COMPOUND ACTIVE SITE, ALPHA-BETA- ALPHA, BETA SANDWICH, TRANSFERASE
1ig3:A (GLN210) to (PHE231) MOUSE THIAMIN PYROPHOSPHOKINASE COMPLEXED WITH THIAMIN | BETA BARREL, ALPHA/BETA/ALPHA SANDWICH, TRANSFERASE
3w6i:A (PHE93) to (ASN124) CRYSTAL STRUCTURE OF 19F PROBE-LABELED HCAI | 19F-NMR, SEMISYNTHETIC BIOSENSOR, CHEMICAL BIOLOGY, LYASE
3w6i:E (PHE93) to (ASN124) CRYSTAL STRUCTURE OF 19F PROBE-LABELED HCAI | 19F-NMR, SEMISYNTHETIC BIOSENSOR, CHEMICAL BIOLOGY, LYASE
2i5y:G (SER115) to (SER209) CRYSTAL STRUCTURE OF CD4M47, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B | HIV-1, GP120, YU2, SCORPION TOXIN, CD4 MIMIC, CD4M47, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1ukq:B (ASP585) to (PRO643) CRYSTAL STRUCTURE OF CYCLODEXTRIN GLUCANOTRANSFERASE COMPLEXED WITH A PSEUDO-MALTOTETRAOSE DERIVED FROM ACARBOSE | CGTASE, ACARBOSE, CARBOHYDRATE-PROTEIN COMPLEX, TRANSFERASE
1ukt:A (ASP585) to (PRO643) CRYSTAL STRUCTURE OF Y100L MUTANT CYCLODEXTRIN GLUCANOTRANSFERASE COMPEXED WITH AN ACARBOSE | CGTASE, ACARBOSE, CARBOHYDRATE/PROTEIN INTERACTION, TRANSFERASE
1io6:A (ASN36) to (PRO50) GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2 (GRB2) C-TERMINAL SH3 DOMAIN COMPLEXED WITH A LIGAND PEPTIDE (NMR, MINIMIZED MEAN STRUCTURE) | SIGNAL TRANSDUCTION, SH3 DOMAIN, PROLINE-RICH PEPTIDE, COMPLEX (SH3 DOMAIN/PEPTIDE), SIGNALING PROTEIN
4m4p:A (THR147) to (GLY174) CRYSTAL STRUCTURE OF EPHA4 ECTODOMAIN | EPH RECEPTOR PROTEIN KINASE, TRANSFERASE
1upj:A (ARG57) to (GLY78) HIV-1 PROTEASE COMPLEX WITH U095438 [3-[1-(4-BROMOPHENYL) ISOBUTYL]-4- HYDROXYCOUMARIN | HYDROLASE (ACID PROTEASE)
2wyr:A (MET62) to (ASP87) 3-D STRUCTURE OF PHTET1-12S, DODECAMER IN THE ASYMMETRIC UNIT | HYDROLASE, LARGE SELF-ASSEMBLED DODECAMER, HYPERTHERMOPHILIC
2wyr:B (MET393) to (ASP418) 3-D STRUCTURE OF PHTET1-12S, DODECAMER IN THE ASYMMETRIC UNIT | HYDROLASE, LARGE SELF-ASSEMBLED DODECAMER, HYPERTHERMOPHILIC
2wyr:C (MET724) to (ASP749) 3-D STRUCTURE OF PHTET1-12S, DODECAMER IN THE ASYMMETRIC UNIT | HYDROLASE, LARGE SELF-ASSEMBLED DODECAMER, HYPERTHERMOPHILIC
2wyr:D (MET1055) to (ASP1080) 3-D STRUCTURE OF PHTET1-12S, DODECAMER IN THE ASYMMETRIC UNIT | HYDROLASE, LARGE SELF-ASSEMBLED DODECAMER, HYPERTHERMOPHILIC
2wyr:F (MET1717) to (ASP1742) 3-D STRUCTURE OF PHTET1-12S, DODECAMER IN THE ASYMMETRIC UNIT | HYDROLASE, LARGE SELF-ASSEMBLED DODECAMER, HYPERTHERMOPHILIC
2wyr:G (MET2048) to (ASP2073) 3-D STRUCTURE OF PHTET1-12S, DODECAMER IN THE ASYMMETRIC UNIT | HYDROLASE, LARGE SELF-ASSEMBLED DODECAMER, HYPERTHERMOPHILIC
2wyr:H (MET2379) to (ASP2404) 3-D STRUCTURE OF PHTET1-12S, DODECAMER IN THE ASYMMETRIC UNIT | HYDROLASE, LARGE SELF-ASSEMBLED DODECAMER, HYPERTHERMOPHILIC
2wyr:I (MET2710) to (ASP2735) 3-D STRUCTURE OF PHTET1-12S, DODECAMER IN THE ASYMMETRIC UNIT | HYDROLASE, LARGE SELF-ASSEMBLED DODECAMER, HYPERTHERMOPHILIC
2wyr:J (MET3041) to (ASP3066) 3-D STRUCTURE OF PHTET1-12S, DODECAMER IN THE ASYMMETRIC UNIT | HYDROLASE, LARGE SELF-ASSEMBLED DODECAMER, HYPERTHERMOPHILIC
2wyr:K (MET3372) to (ASP3397) 3-D STRUCTURE OF PHTET1-12S, DODECAMER IN THE ASYMMETRIC UNIT | HYDROLASE, LARGE SELF-ASSEMBLED DODECAMER, HYPERTHERMOPHILIC
2wyr:L (MET3703) to (ASP3728) 3-D STRUCTURE OF PHTET1-12S, DODECAMER IN THE ASYMMETRIC UNIT | HYDROLASE, LARGE SELF-ASSEMBLED DODECAMER, HYPERTHERMOPHILIC
1ivt:A (GLU460) to (LYS490) NMR STRUCTURES OF THE C-TERMINAL GLOBULAR DOMAIN OF HUMAN LAMIN A/C | BETA BARREL, ALL SHEET, IG-FOLD, STRUCTURAL PROTEIN
1usr:A (ARG485) to (SER508) NEWCASTLE DISEASE VIRUS HEMAGGLUTININ-NEURAMINIDASE: EVIDENCE FOR A SECOND SIALIC ACID BINDING SITE AND IMPLICATIONS FOR FUSION | HYDROLASE, SIALIDASE, NEURAMINIDASE, HEMAGGLUTININ-NEURAMINIDASE, HEMAGGLUTININ, GLYCOPROTEIN
1usr:B (ARG485) to (SER508) NEWCASTLE DISEASE VIRUS HEMAGGLUTININ-NEURAMINIDASE: EVIDENCE FOR A SECOND SIALIC ACID BINDING SITE AND IMPLICATIONS FOR FUSION | HYDROLASE, SIALIDASE, NEURAMINIDASE, HEMAGGLUTININ-NEURAMINIDASE, HEMAGGLUTININ, GLYCOPROTEIN
1usx:B (ARG485) to (SER508) CRYSTAL STRUCTURE OF THE NEWCASTLE DISEASE VIRUS HEMAGGLUTININ-NEURAMINIDASE COMPLEXED WITH THIOSIALOSIDE | HYDROLASE, NEURAMINIDASE, HEMAGGLUTININ, SIALIDASE
3wdz:A (LEU373) to (ASN397) CRYSTAL STRUCTURE OF KEAP1 IN COMPLEX WITH PHOSPHORYLATED P62 | KELCH REPEAT, TRANSCRIPTION, P62, NUCLEUS
3we4:A (GLU92) to (THR112) CRYSTAL STRUCTURE OF S6K1 KINASE DOMAIN IN COMPLEX WITH A PYRIMIDINE DERIVATIVE PF-4708671 2-{[4-(5-ETHYLPYRIMIDIN-4-YL)PIPERAZIN-1- YL]METHYL}-5-(TRIFLUOROMETHYL)-1H-BENZIMIDAZOLE | SERINE/THREONINE PROTEIN KINASE DOMAIN, TRANSFERASE, PHOSPHORYLATION, ATP-BINDING, ZINC-BINDING, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
5adh:A (LYS5) to (PRO30) INTERDOMAIN MOTION IN LIVER ALCOHOL DEHYDROGENASE. STRUCTURAL AND ENERGETIC ANALYSIS OF THE HINGE BENDING MODE | OXIDOREDUCTASE (NAD(A)-CHOH(D))
2ik0:A (TRP52) to (VAL80) YEAST INORGANIC PYROPHOSPHATASE VARIANT E48D WITH MAGNESIUM AND PHOSPHATE | INORGANIC PYROPHOSPHATASE, MECHANISM, X-RAY CRYSTALLOGRAPHY, STRUCTURE-FUNCTION, MUTAGENESIS, HYDROLASE
2ik0:B (TRP52) to (VAL80) YEAST INORGANIC PYROPHOSPHATASE VARIANT E48D WITH MAGNESIUM AND PHOSPHATE | INORGANIC PYROPHOSPHATASE, MECHANISM, X-RAY CRYSTALLOGRAPHY, STRUCTURE-FUNCTION, MUTAGENESIS, HYDROLASE
2ik1:B (TRP52) to (VAL80) YEAST INORGANIC PYROPHOSPHATASE VARIANT Y93F WITH MAGNESIUM AND PHOSPHATE | INORGANIC PYROPHOSPHATASE, MECHANISM, X-RAY CRYSTALLOGRAPHY, STRUCTURE-FUNCTION, MUTAGENESIS, HYDROLASE
2ik2:A (TRP52) to (VAL80) YEAST INORGANIC PYROPHOSPHATASE VARIANT D115E WITH MAGNESIUM AND PHOSPHATE | INORGANIC PYROPHOSPHATASE, MECHANISM, X-RAY CRYSTALLOGRAPHY, STRUCTURE-FUNCTION, MUTAGENESIS, HYDROLASE
2ik2:B (TRP52) to (VAL80) YEAST INORGANIC PYROPHOSPHATASE VARIANT D115E WITH MAGNESIUM AND PHOSPHATE | INORGANIC PYROPHOSPHATASE, MECHANISM, X-RAY CRYSTALLOGRAPHY, STRUCTURE-FUNCTION, MUTAGENESIS, HYDROLASE
2ik4:A (TRP52) to (VAL80) YEAST INORGANIC PYROPHOSPHATASE VARIANT D117E WITH MAGNESIUM AND PHOSPHATE | INORGANIC PYROPHOSPHATASE, MECHANISM, X-RAY CRYSTALLOGRAPHY, STRUCTURE-FUNCTION, MUTAGENESIS, HYDROLASE
2ik4:B (TRP52) to (VAL80) YEAST INORGANIC PYROPHOSPHATASE VARIANT D117E WITH MAGNESIUM AND PHOSPHATE | INORGANIC PYROPHOSPHATASE, MECHANISM, X-RAY CRYSTALLOGRAPHY, STRUCTURE-FUNCTION, MUTAGENESIS, HYDROLASE
2ik6:A (TRP52) to (VAL80) YEAST INORGANIC PYROPHOSPHATASE VARIANT D120E WITH MAGNESIUM AND PHOSPHATE | INORGANIC PYROPHOSPHATASE, MECHANISM, X-RAY CRYSTALLOGRAPHY, STRUCTURE-FUNCTION, MUTAGENESIS, HYDROLASE
2ik6:B (TRP52) to (VAL80) YEAST INORGANIC PYROPHOSPHATASE VARIANT D120E WITH MAGNESIUM AND PHOSPHATE | INORGANIC PYROPHOSPHATASE, MECHANISM, X-RAY CRYSTALLOGRAPHY, STRUCTURE-FUNCTION, MUTAGENESIS, HYDROLASE
2ik9:A (TRP52) to (VAL80) YEAST INORGANIC PYROPHOSPHATASE VARIANT D152E WITH MAGNESIUM AND PHOSPHATE | INORGANIC PYROPHOSPHATASE, MECHANISM, X-RAY CRYSTALLOGRAPHY, STRUCTURE-FUNCTION, MUTAGENESIS, HYDROLASE
1ize:A (ASP84) to (ALA105) CRYSTAL STRUCTURE OF ASPERGILLUS ORYZAE ASPARTIC PROTEINASE COMPLEXED WITH PEPSTATIN | ACID PROTEASE, SUGAR BINDING, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1ize:A (TRP191) to (THR215) CRYSTAL STRUCTURE OF ASPERGILLUS ORYZAE ASPARTIC PROTEINASE COMPLEXED WITH PEPSTATIN | ACID PROTEASE, SUGAR BINDING, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1izi:A (ARG57) to (GLY78) INHIBITOR OF HIV PROTEASE WITH UNUSUAL BINDING MODE POTENTLY INHIBITING MULTI-RESISTANT PROTEASE MUTANTS | HIV-1 PROTEINASE, TRIPLE MUTANT, POTENT INHIBITOR, SUBSITE BINDING, HYDROLASE
1uyp:F (GLY13) to (ARG37) THE THREE-DIMENSIONAL STRUCTURE OF BETA-FRUCTOSIDASE (INVERTASE) FROM THERMOTOGA MARITIMA | INVERTASE, GLYCOSYL HYDROLASE FAMILY 32, SUCROSE DEGRADATION, BETA-PROPELLER, HYDROLASE
2x2m:A (GLY736) to (LEU760) CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR | HIRSCHSPRUNG DISEASE, GDNF RECEPTOR, TRANSMEMBRANE, PROTO-ONCOGENE, PHOSPHOPROTEIN, DISEASE MUTATION, PHOSPHOTRANSFERASE, RET, KINASE, MEMBRANE, TRANSFERASE
2x2m:B (LYS737) to (LEU760) CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR | HIRSCHSPRUNG DISEASE, GDNF RECEPTOR, TRANSMEMBRANE, PROTO-ONCOGENE, PHOSPHOPROTEIN, DISEASE MUTATION, PHOSPHOTRANSFERASE, RET, KINASE, MEMBRANE, TRANSFERASE
5ahs:A (LEU163) to (ASP188) 3-SULFINOPROPIONYL-COENZYME A (3SP-COA) DESULFINASE FROM ADVENELLA MIMGARDEFORDENSIS DPN7T: HOLO CRYSTAL STRUCTURE WITH THE SUBSTRATE ANALOG SUCCINYL-COA | OXIDOREDUCTASE
5ahs:C (LEU163) to (ASP188) 3-SULFINOPROPIONYL-COENZYME A (3SP-COA) DESULFINASE FROM ADVENELLA MIMGARDEFORDENSIS DPN7T: HOLO CRYSTAL STRUCTURE WITH THE SUBSTRATE ANALOG SUCCINYL-COA | OXIDOREDUCTASE
5ahs:D (LEU163) to (ASP188) 3-SULFINOPROPIONYL-COENZYME A (3SP-COA) DESULFINASE FROM ADVENELLA MIMGARDEFORDENSIS DPN7T: HOLO CRYSTAL STRUCTURE WITH THE SUBSTRATE ANALOG SUCCINYL-COA | OXIDOREDUCTASE
1j21:B (VAL251) to (PRO273) CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS HB8 ARGININOSUCCINATE SYNTHETASE IN COMPLEX WITH ATP AND CITRULLINE | LIGASE, ATP-BINDING, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, STRUCTURAL GENOMICS
1j21:C (VAL251) to (PRO273) CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS HB8 ARGININOSUCCINATE SYNTHETASE IN COMPLEX WITH ATP AND CITRULLINE | LIGASE, ATP-BINDING, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, STRUCTURAL GENOMICS
1j2g:A (PHE17) to (ASN48) CRYSTAL STRUCTURE OF URATE OXIDASE FROM BACILLUS SP. TB-90 CO- CRYSTALLIZED WITH 8-AZAXANTHINE | T-FOLD BARREL, PURINE, OXIDOREDUCTASE
1j2g:D (PHE17) to (ASN48) CRYSTAL STRUCTURE OF URATE OXIDASE FROM BACILLUS SP. TB-90 CO- CRYSTALLIZED WITH 8-AZAXANTHINE | T-FOLD BARREL, PURINE, OXIDOREDUCTASE
2itp:A (GLY724) to (LEU747) CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH AEE788 | RECEPTOR, CELL CYCLE, ATP-BINDING, TRANSFERASE, TRANSMEMBRANE, PHOSPHORYLATION, DISEASE MUTATION, POLYMORPHISM, GLYCOPROTEIN, ANTI-ONCOGENE, NUCLEOTIDE- BINDING, ALTERNATIVE SPLICING, AEE788, EGFR, G719S, KINASE, MEMBRANE, TYROSINE-PROTEIN KINASE, EPIDERMAL GROWTH FACTOR
1j6p:A (MSE1) to (ASN25) CRYSTAL STRUCTURE OF METAL-DEPENDENT HYDROLASE OF CYTOSINEDEMANIASE/CHLOROHYDROLASE FAMILY (TM0936) FROM THERMOTOGA MARITIMA AT 1.9 A RESOLUTION | STRUCTURAL GENOMICS, TM0936, JCSG, METAL-DEPENDENT HYDROLASE OF CYTOSINEDEMANIASE/CHLOROHYDROLASE FAMILY, PSI, PROTEIN STRUCTURE INITIATIVE, JOINT CENTER FOR STRUCTURAL GENOMICS, HYDROLASE
2ity:A (GLY724) to (LEU747) CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH IRESSA | RECEPTOR, CELL CYCLE, ATP-BINDING, TRANSFERASE, TRANSMEMBRANE, PHOSPHORYLATION, DISEASE MUTATION, GLYCOPROTEIN, ANTI-ONCOGENE, NUCLEOTIDE- BINDING, IRESSA, EGFR, ZD1839, MEMBRANE TYROSINE-PROTEIN KINASE, EPIDERMAL GROWTH FACTOR
4mjt:A (CYS65) to (PRO89) CRYSTAL STRUCTURE OF THE OLIGOMERIC PORE-FORMING TOXIN PRO-MONALYSIN | PORE-FORMING TOXIN, TOXIN
4mjt:B (ILE70) to (PRO89) CRYSTAL STRUCTURE OF THE OLIGOMERIC PORE-FORMING TOXIN PRO-MONALYSIN | PORE-FORMING TOXIN, TOXIN
4mjt:D (CYS65) to (PRO89) CRYSTAL STRUCTURE OF THE OLIGOMERIC PORE-FORMING TOXIN PRO-MONALYSIN | PORE-FORMING TOXIN, TOXIN
4mjt:E (ILE70) to (PRO89) CRYSTAL STRUCTURE OF THE OLIGOMERIC PORE-FORMING TOXIN PRO-MONALYSIN | PORE-FORMING TOXIN, TOXIN
4mjt:F (ILE70) to (PRO89) CRYSTAL STRUCTURE OF THE OLIGOMERIC PORE-FORMING TOXIN PRO-MONALYSIN | PORE-FORMING TOXIN, TOXIN
4mjt:G (ILE70) to (PRO89) CRYSTAL STRUCTURE OF THE OLIGOMERIC PORE-FORMING TOXIN PRO-MONALYSIN | PORE-FORMING TOXIN, TOXIN
3wlv:A (PHE17) to (ASN48) THERMOSTABLE URATE OXIDASE FROM BACILLUS SP. TB-90 | TUNNEL FOLD MOTIF, OXIDASE, OXIDOREDUCTASE
3wlv:B (PHE17) to (ASN48) THERMOSTABLE URATE OXIDASE FROM BACILLUS SP. TB-90 | TUNNEL FOLD MOTIF, OXIDASE, OXIDOREDUCTASE
3wlv:C (PHE17) to (ASN48) THERMOSTABLE URATE OXIDASE FROM BACILLUS SP. TB-90 | TUNNEL FOLD MOTIF, OXIDASE, OXIDOREDUCTASE
3wlv:D (PHE17) to (ASN48) THERMOSTABLE URATE OXIDASE FROM BACILLUS SP. TB-90 | TUNNEL FOLD MOTIF, OXIDASE, OXIDOREDUCTASE
4mk0:A (SER192) to (ASP212) CRYSTAL STRUCTURE OF G PROTEIN-COUPLED RECEPTOR KINASE 2 IN COMPLEX WITH A A RATIONALLY DESIGNED PAROXETINE DERIVATIVE | INHIBITOR COMPLEX, PROTEIN KINASE, HYDROLASE, ATP BINDING, PHOSPHORYLATION, PERIPHERAL MEMBRANE PROTEIN, SIGNALING PROTEIN- INHIBITOR COMPLEX
4mko:A (ILE70) to (PRO89) CRYSTAL STRUCTURE OF THE MONOMERIC, CLEAVED FORM OF THE PORE-FORMING TOXIN MONALYSIN | PORE-FORMING TOXIN, TOXIN
4mko:B (ILE70) to (PRO89) CRYSTAL STRUCTURE OF THE MONOMERIC, CLEAVED FORM OF THE PORE-FORMING TOXIN MONALYSIN | PORE-FORMING TOXIN, TOXIN
4mko:C (ILE70) to (PRO89) CRYSTAL STRUCTURE OF THE MONOMERIC, CLEAVED FORM OF THE PORE-FORMING TOXIN MONALYSIN | PORE-FORMING TOXIN, TOXIN
4mko:D (ILE70) to (PRO89) CRYSTAL STRUCTURE OF THE MONOMERIC, CLEAVED FORM OF THE PORE-FORMING TOXIN MONALYSIN | PORE-FORMING TOXIN, TOXIN
4mkq:A (ILE70) to (PRO89) CRYSTAL STRUCTURE OF THE PORE-FORMING TOXIN MONALYSIN MUTANT DELETED OF THE MEMBRANE-SPANNING DOMAIN | PORE-FORMING TOXIN, TOXIN
4mkq:B (ILE70) to (PRO89) CRYSTAL STRUCTURE OF THE PORE-FORMING TOXIN MONALYSIN MUTANT DELETED OF THE MEMBRANE-SPANNING DOMAIN | PORE-FORMING TOXIN, TOXIN
3wnq:A (SER5) to (PRO29) CRYSTAL STRUCTURE OF (R)-CARBONYL REDUCTASE H49A MUTANT FROM CANDIDA PARAPSILOSIS IN COMPLEX WITH 2-HYDROXYACETOPHENONE | ALCOHOL DEHYDROGENASE, CARBONYL REDUCTASE, OXIDOREDUCTASE
3wnq:B (SER5) to (PRO29) CRYSTAL STRUCTURE OF (R)-CARBONYL REDUCTASE H49A MUTANT FROM CANDIDA PARAPSILOSIS IN COMPLEX WITH 2-HYDROXYACETOPHENONE | ALCOHOL DEHYDROGENASE, CARBONYL REDUCTASE, OXIDOREDUCTASE
3wnq:D (SER5) to (PRO29) CRYSTAL STRUCTURE OF (R)-CARBONYL REDUCTASE H49A MUTANT FROM CANDIDA PARAPSILOSIS IN COMPLEX WITH 2-HYDROXYACETOPHENONE | ALCOHOL DEHYDROGENASE, CARBONYL REDUCTASE, OXIDOREDUCTASE
2ix3:A (LEU430) to (LYS453) STRUCTURE OF YEAST ELONGATION FACTOR 3 | PROTEIN BIOSYNTHESIS, TRANSLATION, ELONGATION FACTOR, PHOSPHORYLATION, NUCLEOTIDE-BINDING, RRNA-BINDING, RNA- BINDING, ACETYLATION, ATP-BINDING
1veb:A (GLU44) to (GLU64) CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH AZEPANE DERIVATIVE 5 | KINASE-INHIBITOR-COMPLEX, SERINE/THREONINE-PROTEIN KINASE, BALANOL DERIVATIVE, TRANSFERASE
2j3l:A (ASP352) to (PRO372) PROLYL-TRNA SYNTHETASE FROM ENTEROCOCCUS FAECALIS COMPLEXED WITH A PROLYL-ADENYLATE ANALOGUE ('5'-O-(N-(L-PROLYL)- SULFAMOYL)ADENOSINE) | BACTERIAL-TYPE PROLYL-TRNA SYNTHETASE, CLASS II AMINOACYL- TRNA SYNTHETASE, EDITING, TRANSLATION, ATP + L-PROLINE + TRNA (PRO) GIVES AMP + PPI + L-PROLYL-TRNA(PRO), LIGASE
2j4z:A (ASP132) to (GLN154) STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA-680626 | TRANSFERASE, PHOSPHORYLATION, NUCLEOTIDE-BINDING, KINASE, CELL CYCLE, ATP-BINDING, NUCLEOTIDE- BINDING, SERINE/THREONINE-PROTEIN KINASE, SERINE-THREONINE-PROTEIN KINASE
1vij:A (ARG57) to (GLY78) HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR HOE/BAY 793 HEXAGONAL FORM | ASPARTYL PROTEASE, HUMAN IMMUNODEFICIENCY VIRUS, HOE/BAY 793: INHIBITOR DESIGN
1vj1:A (HIS-1) to (LEU31) CRYSTAL STRUCTURE OF PUTATIVE NADPH-DEPENDENT OXIDOREDUCTASE FROM MUS MUSCULUS AT 2.10 A RESOLUTION | PUTATIVE NADPH-DEPENDENT OXIDOREDUCTASE, STRUCTURAL GENOMICS, JCSG, PSI, PROTEIN STRUCTURE INITIATIVE, JOINT CENTER FOR STRUCTURAL GENOMICS, UNKNOWN FUNCTION
1vl2:A (VAL261) to (GLY284) CRYSTAL STRUCTURE OF ARGININOSUCCINATE SYNTHASE (TM1780) FROM THERMOTOGA MARITIMA AT 1.65 A RESOLUTION | TM1780, ARGININOSUCCINATE SYNTHASE, STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI, JOINT CENTER FOR STRUCTURAL GENOMICS, LIGASE
1vl2:C (GLY262) to (GLY284) CRYSTAL STRUCTURE OF ARGININOSUCCINATE SYNTHASE (TM1780) FROM THERMOTOGA MARITIMA AT 1.65 A RESOLUTION | TM1780, ARGININOSUCCINATE SYNTHASE, STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI, JOINT CENTER FOR STRUCTURAL GENOMICS, LIGASE
1vl4:A (VAL408) to (GLU428) CRYSTAL STRUCTURE OF A PUTATIVE MODULATOR OF A DNA GYRASE (TM0727) FROM THERMOTOGA MARITIMA MSB8 AT 1.95 A RESOLUTION | PMBA-RELATED PROTEIN, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI, GENE REGULATION
1vl4:B (VAL408) to (GLU428) CRYSTAL STRUCTURE OF A PUTATIVE MODULATOR OF A DNA GYRASE (TM0727) FROM THERMOTOGA MARITIMA MSB8 AT 1.95 A RESOLUTION | PMBA-RELATED PROTEIN, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI, GENE REGULATION
5awf:C (MET1) to (PRO26) CRYSTAL STRUCTURE OF SUFB-SUFC-SUFD COMPLEX FROM ESCHERICHIA COLI | IRON-SULFUR CLUSTERS, IRON-SULFUR PROTEINS, ABC PROTEINS, ABC ATPASE, TRANSPORT PROTEIN-PROTEIN BINDING COMPLEX
2j98:B (LYS8) to (ASN31) HUMAN CORONAVIRUS 229E NON STRUCTURAL PROTEIN 9 CYS69ALA MUTANT (NSP9) | SSB, HCOV, MEMBRANE, HELICASE, SARS COV, VIRAL REPLICASE, RNA REPLICATION, ATP-BINDING, NUCLEOTIDE-BINDING, RIBOSOMAL FRAMESHIFT, RNA-BINDING PROTEIN
2j9j:A (ARG57) to (GLY78) ATOMIC-RESOLUTION CRYSTAL STRUCTURE OF CHEMICALLY-SYNTHESIZED HIV-1 PROTEASE COMPLEXED WITH INHIBITOR JG-365 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASE, HYDROLASE, HIGH RESOLUTION, RNA-DIRECTED DNA POLYMERASE, ASPARTYL PROTEASE, HUMAN IMMUNODEFICIENCY VIRUS 1, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
2j9k:A (ARG57) to (GLY78) ATOMIC-RESOLUTION CRYSTAL STRUCTURE OF CHEMICALLY-SYNTHESIZED HIV-1 PROTEASE COMPLEXED WITH INHIBITOR MVT-101 | PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ASPARTYL PROTEASE, HUMAN IMMUNODEFICIENCY VIRUS 1
3wxm:F (ASP34) to (ARG61) CRYSTAL STRUCTURE OF ARCHAEAL PELOTA AND GTP-BOUND EF1 ALPHA COMPLEX | MRNA SURVEILLANCE, RIBOSOME, TRANSLATION-HYDROLASE COMPLEX
5ayj:A (PHE17) to (ASN48) HYPERTHERMOSTABLE MUTANT OF BACILLUS SP. TB-90 URATE OXIDASE - R298C | DISULFIDE BOND, THERMOSTABILITY, PROTEIN ENGINEERING, OXIDASE, SUBUNIT-SUBUNIT INTERACTION, OXIDOREDUCTASE
5ayj:B (PHE17) to (ASN48) HYPERTHERMOSTABLE MUTANT OF BACILLUS SP. TB-90 URATE OXIDASE - R298C | DISULFIDE BOND, THERMOSTABILITY, PROTEIN ENGINEERING, OXIDASE, SUBUNIT-SUBUNIT INTERACTION, OXIDOREDUCTASE
5ayj:D (PHE17) to (ASN48) HYPERTHERMOSTABLE MUTANT OF BACILLUS SP. TB-90 URATE OXIDASE - R298C | DISULFIDE BOND, THERMOSTABILITY, PROTEIN ENGINEERING, OXIDASE, SUBUNIT-SUBUNIT INTERACTION, OXIDOREDUCTASE
1ju9:A (LYS5) to (PRO30) HORSE LIVER ALCOHOL DEHYDROGENASE VAL292SER MUTANT | DEHYDROGENASE, ALCOHOL, NICOTINAMIDE COENZYME, OXIDOREDUCTASE, MUTANT
1ju9:B (LYS5) to (PRO30) HORSE LIVER ALCOHOL DEHYDROGENASE VAL292SER MUTANT | DEHYDROGENASE, ALCOHOL, NICOTINAMIDE COENZYME, OXIDOREDUCTASE, MUTANT
4myw:C (CYS106) to (HIS154) STRUCTURE OF HSV-2 GD BOUND TO NECTIN-1 | IGV-LIKE CORE, N-/C-TERMINAL EXTENSIONS, TANDEM ARRANGED V-C-C IG- LIKE DOMAINS, RECEPTOR BINDING, CELL SURFACE ATTACHMENT, VIRAL, CELLULAR SURFACE, VIRAL PROTEIN-CELL ADHESION COMPLEX
1jv2:A (TYR290) to (ALA322) CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHAVBETA3 | GENU, HYBRID DOMAIN, BETA-TAIL DOMAIN, PSI DOMAIN, EGF DOMAIN, MIDAS, ADMIDAS, CAGE MOTIF, PROPELLER, A-DOMAIN, THIGH DOMAIN, CALF DOMAIN, CELL ADHESION
3wz6:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH GEWALD REACTION-DERIVED INHIBITOR (5) | ASPARTIC PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3wz7:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH GEWALD REACTION-DERIVED INHIBITOR (6) | ASPARTIC PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3wz8:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH GEWALD REACTION-DERIVED INHIBITOR (8) | ASPARTIC PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5b18:C (LEU53) to (GLY78) CRYSTAL STRUCTURE OF A DARUNAVIR RESISTANT HIV-1 PROTEASE | HIV-1 PROTEASE, DRUG RESISTANCE, DARUNAVIR, FLAP, HYDROLASE
1w26:A (ASP162) to (ALA188) TRIGGER FACTOR IN COMPLEX WITH THE RIBOSOME FORMS A MOLECULAR CRADLE FOR NASCENT PROTEINS | CHAPERONE, PROTEIN FOLDING, RIBOSOME ASSOCIATED PROTEIN, NASCENT CHAIN, CELL DIVISION, ISOMERASE
5b2c:A (ASN498) to (ALA521) CRYSTAL STRUCTURE OF MUMPS VIRUS HEMAGGLUTININ-NEURAMINIDASE | GLYCOPROTEIN, VIRAL PROTEIN, BETA-PROPELLER, RECEPTOR BINDING
5b2d:A (ASN498) to (LEU522) CRYSTAL STRUCTURE OF MUMPS VIRUS HEMAGGLUTININ-NEURAMINIDASE BOUND TO 3-SIALYLLACTOSE | GLYCOPROTEIN, VIRAL PROTEIN, BETA-PROPELLER, RECEPTOR BINDING, SUGAR
5b2d:B (PHE499) to (LEU522) CRYSTAL STRUCTURE OF MUMPS VIRUS HEMAGGLUTININ-NEURAMINIDASE BOUND TO 3-SIALYLLACTOSE | GLYCOPROTEIN, VIRAL PROTEIN, BETA-PROPELLER, RECEPTOR BINDING, SUGAR
3zbm:A (GLY402) to (MET421) STRUCTURE OF M92A VARIANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII | ELECTRON TRANSFER, OXIDOREDUCTASE, PROTON CHANNEL, DENITRIFICATION
2je4:A (ARG57) to (GLY78) ATOMIC-RESOLUTION CRYSTAL STRUCTURE OF CHEMICALLY-SYNTHESIZED HIV-1 PROTEASE IN COMPLEX WITH JG-365 | PROTEASE, HYDROLASE, HIGH RESOLUTION, ASPARTYL PROTEASE, HUMAN IMMUNODEFICIENCY VIRUS 1, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5b58:D (LEU2) to (PRO26) INWARD-FACING CONFORMATION OF ABC HEME IMPORTER BHUUV IN COMPLEX WITH PERIPLASMIC HEME BINDING PROTEIN BHUT FROM BURKHOLDERIA CENOCEPACIA | METAL-BINDING, METAL BINDING PROTEIN
4n72:A (ILE571) to (PHE600) CATALYTIC DOMAIN FROM DIHYDROLIPOAMIDE ACETYLTRANSFERASE OF PYRUVATE DEHYDROGENASE FROM ESCHERICHIA COLI | DIHYDROLIPOAMIDE ACETYLTRANSFERASE CATALYTIC DOMAIN, PYRUVATE DEHYDROGENASE, ACETYLTRANSFERASE, TRANSFERASE
4n72:B (VAL569) to (PHE600) CATALYTIC DOMAIN FROM DIHYDROLIPOAMIDE ACETYLTRANSFERASE OF PYRUVATE DEHYDROGENASE FROM ESCHERICHIA COLI | DIHYDROLIPOAMIDE ACETYLTRANSFERASE CATALYTIC DOMAIN, PYRUVATE DEHYDROGENASE, ACETYLTRANSFERASE, TRANSFERASE
1w6h:B (TRP193) to (SER215) NOVEL PLASMEPSIN II-INHIBITOR COMPLEX | MALARIA, DRUG, ASPARTIC PROTEASE, PLASMEPSIN, HYDROLASE, GLYCOPROTEIN
2xts:A (PRO150) to (GLY190) CRYSTAL STRUCTURE OF THE SULFANE DEHYDROGENASE SOXCD FROM PARACOCCUS PANTOTROPHUS | OXIDOREDUCTASE-ELECTRON TRANSPORT COMPLEX, SOX SYSTEM, SULFANE OXIDATION, MOLYBDENUM COFACTOR, HEME, ELECTRON TRANSFER
2xts:C (PRO150) to (GLY190) CRYSTAL STRUCTURE OF THE SULFANE DEHYDROGENASE SOXCD FROM PARACOCCUS PANTOTROPHUS | OXIDOREDUCTASE-ELECTRON TRANSPORT COMPLEX, SOX SYSTEM, SULFANE OXIDATION, MOLYBDENUM COFACTOR, HEME, ELECTRON TRANSFER
3zfm:A (GLU634) to (LEU655) CRYSTAL STRUCTURE OF EPHB2 | TRANSFERASE
4n9z:B (GLY778) to (ASP800) CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN MUTANT E749Q | POLY(ADP-RIBOSE) GLYCOHYDROLASE, PARG, HYDROLASE
4na6:A (GLY778) to (ASP800) CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN MUTANT E749N | POLY(ADP-RIBOSE) GLYCOHYDROLASE, PARG, HYDROLASE
4na6:B (GLY778) to (ASP800) CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN MUTANT E749N | POLY(ADP-RIBOSE) GLYCOHYDROLASE, PARG, HYDROLASE
1k2c:A (ARG57) to (GLY78) COMBINING MUTATIONS IN HIV-1 PROTEASE TO UNDERSTAND MECHANISMS OF RESISTANCE | HIV-1 PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
2jji:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH A GEM-DIOL INHIBITOR. | ACID PROTEINASE, ASPARTYL PROTEASE, ZYMOGEN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1k3a:A (GLY981) to (VAL1005) STRUCTURE OF THE INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR KINASE | PROTEIN KINASE, TYROSINE KINASE, TYROSINE PHOSPHORYLATION, PROTEIN-SUBSTRATE COMPLEX, TRANSFERASE
1k6p:B (ARG57) to (GLY78) LACK OF SYNERGY FOR INHIBITORS TARGETING A MULTI-DRUG RESISTANT HIV-1 PROTEASE | INDINAVIR, INHIBITOR RECOGNITION, DRUG RESISTANCE, HIV-1 PROTEASE, HYDROLASE
3ziy:A (GLY402) to (MET421) STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.01 A RESOLUTION | ELECTRON TRANSFER, OXIDOREDUCTASE, PROTON CHANNEL, DENITRIFICATION
2jsb:A (ARG1) to (TRP21) SOLUTION STRUCTURE OF ARENICIN-1 | ARENICIN, ARENICIN-1, ANTIMICROBIAL, PEPTIDE, ARENICOLA MARINA, POREFORMING, NMR, ANTIMICROBIAL PROTEIN
1wgj:A (TRP52) to (VAL80) STRUCTURE OF INORGANIC PYROPHOSPHATASE | PYROPHOSPHATE PHOSPHOHYDROLASE, HYDROLASE, MANGANESE
1wgj:B (TRP52) to (VAL80) STRUCTURE OF INORGANIC PYROPHOSPHATASE | PYROPHOSPHATE PHOSPHOHYDROLASE, HYDROLASE, MANGANESE
1wgq:A (THR9) to (ILE31) SOLUTION STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN OF MOUSE ETHANOL DECREASED 4 PROTEIN | PLECKSTRIN HOMOLOY DOMAIN, SIGNAL TRANSDUCTION, STRUCTURAL GENOMICS, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, SUGAR BINDING PROTEIN
2kc2:A (SER83) to (SER105) NMR STRUCTURE OF THE F1 DOMAIN (RESIDUES 86-202) OF THE TALIN | TALIN, FERM, F1, ADHESION, CELL MEMBRANE, CELL PROJECTION, CYTOPLASM, CYTOSKELETON, MEMBRANE, PHOSPHOPROTEIN, STRUCTURAL PROTEIN
4njt:B (ARG57) to (GLY78) CRYSTAL STRUCTURE OF MULTIDRUG-RESISTANT CLINICAL ISOLATE A02 HIV-1 PROTEASE IN COMPLEX WITH DARUNAVIR | MULTIDRUG-RESISTANCE, HIV-1 PROTEASE, DARUNAVIR, NON-PEPTIDIC INHIBITOR, PROTEASE INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4njt:D (ARG57) to (GLY78) CRYSTAL STRUCTURE OF MULTIDRUG-RESISTANT CLINICAL ISOLATE A02 HIV-1 PROTEASE IN COMPLEX WITH DARUNAVIR | MULTIDRUG-RESISTANCE, HIV-1 PROTEASE, DARUNAVIR, NON-PEPTIDIC INHIBITOR, PROTEASE INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4nju:B (ARG57) to (GLY78) CRYSTAL STRUCTURE OF MULTIDRUG-RESISTANT CLINICAL ISOLATE A02 HIV-1 PROTEASE IN COMPLEX WITH TIPRANAVIR | MULTIDRUG-RESISTANCE, HIV-1 PROTEASE, TIPRANAVIR, TPV, PROTEASE INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4nju:D (ARG57) to (GLY78) CRYSTAL STRUCTURE OF MULTIDRUG-RESISTANT CLINICAL ISOLATE A02 HIV-1 PROTEASE IN COMPLEX WITH TIPRANAVIR | MULTIDRUG-RESISTANCE, HIV-1 PROTEASE, TIPRANAVIR, TPV, PROTEASE INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4njv:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF MULTIDRUG-RESISTANT CLINICAL ISOLATE A02 HIV-1 PROTEASE IN COMPLEX WITH RITONAVIR | MULTIDRUG-RESISTANCE, HIV-1 PROTEASE, RITONAVIR, RIT, PROTEASE INHIBITOR, KALETRA, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4njv:B (ARG57) to (GLY78) CRYSTAL STRUCTURE OF MULTIDRUG-RESISTANT CLINICAL ISOLATE A02 HIV-1 PROTEASE IN COMPLEX WITH RITONAVIR | MULTIDRUG-RESISTANCE, HIV-1 PROTEASE, RITONAVIR, RIT, PROTEASE INHIBITOR, KALETRA, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4njv:D (ARG57) to (GLY78) CRYSTAL STRUCTURE OF MULTIDRUG-RESISTANT CLINICAL ISOLATE A02 HIV-1 PROTEASE IN COMPLEX WITH RITONAVIR | MULTIDRUG-RESISTANCE, HIV-1 PROTEASE, RITONAVIR, RIT, PROTEASE INHIBITOR, KALETRA, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
2y3v:A (ASN7) to (LEU34) N-TERMINAL HEAD DOMAIN OF DANIO RERIO SAS-6 | STRUCTURAL PROTEIN, CYTOSKELETON, BASAL BODY, CENTRIOLE, CARTWHEEL, CARTWHEEL HUB
1wq9:A (VAL59) to (MET86) CRYSTAL STRUCTURE OF VR-1, A VEGF-F FROM A SNAKE VENOM | SNAKE VENOM, VASCULAR ENDOTHELIAL GROWTH FACTOR, VEGF, VEGF- F, TOXIN
1wq9:B (VAL59) to (MET86) CRYSTAL STRUCTURE OF VR-1, A VEGF-F FROM A SNAKE VENOM | SNAKE VENOM, VASCULAR ENDOTHELIAL GROWTH FACTOR, VEGF, VEGF- F, TOXIN
5c16:C (GLU104) to (ASP131) MYOTUBULARIN-RELATED PROETIN 1 | MTMR, PHOSPHATASE, HYDROLASE
2l0d:A (LYS33) to (SER59) SOLUTION NMR STRUCTURE OF PUTATIVE CELL SURFACE PROTEIN MA_4588 (272- 376 DOMAIN) FROM METHANOSARCINA ACETIVORANS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET MVR254A | STRUCTURAL GENOMICS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG), PSI-2, PROTEIN STRUCTURE INITIATIVE, CELL ADHESION
2l4r:A (GLU91) to (ASN117) NMR SOLUTION STRUCTURE OF THE N-TERMINAL PAS DOMAIN OF HERG | HERG, POTASSIUM CHANNEL, PAS DOMAIN, EAG DOMAIN, TRANSPORT PROTEIN
1kgq:A (SER231) to (LYS254) CRYSTAL STRUCTURE OF TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE IN COMPLEX WITH L-2-AMINOPIMELATE AND SUCCINAMIDE-COA | LEFT-HANDED PARALLEL BETA HELIX, TRANSFERASE
1kgt:A (SER231) to (LYS254) CRYSTAL STRUCTURE OF TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE IN COMPLEX WITH PIMELATE AND SUCCINYL-COA | LEFT-HANDED PARALLEL BETA HELIX, TRANSFERASE
2y7s:B (HIS103) to (PHE129) STRUCTURE OF A DESIGNED MENINGOCOCCAL ANTIGEN (FACTOR H BINDING PROTEIN, MUTANT G1) INDUCING BROAD PROTECTIVE IMMUNITY | IMMUNE SYSTEM, ANTIGEN, EPITOPE, ANTIBODY, STRUCTURE-BASED DESIGN, VACCINE
1kh1:B (VAL251) to (PRO273) CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS HB8 ARGININOSUCCINATE SYNTHETASE | LIGASE, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, STRUCTURAL GENOMICS
1kh3:B (VAL251) to (PRO273) CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS HB8 ARGININOSUCCINATE SYNTHETASE IN COMPLEX WITH INHIBITOR | LIGASE, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, STRUCTURAL GENOMICS
5c1u:B (VAL120) to (ASN139) CRYSTAL STRUCTURE OF EV71 3C PROTEINASE IN COMPLEX WITH COMPOUND XB | HYDROLASE, CYSTEINE PROTEINASE, INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
2lc7:A (GLY173) to (ILE197) SOLUTION STRUCTURE OF THE ISOLATED PAR-6 PDZ DOMAIN | CRIB, ALLOSTERY, CELL POLARITY, CELL ADHESION
1kj7:B (ARG57) to (GLY78) SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES | P2-NUCLEOCAPSID, SUBSTRATE RECOGNITION, HYDROLASE
1kjg:A (ARG57) to (GLY78) SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES | REVERSE TRANSCRIPTASE, RNASE H, SUBSTRATE RECOGNITION, HYDROLASE
1kjg:B (ARG57) to (GLY78) SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES | REVERSE TRANSCRIPTASE, RNASE H, SUBSTRATE RECOGNITION, HYDROLASE
1kjh:B (ARG57) to (GLY78) SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES | RNASE H, INTEGRASE, SUBSTRATE RECOGNITION, HYDROLASE
3zqn:A (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 2) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqn:B (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 2) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqn:C (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 2) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqn:D (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 2) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqn:E (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 2) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqn:F (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 2) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqn:G (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 2) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqn:H (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 2) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqn:I (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 2) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqn:J (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 2) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqo:A (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 3) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqo:B (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 3) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqo:C (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 3) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqo:D (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 3) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqo:E (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 3) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqo:F (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 3) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqo:G (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 3) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqo:H (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 3) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqo:I (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 3) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqo:J (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 3) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqo:L (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 3) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqo:M (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 3) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqo:N (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 3) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqo:O (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 3) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqo:P (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 3) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqo:Q (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 3) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqo:R (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 3) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqp:B (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE | DNA-BINDING PROTEIN, DNA PACKAGING
3zqp:C (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE | DNA-BINDING PROTEIN, DNA PACKAGING
3zqp:D (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE | DNA-BINDING PROTEIN, DNA PACKAGING
3zqp:E (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE | DNA-BINDING PROTEIN, DNA PACKAGING
3zqp:F (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE | DNA-BINDING PROTEIN, DNA PACKAGING
3zqp:G (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE | DNA-BINDING PROTEIN, DNA PACKAGING
3zqp:H (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE | DNA-BINDING PROTEIN, DNA PACKAGING
3zqp:I (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE | DNA-BINDING PROTEIN, DNA PACKAGING
2yaa:A (PHE12) to (SER34) CRYSTAL STRUCTURE OF THE AUTOINHIBITED FORM OF MOUSE DAPK2 IN COMPLEX WITH ATP | TRANSFERASE, APOPTOSIS
3jbr:F (LYS588) to (PRO613) CRYO-EM STRUCTURE OF THE RABBIT VOLTAGE-GATED CALCIUM CHANNEL CAV1.1 COMPLEX AT 4.2 ANGSTROM | MEMBRANE PROTEIN, VOLTAGE-GATED CALCIUM CHANNEL
2lpr:A (THR163) to (ASN184) STRUCTURAL BASIS FOR BROAD SPECIFICITY IN ALPHA-LYTIC PROTEASE MUTANTS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
2lul:A (ILE16) to (LYS45) SOLUTION NMR STRUCTURE OF PH DOMAIN OF TYROSINE-PROTEIN KINASE TEC FROM HOMO SAPIENS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET HR3504C | STRUCTURAL GENOMICS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, PSI-BIOLOGY, PROTEIN STRUCTURE INITIATIVE, TRANSFERASE
2lwj:A (VAL21) to (GLU46) NMR SOLUTION STRUCTURE MYXOCCOCCUS XANTHUS CDNL | CDNL, CARD, TRCF-RID, PF02559, RNA POLYMERASE, TRANSCRIPTION
2m4f:A (GLY104) to (ILE133) SOLUTION STRUCTURE OF OUTER SURFACE PROTEIN E | OSPE, OUTER SURFACE PROTEIN E, BORRELIA BURGDORFERI N40, BBCRASP-3, ERP, COMPLEMENT, INNATE IMMUNITY, IMMUNE EVASION, IMMUNE SYSTEM
1kor:B (VAL251) to (PRO273) CRYSTAL STRUCTURE OF THERMUS THERMOPHILUS HB8 ARGININOSUCCINATE SYNTHETASE IN COMPLEX WITH INHIBITORS | LIGASE, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, STRUCTURAL GENOMICS
1x9t:A (ASN141) to (PRO171) THE CRYSTAL STRUCTURE OF HUMAN ADENOVIRUS 2 PENTON BASE IN COMPLEX WITH AN AD2 N-TERMINAL FIBRE PEPTIDE | JELLYROLL DOMAIN, INSERTION DOMAIN, ANTI-PARALLEL BETA SHEETS, VIRUS LIKE PARTICLE/PEPTIDE COMPLEX
4ny0:C (LYS255) to (GLY275) CRYSTAL STRUCTURE OF FERM DOMAIN OF HUMAN FOCAL ADHESION KINASE | FERM DOMAIN, FOCAL ADHESION KINASE, FOCAL TARGETING DOMAIN, INTEGRIN SIGNALING, TRANSFERASE
5c8n:A (THR725) to (LEU747) EGFR KINASE DOMAIN MUTANT "TMLR" WITH COMPOUND 23 | PROTEIN KINASE INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
1xdh:A (TRP193) to (SER215) STRUCTURE OF PLASMEPSIN II IN COMPLEX WITH PEPSTATIN A | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1xdj:A (GLY478) to (GLY502) CRYSTAL STRUCTURE OF T. MARITIMA COBALAMIN-INDEPENDENT METHIONINE SYNTHASE COMPLEXED WITH ZN2+ AND HOMOCYSTEINE | TIM BARREL, HOMOCYSTEINE, METHYLTETRAHYDROFOLATE, ZINC, TRANSFERASE
1xdj:B (GLY478) to (GLY502) CRYSTAL STRUCTURE OF T. MARITIMA COBALAMIN-INDEPENDENT METHIONINE SYNTHASE COMPLEXED WITH ZN2+ AND HOMOCYSTEINE | TIM BARREL, HOMOCYSTEINE, METHYLTETRAHYDROFOLATE, ZINC, TRANSFERASE
5c9b:C (ALA179) to (GLY200) CRYSTAL STRUCTURE OF A RETROPEPSIN-LIKE ASPARTIC PROTEASE FROM RICKETTSIA CONORII | PEPSIN, APRICK, HYDROLASE
5c9b:D (ALA179) to (GLY200) CRYSTAL STRUCTURE OF A RETROPEPSIN-LIKE ASPARTIC PROTEASE FROM RICKETTSIA CONORII | PEPSIN, APRICK, HYDROLASE
1xe5:A (TRP193) to (SER215) STRUCTURE OF PLASMEPSIN II IN COMPLEX OF AN PEPSTATIN ANALOGUE | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1xe5:B (TRP193) to (SER215) STRUCTURE OF PLASMEPSIN II IN COMPLEX OF AN PEPSTATIN ANALOGUE | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
2nq2:C (ALA4) to (LYS30) AN INWARD-FACING CONFORMATION OF A PUTATIVE METAL-CHELATE TYPE ABC TRANSPORTER. | PUTATIVE IRON CHELATIN ABC TRANSPORTER, ATP-BINDING PROTEIN, NUCLEOTIDE BINDING DOMAIN, TRANSMEMBRANE DOMAIN, METAL TRANSPORT
3js8:A (GLU11) to (ARG37) SOLVENT-STABLE CHOLESTEROL OXIDASE | CHOLSTEROL, OXIDASE, ORGANIC SOLVENT STABILITY, OXYGEN CHANNEL, FAD, FLAVOPROTEIN, OXIDOREDUCTASE
1xh7:A (GLU44) to (GLU64) CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS | PKA, KINASE-INHIBITOR-COMPLEX, SERINE/THREONINE-PROTEIN KINASE, BALANOL DERIVATIVE, TRANSFERASE/TRANSFERASE INHIBITOR COMPLEX
3jvw:A (ARG57) to (GLY78) HIV-1 PROTEASE MUTANT G86A WITH SYMMETRIC INHIBITOR DMP323 | HIV-1 PROTEASE, MUTANT G86A, SYMMETRIC INHIBITOR, DMP323, AIDS, ASPARTYL PROTEASE, HYDROLASE
3jxv:A (ASP177) to (PHE201) CRYSTAL STRUCTURE OF THE 3 FKBP DOMAINS OF WHEAT FKBP73 | FKBP- BINDING DOMAIN FIVE-STRANDED ANTI-PARALLEL BETA-SHEET AND AN ALPHA-HELIX CROSSING THIS SHEET, STRUCTURAL GENOMICS, ISRAEL STRUCTURAL PROTEOMICS CENTER, ISPC, CALMODULIN-BINDING, ISOMERASE, ROTAMASE, STRESS RESPONSE, TPR REPEAT
2yqb:A (LEU400) to (MET421) STRUCTURE OF P93A VARIANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.4 A RESOLUTION | ELECTRON TRANSFER, OXIDOREDUCTASE, PROTON CHANNEL, DENITRIFICATION
5cgt:A (THR586) to (ASP638) MALTOTRIOSE COMPLEX OF PRECONDITIONED CYCLODEXTRIN GLYCOSYLTRANSFERASE MUTANT | GLYCOSYLTRANSFERASE, STARCH DEGRADATION, CYCLODEXTRIN
4obf:C (GLY52) to (GLY78) CRYSTAL STRUCTURE OF NELFINAVIR-RESISTANT, INACTIVE HIV-1 PROTEASE VARIANT (D30N/N88D) IN COMPLEX WITH THE P1-P6 SUBSTRATE VARIANT (S451N) | CO-EVOLUTION, RESISTANCE, HYDROLASE
1ldy:A (LYS5) to (ALA29) HORSE LIVER ALCOHOL DEHYDROGENASE COMPLEXED TO NADH AND CYCLOHEXYL FORMAMIDE (CXF) | DEHYDROGENASE, ALCOHOL, NICOTINAMIDE COENZYME, FORMAMIDES
1ldy:C (LYS5) to (ALA29) HORSE LIVER ALCOHOL DEHYDROGENASE COMPLEXED TO NADH AND CYCLOHEXYL FORMAMIDE (CXF) | DEHYDROGENASE, ALCOHOL, NICOTINAMIDE COENZYME, FORMAMIDES
1ldy:D (LYS5) to (ALA29) HORSE LIVER ALCOHOL DEHYDROGENASE COMPLEXED TO NADH AND CYCLOHEXYL FORMAMIDE (CXF) | DEHYDROGENASE, ALCOHOL, NICOTINAMIDE COENZYME, FORMAMIDES
2nxd:A (ARG57) to (GLY78) STRUCTURE OF HIV-1 PROTEASE D25N COMPLEXED WITH RT-RH ANALOGUE PEPTIDE GLY-ALA-ASP-ILE-PHE*TYR-LEU-ASP-GLY-ALA | PEPTIDE DESIGN; MOLECULAR DYNAMICS; HIV PROTEASE; SUBSTRATE RECOGNITION; CALORIMETRY, HYDROLASE/HYDROLASE SUBSTRATE COMPLEX
1lf4:A (TRP193) to (SER215) STRUCTURE OF PLASMEPSIN II | HYDROLASE
5cje:A (PRO30) to (GLY49) STRUCTURE OF CYP107L2 | STREPTOMYCES AVERMITILIS, P450, CYP107L2, OXIDOREDUCTASE
3k3c:A (PRO84) to (ALA116) THE N-TERMINAL PAS DOMAIN CRYSTAL STRUCTURE OF RV1364C FROM MYCOBACTERIUM TUBERCULOSIS AT 1.62 | SENSOR, PAS, SIGNAL TRANSDUCTION, FATTY-ACID BINDING, SIGMA FACTOR REGULATOR, SIGNALING PROTEIN
3k3c:B (PRO84) to (ALA116) THE N-TERMINAL PAS DOMAIN CRYSTAL STRUCTURE OF RV1364C FROM MYCOBACTERIUM TUBERCULOSIS AT 1.62 | SENSOR, PAS, SIGNAL TRANSDUCTION, FATTY-ACID BINDING, SIGMA FACTOR REGULATOR, SIGNALING PROTEIN
5cl1:A (MET1040) to (CYS1065) COMPLEX STRUCTURE OF NORRIN WITH HUMAN FRIZZLED 4 | WNT, NORRIN, FRIZZLED, SIGNALING PROTEIN
2o1t:A (MET370) to (VAL389) STRUCTURE OF MIDDLE PLUS C-TERMINAL DOMAINS (M+C) OF GRP94 | GRP94, HSP82, HSP90, HTPG, CHAPERONE, GP96, ENDOPLASMIN
2o1t:C (MET370) to (VAL389) STRUCTURE OF MIDDLE PLUS C-TERMINAL DOMAINS (M+C) OF GRP94 | GRP94, HSP82, HSP90, HTPG, CHAPERONE, GP96, ENDOPLASMIN
2o1t:E (MET370) to (VAL389) STRUCTURE OF MIDDLE PLUS C-TERMINAL DOMAINS (M+C) OF GRP94 | GRP94, HSP82, HSP90, HTPG, CHAPERONE, GP96, ENDOPLASMIN
2o1t:G (MET370) to (VAL389) STRUCTURE OF MIDDLE PLUS C-TERMINAL DOMAINS (M+C) OF GRP94 | GRP94, HSP82, HSP90, HTPG, CHAPERONE, GP96, ENDOPLASMIN
2o40:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF A CHEMICALLY SYNTHESIZED 203 AMINO ACID 'COVALENT DIMER' HIV-1 PROTEASE MOLECULE | BETA-TURN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1lv1:A (ARG1057) to (GLY1078) CRYSTAL STRUCTURE ANALYSIS OF THE NON-ACTIVE SITE MUTANT OF TETHERED HIV-1 PROTEASE TO 2.1A RESOLUTION | BETA-RIBBON FLAP, HYDROLASE
4a6f:B (ILE470) to (PRO494) CRYSTAL STRUCTURE OF SLM1-PH DOMAIN IN COMPLEX WITH PHOSPHOSERINE | SIGNALING PROTEIN, POST TRANSLATIONAL MODIFICATION
2zbn:A (ASP39) to (VAL66) CRYSTAL STRUCTURE OF PH1033 FROM PYROCOCCUS HORIKOSHII OT3 | PYROCOCCUS HORIKOSHII OT3, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, UNKNOWN FUNCTION
1m1f:A (ARG38) to (THR79) KID TOXIN PROTEIN FROM E.COLI PLASMID R1 | TOXIN-ANTITOXIN, PLASMID MAINTENANCE, POST SEGREGATIONAL KILLING, DNA REPLICATION, MUTATIONAL ANALYSIS, CCDB
1m1f:B (ARG38) to (THR79) KID TOXIN PROTEIN FROM E.COLI PLASMID R1 | TOXIN-ANTITOXIN, PLASMID MAINTENANCE, POST SEGREGATIONAL KILLING, DNA REPLICATION, MUTATIONAL ANALYSIS, CCDB
1m1x:A (TYR290) to (ALA322) CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHA VBETA3 BOUND TO MN2+ | GENU, HYBRID DOMAIN, BETA-TAIL DOMAIN, PSI DOMAIN, EGF DOMAIN, MIDAS, ADMIDAS, CAGE MOTIF, PROPELLER, A-DOMAIN, THIGH DOMAIN, CALF DOMAIN, CELL ADHESION
1xpg:B (GLY478) to (GLY502) CRYSTAL STRUCTURE OF T. MARITIMA COBALAMIN-INDEPENDENT METHIONINE SYNTHASE COMPLEXED WITH ZN2+ AND METHYLTETRAHYDROFOLATE | TIM BARREL, ZINC, HOMOCYSTEINE, METHYLTETRAHYDROFOLATE, TRANSFERASE
1m38:A (TRP52) to (VAL80) STRUCTURE OF INORGANIC PYROPHOSPHATASE | PYROPHOSPHATE PHOSPHOHYDROLASE, HYDROLASE, COBALT
1m38:B (TRP52) to (VAL80) STRUCTURE OF INORGANIC PYROPHOSPHATASE | PYROPHOSPHATE PHOSPHOHYDROLASE, HYDROLASE, COBALT
3kdd:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K, L33I, L63I) IN COMPLEX WITH KNI-10265 | VIRAL PROTEIN, HYDROLASE, PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4opg:A (GLU70) to (LEU96) CONSTRUCTING TAILORED ISOPRENOID PRODUCTS BY STRUCTURE-GUIDED MODIFICATION OF GERANYLGERANYL REDUCTASE. | ROSSMANN FOLD, OXIDOREDUCTASE, ARCHAEAL PROTEIN
4opl:A (GLU70) to (LEU96) CONSTRUCTING TAILORED ISOPRENOID PRODUCTS BY STRUCTURE-GUIDED MODIFICATION OF GERANYLGERANYL REDUCTASE. | ROSSMANN FOLD, OXIDOREDUCTASE, ARCHAEAL PROTEIN
4opi:A (GLU70) to (LEU96) CONSTRUCTING TAILORED ISOPRENOID PRODUCTS BY STRUCTURE-GUIDED MODIFICATION OF GERANYLGERANYL REDUCTASE. | ROSSMANN FOLD, OXIDOREDUCTASE, ARCHAEAL PROTEIN
4opt:A (GLU70) to (LEU96) CONSTRUCTING TAILORED ISOPRENOID PRODUCTS BY STRUCTURE-GUIDED MODIFICATION OF GERANYLGERANYL REDUCTASE | ROSSMANN FOLD, OXIDOREDUCTASE, ARCHAEAL PROTEIN
5cwe:A (PRO30) to (GLY49) STRUCTURE OF CYP107L2 FROM STREPTOMYCES AVERMITILIS WITH LAURIC ACID | STREPTOMYCES AVERMITILIS, P450, CYP107L2, LAURIC ACID, OXIDOREDUCTASE
5cwe:B (PRO30) to (GLY49) STRUCTURE OF CYP107L2 FROM STREPTOMYCES AVERMITILIS WITH LAURIC ACID | STREPTOMYCES AVERMITILIS, P450, CYP107L2, LAURIC ACID, OXIDOREDUCTASE
1xtv:C (LEU47) to (ASP69) SULFOLOBUS SOLFATARICUS URACIL PHOSPHORIBOSYLTRANSFERASE WITH URIDINE 5'-MONOPHOSPHATE (UMP) BOUND TO HALF OF THE SUBUNITS | TETRAMER, TYPE 1 PHOSPHORIBOSYLTRANSFERASE, UMP COMPLEX
1xtv:G (LEU47) to (ASP69) SULFOLOBUS SOLFATARICUS URACIL PHOSPHORIBOSYLTRANSFERASE WITH URIDINE 5'-MONOPHOSPHATE (UMP) BOUND TO HALF OF THE SUBUNITS | TETRAMER, TYPE 1 PHOSPHORIBOSYLTRANSFERASE, UMP COMPLEX
2zm3:C (MET1012) to (VAL1035) COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND ISOQUINOLINEDIONE INHIBITOR | IGFR, PROTEIN-INHIBITOR COMPLEX, TYROSINE KINASE, ATP- BINDING, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISEASE MUTATION, GLYCOPROTEIN, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE
3kfn:A (ARG57) to (GLY78) HIV PROTEASE (PR) WITH INHIBITOR TL-3 AND FRAGMENT HIT 4D9 BY SOAKING | HIV-1, PROTEASE, EXO SITE, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5cxf:C (PHE297) to (ALA328) CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF GLYCOPROTEIN B FROM HUMAN CYTOMEGALOVIRUS | TYPE III VIRAL FUSOGEN, GLYCOPROTEIN, CYTOMEGALOVIRUS, GB, POSTFUSION FORM, VIRAL PROTEIN
4ou9:D (LYS314) to (ASP353) CRYSTAL STRUCTURE OF APOCAROTENOID OXYGENASE IN THE PRESENCE OF TRITON X-100 | MONOTOPIC MEMBRANE PROTEIN, NON-HEME IRON, METALLOENZYME, 4-HIS IRON CENTER, BETA PROPELLER, CAROTENOID OXYGENASE, OXIDOREDUCTASE
1mal:A (PRO361) to (TRP421) STRUCTURAL BASIS FOR SUGAR TRANSLOCATION THROUGH MALTOPORIN CHANNELS AT 3.1 ANGSTROMS RESOLUTION | OUTER MEMBRANE PROTEIN
1mal:B (PRO361) to (TRP421) STRUCTURAL BASIS FOR SUGAR TRANSLOCATION THROUGH MALTOPORIN CHANNELS AT 3.1 ANGSTROMS RESOLUTION | OUTER MEMBRANE PROTEIN
1mal:C (PRO361) to (TRP421) STRUCTURAL BASIS FOR SUGAR TRANSLOCATION THROUGH MALTOPORIN CHANNELS AT 3.1 ANGSTROMS RESOLUTION | OUTER MEMBRANE PROTEIN
1y0o:C (GLN431) to (ARG460) CRYSTAL STRUCTURE OF REDUCED ATFKBP13 | REDUCED ATFKBP13, FK-506 BINDING PROTEIN, ISOMERASE
1mc0:A (GLN265) to (PRO283) REGULATORY SEGMENT OF MOUSE 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE 2A, CONTAINING THE GAF A AND GAF B DOMAINS | GAF DOMAIN, 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE, 3',5'- GUANOSINE MONOPHOSPHATE, HYDROLASE
4owj:E (ASN436) to (PRO453) CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN | LECTIN, PORE-FORMING TOXIN, BETA-TREFOIL, R-TYPE LECTIN, TOXIN
1mes:A (ARG57) to (GLY78) HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP323 | HYDROLASE, ACID PROTEINASE, ASPARTYL PROTEASE
3kk9:A (ASN12) to (THR34) CAMKII SUBSTRATE COMPLEX B | CAMKII, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, SERINE/THREONINE- PROTEIN KINASE, TRANSFERASE
3kl9:A (MET67) to (ASN92) CRYSTAL STRUCTURE OF PEPA FROM STREPTOCOCCUS PNEUMONIAE | GLUTAMYL AMINOPEPTIDASE, PEPA, TETRAHEDRAL AMINOPEPTIDASE, SUBSTRATE SPECIFICITY, METALLOPEPTIDASE M42, AMINOPEPTIDASE, HYDROLASE
3kl9:B (MET67) to (ASN92) CRYSTAL STRUCTURE OF PEPA FROM STREPTOCOCCUS PNEUMONIAE | GLUTAMYL AMINOPEPTIDASE, PEPA, TETRAHEDRAL AMINOPEPTIDASE, SUBSTRATE SPECIFICITY, METALLOPEPTIDASE M42, AMINOPEPTIDASE, HYDROLASE
3kl9:C (MET67) to (ASN92) CRYSTAL STRUCTURE OF PEPA FROM STREPTOCOCCUS PNEUMONIAE | GLUTAMYL AMINOPEPTIDASE, PEPA, TETRAHEDRAL AMINOPEPTIDASE, SUBSTRATE SPECIFICITY, METALLOPEPTIDASE M42, AMINOPEPTIDASE, HYDROLASE
3kl9:D (MET67) to (ASN92) CRYSTAL STRUCTURE OF PEPA FROM STREPTOCOCCUS PNEUMONIAE | GLUTAMYL AMINOPEPTIDASE, PEPA, TETRAHEDRAL AMINOPEPTIDASE, SUBSTRATE SPECIFICITY, METALLOPEPTIDASE M42, AMINOPEPTIDASE, HYDROLASE
3kl9:E (MET67) to (ASN92) CRYSTAL STRUCTURE OF PEPA FROM STREPTOCOCCUS PNEUMONIAE | GLUTAMYL AMINOPEPTIDASE, PEPA, TETRAHEDRAL AMINOPEPTIDASE, SUBSTRATE SPECIFICITY, METALLOPEPTIDASE M42, AMINOPEPTIDASE, HYDROLASE
3kl9:F (MET67) to (ASN92) CRYSTAL STRUCTURE OF PEPA FROM STREPTOCOCCUS PNEUMONIAE | GLUTAMYL AMINOPEPTIDASE, PEPA, TETRAHEDRAL AMINOPEPTIDASE, SUBSTRATE SPECIFICITY, METALLOPEPTIDASE M42, AMINOPEPTIDASE, HYDROLASE
3kl9:G (MET67) to (ASN92) CRYSTAL STRUCTURE OF PEPA FROM STREPTOCOCCUS PNEUMONIAE | GLUTAMYL AMINOPEPTIDASE, PEPA, TETRAHEDRAL AMINOPEPTIDASE, SUBSTRATE SPECIFICITY, METALLOPEPTIDASE M42, AMINOPEPTIDASE, HYDROLASE
3kl9:H (MET67) to (ASN92) CRYSTAL STRUCTURE OF PEPA FROM STREPTOCOCCUS PNEUMONIAE | GLUTAMYL AMINOPEPTIDASE, PEPA, TETRAHEDRAL AMINOPEPTIDASE, SUBSTRATE SPECIFICITY, METALLOPEPTIDASE M42, AMINOPEPTIDASE, HYDROLASE
3kl9:I (MET67) to (ASN92) CRYSTAL STRUCTURE OF PEPA FROM STREPTOCOCCUS PNEUMONIAE | GLUTAMYL AMINOPEPTIDASE, PEPA, TETRAHEDRAL AMINOPEPTIDASE, SUBSTRATE SPECIFICITY, METALLOPEPTIDASE M42, AMINOPEPTIDASE, HYDROLASE
3kl9:J (MET67) to (ASN92) CRYSTAL STRUCTURE OF PEPA FROM STREPTOCOCCUS PNEUMONIAE | GLUTAMYL AMINOPEPTIDASE, PEPA, TETRAHEDRAL AMINOPEPTIDASE, SUBSTRATE SPECIFICITY, METALLOPEPTIDASE M42, AMINOPEPTIDASE, HYDROLASE
3kl9:K (MET67) to (ASN92) CRYSTAL STRUCTURE OF PEPA FROM STREPTOCOCCUS PNEUMONIAE | GLUTAMYL AMINOPEPTIDASE, PEPA, TETRAHEDRAL AMINOPEPTIDASE, SUBSTRATE SPECIFICITY, METALLOPEPTIDASE M42, AMINOPEPTIDASE, HYDROLASE
3kl9:L (MET67) to (ASN92) CRYSTAL STRUCTURE OF PEPA FROM STREPTOCOCCUS PNEUMONIAE | GLUTAMYL AMINOPEPTIDASE, PEPA, TETRAHEDRAL AMINOPEPTIDASE, SUBSTRATE SPECIFICITY, METALLOPEPTIDASE M42, AMINOPEPTIDASE, HYDROLASE
4ae2:A (SER154) to (LEU192) CRYSTAL STRUCTURE OF HUMAN FIBRILLAR PROCOLLAGEN TYPE III C- PROPEPTIDE TRIMER | STRUCTURAL PROTEIN, FIBRILLAR COLLAGEN, EXTRACELLULAR MATRIX, FIBROSIS
4ae2:B (SER154) to (LEU192) CRYSTAL STRUCTURE OF HUMAN FIBRILLAR PROCOLLAGEN TYPE III C- PROPEPTIDE TRIMER | STRUCTURAL PROTEIN, FIBRILLAR COLLAGEN, EXTRACELLULAR MATRIX, FIBROSIS
4ae2:C (SER154) to (LEU192) CRYSTAL STRUCTURE OF HUMAN FIBRILLAR PROCOLLAGEN TYPE III C- PROPEPTIDE TRIMER | STRUCTURAL PROTEIN, FIBRILLAR COLLAGEN, EXTRACELLULAR MATRIX, FIBROSIS
4p06:B (GLY260) to (GLU288) BACTERIAL ARYLSULFATE SULFOTRANSFERASE (ASST) H436N MUTANT WITH 4- METHYLUMBELLIFERYL SULFATE (MUS) IN THE ACTIVE SITE | SULFOTRANSFERASE, BETA PROPELLER, ACTIVE SITE MUTANT
4p0d:A (LYS437) to (ILE480) THE T6 BACKBONE PILIN OF SEROTYPE M6 STREPTOCOCCUS PYOGENES HAS A MODULAR THREE-DOMAIN STRUCTURE DECORATED WITH VARIABLE LOOPS AND EXTENSIONS | IG-LIKE FOLDISOPEPTIDE BONDSORTASE MOTIFGRAM-POSITIVE PILI, STRUCTURAL PROTEIN
1mka:B (ILE139) to (LEU164) E. COLI BETA-HYDROXYDECANOYL THIOL ESTER DEHYDRASE MODIFIED BY ITS CLASSIC MECHANISM-BASED INACTIVATOR, 3-DECYNOYL-N- ACETYL CYSTEAMINE | FATTY ACID BIOSYNTHESIS
1mkg:D (THR71) to (LEU97) DISULFIDE DEFICIENT MUTANT OF VASCULAR ENDOTHELIAL GROWTH FACTOR A (C57A AND C102A) | CYSTINE-KNOT GROWTH FACTOR, HORMONE/GROWTH FACTOR COMPLEX
1y6b:A (GLY844) to (LEU868) CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 2-ANILINO-5-ARYL-OXAZOLE INHIBITOR | TRANSFERASE
1mpn:A (PRO361) to (TRP421) MALTOPORIN MALTOTRIOSE COMPLEX | MEMBRANE PROTEIN, SUGAR TRANSPORT, SPECIFIC PORIN, BETA BARREL
1mpn:B (PRO361) to (TRP421) MALTOPORIN MALTOTRIOSE COMPLEX | MEMBRANE PROTEIN, SUGAR TRANSPORT, SPECIFIC PORIN, BETA BARREL
1mpn:C (PRO361) to (TRP421) MALTOPORIN MALTOTRIOSE COMPLEX | MEMBRANE PROTEIN, SUGAR TRANSPORT, SPECIFIC PORIN, BETA BARREL
1mpm:A (PRO361) to (TRP421) MALTOPORIN MALTOSE COMPLEX | MEMBRANE PROTEIN, SUGAR TRANSPORT, SPECIFIC PORIN, BETA BARREL
1mpm:B (PRO361) to (TRP421) MALTOPORIN MALTOSE COMPLEX | MEMBRANE PROTEIN, SUGAR TRANSPORT, SPECIFIC PORIN, BETA BARREL
1mpm:C (PRO361) to (TRP421) MALTOPORIN MALTOSE COMPLEX | MEMBRANE PROTEIN, SUGAR TRANSPORT, SPECIFIC PORIN, BETA BARREL
1mpo:A (PRO361) to (TRP421) MALTOPORIN MALTOHEXAOSE COMPLEX | MEMBRANE PROTEIN, SPECIFIC PORIN, BETA BARREL MEMBRANE PROTEIN, SUGAR TRANSPORT, BETA BARREL
1mpo:B (PRO361) to (TRP421) MALTOPORIN MALTOHEXAOSE COMPLEX | MEMBRANE PROTEIN, SPECIFIC PORIN, BETA BARREL MEMBRANE PROTEIN, SUGAR TRANSPORT, BETA BARREL
1mpo:C (PRO361) to (TRP421) MALTOPORIN MALTOHEXAOSE COMPLEX | MEMBRANE PROTEIN, SPECIFIC PORIN, BETA BARREL MEMBRANE PROTEIN, SUGAR TRANSPORT, BETA BARREL
1mpq:A (PRO361) to (TRP421) MALTOPORIN TREHALOSE COMPLEX | MEMBRANE PROTEIN, SPECIFIC PORIN, BETA BARREL, SUGAR TRANSPORT
1mpq:B (PRO361) to (TRP421) MALTOPORIN TREHALOSE COMPLEX | MEMBRANE PROTEIN, SPECIFIC PORIN, BETA BARREL, SUGAR TRANSPORT
1mpq:C (PRO361) to (TRP421) MALTOPORIN TREHALOSE COMPLEX | MEMBRANE PROTEIN, SPECIFIC PORIN, BETA BARREL, SUGAR TRANSPORT
4p71:A (SER565) to (GLY595) APO PHERS FROM P. AEURIGINOSA | PHENYLALANINE TRNA SYNTHETASE, PHERS, LIGASE
4p71:B (SER565) to (GLY595) APO PHERS FROM P. AEURIGINOSA | PHENYLALANINE TRNA SYNTHETASE, PHERS, LIGASE
4p72:A (SER565) to (GLY595) PHERS IN COMPLEX WITH COMPOUND 2A | PHENYLALANINE TRNA SYNTHETASE, PHERS, LIGASE-LIGASE INHIBITOR COMPLEX
4p72:B (SER565) to (GLY595) PHERS IN COMPLEX WITH COMPOUND 2A | PHENYLALANINE TRNA SYNTHETASE, PHERS, LIGASE-LIGASE INHIBITOR COMPLEX
4p73:A (ARG566) to (GLY595) PHERS IN COMPLEX WITH COMPOUND 1A | PHENYLALANYL-TRNA SYNTHETASE, PHERS, LIGASE-LIGASE INHIBITOR COMPLEX
4p73:B (ARG566) to (GLY595) PHERS IN COMPLEX WITH COMPOUND 1A | PHENYLALANYL-TRNA SYNTHETASE, PHERS, LIGASE-LIGASE INHIBITOR COMPLEX
4p74:A (SER565) to (GLY595) PHERS IN COMPLEX WITH COMPOUND 3A | PHENYLALANINE TRNA SYNTHETASE, PHERS, LIGASE-LIGASE INHIBITOR COMPLEX
4p74:B (SER565) to (GLY595) PHERS IN COMPLEX WITH COMPOUND 3A | PHENYLALANINE TRNA SYNTHETASE, PHERS, LIGASE-LIGASE INHIBITOR COMPLEX
4p75:A (SER565) to (GLY595) PHERS IN COMPLEX WITH COMPOUND 4A | PHENYLALANINE TRNA SYNTHETASE, PHERS, LIGASE-LIGASE INHIBITOR COMPLEX
4p75:B (SER565) to (GLY595) PHERS IN COMPLEX WITH COMPOUND 4A | PHENYLALANINE TRNA SYNTHETASE, PHERS, LIGASE-LIGASE INHIBITOR COMPLEX
1mrw:A (ARG57) to (GLY78) STRUCTURE OF HIV PROTEASE (MUTANT Q7K L33I L63I) COMPLEXED WITH KNI- 577 | HIV, KNI-577, PROTEASE, DRUG TARGET, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1mrx:A (ARG57) to (GLY78) STRUCTURE OF HIV PROTEASE (MUTANT Q7K L33I L63I V82F I84V ) COMPLEXED WITH KNI-577 | HIV, KNI-577, PROTEASE, DRUG TARGET, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3a1z:A (PRO42) to (GLY69) CRYSTAL STRUCTURE OF JUVENILE HORMONE BINDING PROTEIN FROM SILKWORM | JUVENILE HORMONE, TRANSPORT PROTEIN
3a1z:B (PRO42) to (GLY69) CRYSTAL STRUCTURE OF JUVENILE HORMONE BINDING PROTEIN FROM SILKWORM | JUVENILE HORMONE, TRANSPORT PROTEIN
3a1z:C (PRO42) to (GLY69) CRYSTAL STRUCTURE OF JUVENILE HORMONE BINDING PROTEIN FROM SILKWORM | JUVENILE HORMONE, TRANSPORT PROTEIN
3a1z:D (PRO42) to (GLY69) CRYSTAL STRUCTURE OF JUVENILE HORMONE BINDING PROTEIN FROM SILKWORM | JUVENILE HORMONE, TRANSPORT PROTEIN
3kqk:A (ASN429) to (PRO452) THREE CONFORMATIONAL SNAPSHOTS OF THE HEPATITIS C VIRUS NS3 HELICASE REVEAL A RATCHET TRANSLOCATION MECHANISM | HELICASE-SUBSTRATE BINARY COMPLEX, HCV, NS3 PROTEIN, HELICASE, DNA-BINDING
5d6a:A (VAL183) to (PRO233) 2.7 ANGSTROM CRYSTAL STRUCTURE OF ABC TRANSPORTER ATPASE FROM VIBRIO VULNIFICUS IN COMPLEX WITH ADENYLYL-IMIDODIPHOSPHATE (AMP-PNP) | ABC TRANSPORTER ATPASE, AMP-PNP, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, HYDROLASE
5d6o:A (GLU16) to (GLY42) ORTHORHOMBIC CRYSTAL STRUCTURE OF AN ACETYLESTER HYDROLASE FROM CORYNEBACTERIUM GLUTAMICUM | ACETYLESTER HYDROLASE, ALPHA/BETA HYDROLASE, TRANSFERASE
5d6o:B (GLU16) to (GLY42) ORTHORHOMBIC CRYSTAL STRUCTURE OF AN ACETYLESTER HYDROLASE FROM CORYNEBACTERIUM GLUTAMICUM | ACETYLESTER HYDROLASE, ALPHA/BETA HYDROLASE, TRANSFERASE
5d6o:C (GLU16) to (GLY42) ORTHORHOMBIC CRYSTAL STRUCTURE OF AN ACETYLESTER HYDROLASE FROM CORYNEBACTERIUM GLUTAMICUM | ACETYLESTER HYDROLASE, ALPHA/BETA HYDROLASE, TRANSFERASE
5d6o:D (GLU16) to (GLY42) ORTHORHOMBIC CRYSTAL STRUCTURE OF AN ACETYLESTER HYDROLASE FROM CORYNEBACTERIUM GLUTAMICUM | ACETYLESTER HYDROLASE, ALPHA/BETA HYDROLASE, TRANSFERASE
1mt7:A (ARG57) to (GLY78) VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE MUTANT: STRUCTURAL INSIGHTS FOR BETTER ANTIVIRAL THERAPY | MATRIX, CAPSID, GAG CLEAVAGE, DRUG RESISTANCE, SUBSTRATE RECOGNITION, HYDROLASE/HYDROLASE INHIBITOR COMPLEX
1mt8:B (ARG57) to (GLY78) VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE MUTANT: STRUCTURAL INSIGHTS FOR BETTER ANTIVIRAL THERAPY | MATRIX, CAPSID, GAG CLEAVAGE, DRUG RESISTANCE, SUBSTRATE RECOGNITION, HYDROLASE/HYDROLASE INHIBITOR COMPLEX
1mtb:B (ARG57) to (GLY78) VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE MUTANT: STRUCTURAL INSIGHTS FOR BETTER ANTIVIRAL THERAPY | HIV-1 PROTEASE, DRUG RESISTANCE, SUBSTRATE RECOGNITION, INHIBITOR BINDING, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5d7b:A (GLU16) to (GLY42) TRIGONAL CRYSTAL STRUCTURE OF AN ACETYLESTER HYDROLASE FROM CORYNEBACTERIUM GLUTAMICUM | ACETYLESTER HYDROLASE, ALPHA/BETA-HYDROLASE, HYDROLASE
5d7b:B (GLU16) to (GLY42) TRIGONAL CRYSTAL STRUCTURE OF AN ACETYLESTER HYDROLASE FROM CORYNEBACTERIUM GLUTAMICUM | ACETYLESTER HYDROLASE, ALPHA/BETA-HYDROLASE, HYDROLASE
1mtr:A (ARG57) to (GLY78) HIV-1 PROTEASE COMPLEXED WITH A CYCLIC PHE-ILE-VAL PEPTIDOMIMETIC INHIBITOR | ASPARTYL PROTEINASE, AIDS, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1mtr:B (ARG57) to (GLY78) HIV-1 PROTEASE COMPLEXED WITH A CYCLIC PHE-ILE-VAL PEPTIDOMIMETIC INHIBITOR | ASPARTYL PROTEINASE, AIDS, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1mui:B (ARG57) to (GLY78) CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH LOPINAVIR. | HYDROLASE
1mui:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH LOPINAVIR. | HYDROLASE
1ye3:A (LYS5) to (PRO30) HORSE LIVER ALCOHOL DEHYDROGENASE APOENZYME | DEHYDROGENASE, ALCOHOL, LIVER, APOENZYME, METHYLPENTANEDIOL, OXIDOREDUCTASE
4paw:A (ALA12) to (SER32) STRUCTURE OF HYPOTHETICAL PROTEIN HP1257. | HYPOTHETICAL PROTEIN
4paw:B (ALA12) to (GLN31) STRUCTURE OF HYPOTHETICAL PROTEIN HP1257. | HYPOTHETICAL PROTEIN
3ks7:C (GLY329) to (ALA355) CRYSTAL STRUCTURE OF PUTATIVE PEPTIDE:N-GLYCOSIDASE F (PNGASE F) (YP_210507.1) FROM BACTEROIDES FRAGILIS NCTC 9343 AT 2.30 A RESOLUTION | PUTATIVE PEPTIDE:N-GLYCOSIDASE F (PNGASE F), STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, HYDROLASE
4pba:A (LYS43) to (PHE64) THE 5-HYDROXYMETHYLCYTOSINE-SPECIFIC RESTRICTION ENZYME ABASI IN A COMPLEX WITH SUBSTRATE-LIKE DNA | HYDROXYMETHYLCYTOSINE-DEPENDENT RESTRICTION ENZYME, HYDROLASE, VSR ENDONUCLEASE-LIKE, SRA DOMAIN-LIKE, EPIGENETIC SEQUENCING TOOL
4pba:D (LYS43) to (PHE64) THE 5-HYDROXYMETHYLCYTOSINE-SPECIFIC RESTRICTION ENZYME ABASI IN A COMPLEX WITH SUBSTRATE-LIKE DNA | HYDROXYMETHYLCYTOSINE-DEPENDENT RESTRICTION ENZYME, HYDROLASE, VSR ENDONUCLEASE-LIKE, SRA DOMAIN-LIKE, EPIGENETIC SEQUENCING TOOL
4pbb:A (LYS43) to (PHE64) THE 5-HYDROXYMETHYLCYTOSINE-SPECIFIC RESTRICTION ENZYME ABASI | HYDROXYMETHYLCYTOSINE-DEPENDENT RESTRICTION ENZYME, HYDROLASE, VSR ENDONUCLEASE-LIKE, SRA DOMAIN-LIKE, EPIGENETIC SEQUENCING TOOL
3kt5:A (ARG1057) to (GLY1078) CRYSTAL STRUCTURE OF N88S MUTANT HIV-1 PROTEASE | DRUG RESISTANT, MUTATION, HIV-1 PROTEASE, N88S, NELFINAVIR, HYDROLASE, PROTEASE
3ktm:F (GLN90) to (PHE111) STRUCTURE OF THE HEPARIN-INDUCED E1-DIMER OF THE AMYLOID PRECURSOR PROTEIN (APP) | PROTEIN STRUCTURE, ALZHEIMER DISEASE, AMYLOID, AMYLOIDOSIS, APOPTOSIS, CELL ADHESION, COPPER, DISEASE MUTATION, DISULFIDE BOND, ENDOCYTOSIS, HEPARIN-BINDING, METAL-BINDING, NEURODEGENERATION, NOTCH SIGNALING PATHWAY, PROTEOGLYCAN, ZINC, SIGNALING PROTEIN
1n05:A (GLY63) to (VAL82) CRYSTAL STRUCTURE OF SCHIZOSACCHAROMYCES POMBE RIBOFLAVIN KINASE REVEALS A NOVEL ATP AND RIBOFLAVIN BINDING FOLD | KINASE, PHOSPHORYL TRANSFERASES, FLAVIN COFACTORS, METAL BINDING
3kxx:A (ARG477) to (GLY499) STRUCTURE OF THE MUTANT FIBROBLAST GROWTH FACTOR RECEPTOR 1 | KINASE, RTK, INTERFACE, PHOSPHORYLATION, ALTERNATIVE SPLICING, ATP-BINDING, CHROMOSOMAL REARRANGEMENT, CRANIOSYNOSTOSIS, DISEASE MUTATION, DISULFIDE BOND, DWARFISM, GLYCOPROTEIN, HEPARIN-BINDING, HYPOGONADOTROPIC HYPOGONADISM, IMMUNOGLOBULIN DOMAIN, KALLMANN SYNDROME, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE
3kxx:B (GLY490) to (LEU516) STRUCTURE OF THE MUTANT FIBROBLAST GROWTH FACTOR RECEPTOR 1 | KINASE, RTK, INTERFACE, PHOSPHORYLATION, ALTERNATIVE SPLICING, ATP-BINDING, CHROMOSOMAL REARRANGEMENT, CRANIOSYNOSTOSIS, DISEASE MUTATION, DISULFIDE BOND, DWARFISM, GLYCOPROTEIN, HEPARIN-BINDING, HYPOGONADOTROPIC HYPOGONADISM, IMMUNOGLOBULIN DOMAIN, KALLMANN SYNDROME, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE
3kxx:D (GLY490) to (MET515) STRUCTURE OF THE MUTANT FIBROBLAST GROWTH FACTOR RECEPTOR 1 | KINASE, RTK, INTERFACE, PHOSPHORYLATION, ALTERNATIVE SPLICING, ATP-BINDING, CHROMOSOMAL REARRANGEMENT, CRANIOSYNOSTOSIS, DISEASE MUTATION, DISULFIDE BOND, DWARFISM, GLYCOPROTEIN, HEPARIN-BINDING, HYPOGONADOTROPIC HYPOGONADISM, IMMUNOGLOBULIN DOMAIN, KALLMANN SYNDROME, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE
3ky2:B (GLY490) to (LEU516) CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN | KINASE, RTK, PHOSPHORYLATION, INTERFACE, ALTERNATIVE SPLICING, ATP-BINDING, CHROMOSOMAL REARRANGEMENT, CRANIOSYNOSTOSIS, DISEASE MUTATION, DISULFIDE BOND, DWARFISM, GLYCOPROTEIN, HEPARIN-BINDING, HYPOGONADOTROPIC HYPOGONADISM, IMMUNOGLOBULIN DOMAIN, KALLMANN SYNDROME, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE
3kyh:D (GLY126) to (PHE151) SACCHAROMYCES CEREVISIAE CET1-CEG1 CAPPING APPARATUS | CAPPING, RNA, 5' MODIFICATION, TRIPHOSPHATASE, GUANYLYLTRANSFERASE, COMPLEX, HYDROLASE, MRNA CAPPING, MRNA PROCESSING, NUCLEUS, PHOSPHOPROTEIN, GTP-BINDING, NUCLEOTIDE-BINDING, NUCLEOTIDYLTRANSFERASE, TRANSFERASE, PROTEIN BINDING
1ypp:A (TRP52) to (VAL80) ACID ANHYDRIDE HYDROLASE | HYDROLASE
1ypp:B (TRP52) to (VAL80) ACID ANHYDRIDE HYDROLASE | HYDROLASE
1n49:B (ARG57) to (GLY78) VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE VARIANT: STRUCTURAL INSIGHTS FOR BETTER ANTI-VIRAL THERAPY | HIV-1 PROTEASE, DRUG RESISTANCE, SUBSTRATE RECOGNITION, INHIBITOR BINDING, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4pib:B (LEU112) to (LYS149) CRYSTAL STRUCTURE OF UNCHARACTERIZED CONSERVED PROTEIN PIXA FROM BURKHOLDERIA THAILANDENSIS | BETA-FOLD, INCLUSION BODY PROTEIN, STRUCTURAL GENOMICS, PSI-BIOLOGY, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG
4pib:C (HIS111) to (LYS149) CRYSTAL STRUCTURE OF UNCHARACTERIZED CONSERVED PROTEIN PIXA FROM BURKHOLDERIA THAILANDENSIS | BETA-FOLD, INCLUSION BODY PROTEIN, STRUCTURAL GENOMICS, PSI-BIOLOGY, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG
4pib:E (GLU118) to (LYS149) CRYSTAL STRUCTURE OF UNCHARACTERIZED CONSERVED PROTEIN PIXA FROM BURKHOLDERIA THAILANDENSIS | BETA-FOLD, INCLUSION BODY PROTEIN, STRUCTURAL GENOMICS, PSI-BIOLOGY, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG
4pib:F (VAL119) to (LYS149) CRYSTAL STRUCTURE OF UNCHARACTERIZED CONSERVED PROTEIN PIXA FROM BURKHOLDERIA THAILANDENSIS | BETA-FOLD, INCLUSION BODY PROTEIN, STRUCTURAL GENOMICS, PSI-BIOLOGY, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG
4pib:G (LEU112) to (LYS149) CRYSTAL STRUCTURE OF UNCHARACTERIZED CONSERVED PROTEIN PIXA FROM BURKHOLDERIA THAILANDENSIS | BETA-FOLD, INCLUSION BODY PROTEIN, STRUCTURAL GENOMICS, PSI-BIOLOGY, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG
4pib:H (VAL119) to (LYS149) CRYSTAL STRUCTURE OF UNCHARACTERIZED CONSERVED PROTEIN PIXA FROM BURKHOLDERIA THAILANDENSIS | BETA-FOLD, INCLUSION BODY PROTEIN, STRUCTURAL GENOMICS, PSI-BIOLOGY, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG
4pib:I (VAL119) to (LYS149) CRYSTAL STRUCTURE OF UNCHARACTERIZED CONSERVED PROTEIN PIXA FROM BURKHOLDERIA THAILANDENSIS | BETA-FOLD, INCLUSION BODY PROTEIN, STRUCTURAL GENOMICS, PSI-BIOLOGY, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG
4pib:J (VAL119) to (LYS149) CRYSTAL STRUCTURE OF UNCHARACTERIZED CONSERVED PROTEIN PIXA FROM BURKHOLDERIA THAILANDENSIS | BETA-FOLD, INCLUSION BODY PROTEIN, STRUCTURAL GENOMICS, PSI-BIOLOGY, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG
5dgw:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF HIV-1 PROTEASE INHIBITOR GRL-105-11A CONTAINING SUBSTITUTED FUSED-TETRAHYDROPYRANYL TETRAHYDROFURAN AS P2-LIGAND | HIV-1 PROTEASE, ENZYME, HYDROLASE, HYDROLASE INHIBITOR
5dgx:A (ASN371) to (ILE394) 1.73 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE ABC-ATPASE DOMAIN (RESIDUES 357-609) OF LIPID A TRANSPORT PROTEIN (MSBA) FROM FRANCISELLA TULARENSIS SUBSP. TULARENSIS SCHU S4 IN COMPLEX WITH ADP | LIPID A TRANSPORT PROTEIN, ABC TRANSPORTER, ATP-BINDING AND MEMBRANE PROTEIN, FRANCISELLA TULARENSIS SUBSP. TULARENSIS SCHU S4, CSGID, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, TRANSPORT PROTEIN
1yrr:B (TYR2) to (ASP25) CRYSTAL STRUCTURE OF THE N-ACETYLGLUCOSAMINE-6-PHOSPHATE DEACETYLASE FROM ESCHERICHIA COLI K12 AT 2.0 A RESOLUTION | (BETA/ALPHA)8 BARREL, BETA SANDWICH, HYDROLASE
1yt9:B (ARG57) to (GLY78) HIV PROTEASE WITH OXIMINOARYLSULFONAMIDE BOUND | HIV PROTEASE, OXIMINOARYLSULFONAMIDES, HYDROLASE
3aff:B (SER149) to (PRO172) CRYSTAL STRUCTURE OF THE HSAA MONOOXYGENASE FROM M. TUBERCULOSIS | HSAA, CHOLESTEROL 3HSA MONOOXYGENASE, OXIDOREDUCTASE
1yth:A (ARG57) to (GLY78) SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT | AIDS, POLYPROTEIN, HYDROLASE, ASPARTYL PROTEASE, ENDONUCLEASE, RNA- DIRECTED DNA POLYMERASE, HYDROLASE-PEPTIDE COMPLEX
1ytj:A (GLY52) to (GLY78) SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT | AIDS, POLYPROTEIN, HYDROLASE, ASPARTYL PROTEASE, ENDONUCLEASE, RNA- DIRECTED DNA POLYMERASE, HYDROLASE-PEPTIDE COMPLEX
5dim:A (ASN448) to (ASN480) MUTANT TOXIN IN 'NATIVE' SPACE GROUP | TOXIN, MUTANT
3agl:A (GLU44) to (GLU64) COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR ARC-1039 | PKA, PROTEIN KINASE A, BISUBSTRATE INHIBITOR, ARC-1039, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX
1yyl:G (SER115) to (SER209) CRYSTAL STRUCTURE OF CD4M33, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B | HIV-1, GP120, YU2, SCORPION TOXIN, CD4 MIMIC, CD4M33, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1z1h:A (ARG57) to (GLY78) HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 3 | MACROCYCLIC INHIBITORS, PEPTIDOMIMETIC INHIBITORS, HIV1 PROTEASE, HYDROLASE
1z1r:A (ARG57) to (GLY78) HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 2 | MACROCYCLIC INHIBITORS, PEPTIDOMIMETIC INHIBITORS, HIV1 PROTEASE, HYDROLASE
3aib:B (GLN762) to (ASN792) CRYSTAL STRUCTURE OF GLUCANSUCRASE | BETA-ALPHA-BARREL, TRANSFERASE
3aid:A (ARG57) to (GLY78) A NEW CLASS OF HIV-1 PROTEASE INHIBITOR: THE CRYSTALLOGRAPHIC STRUCTURE, INHIBITION AND CHEMICAL SYNTHESIS OF AN AMINIMIDE PEPTIDE ISOSTERE | ASPARTYL PROTEASE, PROTEASE, HIV, PEPTIDE ISOSTERE INHIBITOR, DRUG DESIGN
1z4v:A (ALA482) to (ASN505) PARAINFLUENZA VIRUS 5 (SV5) HEMAGGLUTININ-NEURAMINIDASE (HN) WITH LIGAND DANA (SOAKED WITH DANA, PH 7.0) | HEMAGGLUTININ,NEURAMINIDASE,FUSION,TETRAMER, HYDROLASE
1z4x:A (GLU481) to (ASN505) PARAINFLUENZA VIRUS 5 (SV5) HEMAGGLUTININ-NEURAMINIDASE (HN) WITH LIGAND SIALYLLACTOSE (SOAKED WITH SIALYLLACTOSE, PH8.0) | HEMAGGLUTININ,NEURAMINIDASE,FUSION,TETRAMER, HYDROLASE
1z4y:A (GLU481) to (ASN505) PARAINFLUENZA VIRUS 5 (SV5) HEMAGGLUTININ-NEURAMINIDASE (HN) (PH 8.0) | HEMAGGLUTININ,NEURAMINIDASE,FUSION,TETRAMER, HYDROLASE
5do7:A (GLU34) to (SER78) CRYSTAL STRUCTURE OF THE HUMAN STEROL TRANSPORTER ABCG5/ABCG8 | ATP-BINDING CASSETTE TRANSPORTER, ABCG, STEROL EFFLUX, SITOSTEROLEMIA, TRANSPORT PROTEIN
5do7:B (ASP33) to (SER97) CRYSTAL STRUCTURE OF THE HUMAN STEROL TRANSPORTER ABCG5/ABCG8 | ATP-BINDING CASSETTE TRANSPORTER, ABCG, STEROL EFFLUX, SITOSTEROLEMIA, TRANSPORT PROTEIN
5do7:D (SER32) to (SER97) CRYSTAL STRUCTURE OF THE HUMAN STEROL TRANSPORTER ABCG5/ABCG8 | ATP-BINDING CASSETTE TRANSPORTER, ABCG, STEROL EFFLUX, SITOSTEROLEMIA, TRANSPORT PROTEIN
5do7:C (HIS36) to (SER78) CRYSTAL STRUCTURE OF THE HUMAN STEROL TRANSPORTER ABCG5/ABCG8 | ATP-BINDING CASSETTE TRANSPORTER, ABCG, STEROL EFFLUX, SITOSTEROLEMIA, TRANSPORT PROTEIN
1z50:A (GLU481) to (ASN505) PARAINFLUENZA VIRUS 5 (SV5) HEMAGGLUTININ-NEURAMINIDASE (HN) WITH LIGAND DANA (SOAKED WITH SIALIC ACID, PH 8.0) | HEMAGGLUTININ,NEURAMINIDASE,FUSION,TETRAMER, HYDROLASE
4pq9:A (ARG140) to (LYS163) CRYSTAL STRUCTURE OF A BETA-1,3-GLUCANASE FROM MYCOBACTERIUM MARINUM | STRUCTURAL GENOMICS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, GLYCOSYL HYDROLASE, HYDROLASE
4pqd:A (GLN90) to (PHE111) THE LONGER CRYSTAL STRUCTURE OF THE GROW FACTOR LIKE DOMAIN FROM BETA AMYPOID PRECUSOR PROTEIN (APP22-126) | ALPHAN AND BETA, GROWTH FACTOR, HEPARIN BINDING, PROTEIN BINDING, ALZHEIMER'S DISEASE, DEATH RECEPTOR 6 BINDING
4pro:B (THR115) to (ASN135) ALPHA-LYTIC PROTEASE COMPLEXED WITH PRO REGION | PRO REGION, FOLDASE, PROTEIN FOLDING, SERINE PROTEASE
1z8c:B (ARG157) to (GLY178) CRYSTAL STRUCTURE OF THE COMPLEX OF MUTANT HIV-1 PROTEASE (L63P, A71V, V82T, I84V) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR BOC- PHE-PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2 | HIV, PROTEASE, PEPTIDOMIMETIC INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5dpz:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 31 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
5dq4:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 66 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
5dq5:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 209 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
5dqp:B (GLY180) to (VAL200) EDTA MONOOXYGENASE (EMOA) FROM CHELATIVORANS SP. BNC1 | MONOOXYGENASE, BIOREMEDIATION, EDTA DEGRADATION, OXIDOREDUCTASE
5dr0:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 203 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
5dr1:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 278 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
5dr8:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 330 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4aoi:A (GLY1090) to (SER1111) CRYSTAL STRUCTURE OF C-MET KINASE DOMAIN IN COMPLEX WITH 4-( 3-((1H- PYRROLO(2,3-B)PYRIDIN-3-YL)METHYL)-(1,2,4)TRIAZOLO( 4,3-B)(1,2,4) TRIAZIN-6-YL)BENZONITRILE | TRANSFERASE, KINASE INHIBITOR
4ape:A (ASP83) to (ALA104) THE ACTIVE SITE OF ASPARTIC PROTEINASES | HYDROLASE (ACID PROTEINASE)
5duj:A (GLY295) to (ILE328) CRYSTAL STRUCTURE OF LDTMT2 IN COMPLEX WITH FAROPENEM ADDUCT | LD-TRANSPEPTIDASE, PEPTIDOGLYCAN SYNTHESIS ENZYME, CELL WALL ENZYME, TRANSFERASE
5duj:B (GLY295) to (ILE328) CRYSTAL STRUCTURE OF LDTMT2 IN COMPLEX WITH FAROPENEM ADDUCT | LD-TRANSPEPTIDASE, PEPTIDOGLYCAN SYNTHESIS ENZYME, CELL WALL ENZYME, TRANSFERASE
4aql:A (HIS11) to (SER37) HUMAN GUANINE DEAMINASE IN COMPLEX WITH VALACYCLOVIR | HYDROLASE, PURINE METABOLISM
3lm8:B (GLU162) to (LEU183) CRYSTAL STRUCTURE OF THIAMINE PYROPHOSPHOKINASE FROM BACILLUS SUBTILIS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET SR677 | STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, ATP- BINDING, KINASE, NUCLEOTIDE-BINDING, TRANSFERASE
3lnp:A (LEU21) to (LYS52) CRYSTAL STRUCTURE OF AMIDOHYDROLASE FAMILY PROTEIN OLEI01672_1_465 FROM OLEISPIRA ANTARCTICA | TIM BARREL, BETA-FOLD, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, HYDROLASE
4q1x:A (ARG57) to (GLY78) MUTATIONS OUTSIDE THE ACTIVE SITE OF HIV-1 PROTEASE ALTER ENZYME STRUCTURE AND DYNAMIC ENSEMBLE OF THE ACTIVE SITE TO CONFER DRUG RESISTANCE | HIV-1 PROTEASE, AIDS, INHIBITOR COMPLEX, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4q1y:A (ARG57) to (GLY78) MUTATIONS OUTSIDE THE ACTIVE SITE OF HIV-1 PROTEASE ALTER ENZYME STRUCTURE AND DYNAMIC ENSEMBLE OF THE ACTIVE SITE TO CONFER DRUG RESISTANCE | HIV-1 PROTEASE, AIDS, INHIBITOR COMPLEX, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4asm:B (ASN85) to (THR119) CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BETA-AGARASE D FROM ZOBELLIA GALACTANIVORANS | HYDROLASE, GLYCOSIDE HYDROLASE, ENDO-BETA-AGARASE
5dzj:A (GLY295) to (ILE328) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS L,D-TRANSPEPTIDASE 2 WITH CARBAPENEM DRUG T206 IN CONFORMATION A | PEPTIDOGLYCAN SYNTHESIS ENZYME, CELL WALL ENZYME, TRANSFERASE
5dzj:B (GLY295) to (ILE328) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS L,D-TRANSPEPTIDASE 2 WITH CARBAPENEM DRUG T206 IN CONFORMATION A | PEPTIDOGLYCAN SYNTHESIS ENZYME, CELL WALL ENZYME, TRANSFERASE
3lpr:A (THR163) to (ASN184) STRUCTURAL BASIS FOR BROAD SPECIFICITY IN ALPHA-LYTIC PROTEASE MUTANTS | SERINE PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3app:A (ASN84) to (ALA105) STRUCTURE AND REFINEMENT OF PENICILLOPEPSIN AT 1.8 ANGSTROMS RESOLUTION | HYDROLASE (ACID PROTEINASE)
1ztz:B (LYS55) to (GLY78) CRYSTAL STRUCTURE OF HIV PROTEASE- METALLACARBORANE COMPLEX | RATIONAL DRUG DESIGN; HIV PROTEASE INHIBITORS; ASPARTIC PROTEASES; CARBORANES; METALLACARBORANES, HYDROLASE
4ax3:B (GLY402) to (MET421) STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION | THREE-DOMAIN HEME-CU NITRITE REDUCTASE, ELECTRON TRANSFER, OXIDOREDUCTASE, PROTON CHANNEL, DENITRIFICATION
3lw0:A (GLY1011) to (VAL1035) IGF-1RK IN COMPLEX WITH LIGAND MSC1609119A-1 | PROTEIN KINASE, TRANSFERASE
3lw0:B (GLY1011) to (VAL1035) IGF-1RK IN COMPLEX WITH LIGAND MSC1609119A-1 | PROTEIN KINASE, TRANSFERASE
3lw0:C (GLY1011) to (VAL1035) IGF-1RK IN COMPLEX WITH LIGAND MSC1609119A-1 | PROTEIN KINASE, TRANSFERASE
3lw0:D (GLY1011) to (VAL1035) IGF-1RK IN COMPLEX WITH LIGAND MSC1609119A-1 | PROTEIN KINASE, TRANSFERASE
4b0i:C (VAL139) to (PHE165) CRYSTAL STRUCTURE OF 3-HYDROXYDECANOYL-ACYL CARRIER PROTEIN DEHYDRATASE (FABA) MUTANT (H70N) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH 3-HYDROXYDECANOYL-N-ACETYL CYSTEAMINE | LYASE, FATTY ACID BIOSYNTHESIS, BACTERIAL VIRULENCE, DRUG DISCOVERY
2a1e:B (ARG57) to (GLY78) HIGH RESOLUTION STRUCTURE OF HIV-1 PR WITH TS-126 | HIV PR, PEPTIDOMIMETIC INHIBITOR, STEREOISOMER, SCREENING A MIXTURE, HYDROLASE
4b1g:A (GLY785) to (ASP807) STRUCTURE OF UNLIGANDED HUMAN PARG CATALYTIC DOMAIN | HYDROLASE
4b1i:A (GLY785) to (ASP807) STRUCTURE OF HUMAN PARG CATALYTIC DOMAIN IN COMPLEX WITH OA-ADP-HPD | POLY ADP-RIBOSE, HYDROLASE
4qd2:D (ASN70) to (GLN86) MOLECULAR BASIS FOR DISRUPTION OF E-CADHERIN ADHESION BY BOTULINUM NEUROTOXIN A COMPLEX | ORAL TOXICITY, BOTULINUM NEUROTOXIN, E-CADHERIN, HA70, HA17, HA33, CELL ADHESION
4b4l:A (TYR13) to (SER34) CRYSTAL STRUCTURE OF AN ARD DAP-KINASE 1 MUTANT | TRANSFERASE, AUTOINHIBITION
3b1b:B (ASP251) to (MET273) THE UNIQUE STRUCTURE OF WILD TYPE CARBONIC ANHYDRASE ALPHA-CA1 FROM CHLAMYDOMONAS REINHARDTII | N-GLYCOSYLATION, ZINC-FINGER, CARBONIC ANHYDRASE, LYASE
4qgi:B (ARG57) to (GLY78) X-RAY CRYSTAL STRUCTURE OF HIV-1 PROTEASE VARIANT G48T/L89M IN COMPLEX WITH SAQUINAVIR | SAQUINAVIR, HIV PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5ef9:A (GLY339) to (GLY361) STRUCTURE OF INFLUENZA B LEE PB2 CAP-BINDING DOMAIN | CAP-BINDING DOMAIN, PROTEIN BINDING
5efa:A (ARG338) to (GLY361) STRUCTURE OF INFLUENZA B LEE PB2 CAP-BINDING DOMAIN BOUND TO M7GTP | CAP-BINDING DOMAIN, PROTEIN BINDING
5efc:A (ARG338) to (GLY361) STRUCTURE OF INFLUENZA B LEE PB2 CAP-BINDING DOMAIN BOUND TO GTP | CAP-BINDING DOMAIN, PROTEIN BINDING
3b33:A (SER72) to (TRP98) CRYSTAL STRUCTURE OF THE PAS DOMAIN OF NITROGEN REGULATION PROTEIN NR(II) FROM VIBRIO PARAHAEMOLYTICUS | STRUCTURAL GENOMICS, PAS DOMAIN, NITROGEN REGULATION PROTEIN, APC91440.4, PSI-2, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, KINASE, PHOSPHORYLATION, TRANSFERASE
5efz:D (GLU14) to (GLY40) MONOCLINIC STRUCTURE OF THE ACETYL ESTERASE MEKB | ALPHA/BETA HYDROLASE, ACETYL ESTER HYDROLASE, PSEUDOMONAS VERONII, TRANSFERASE, HYDROLASE
4b92:A (ASP401) to (ARG442) CRYSTAL STRUCTURE OF TRUNCATED HUMAN CRMP-5 SOAKED WITH ZN | SIGNALING PROTEIN, NEUROGENESIS, PHOSPHOPROTEIN, CRMP, TIM BARREL, AXONAL OUTGROWTH, DEVELOPMENTAL PROTEIN
4qj7:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF INACTIVE HIV-1 PROTEASE VARIANT (I50V/A71V) IN COMPLEX WITH P1-P6 SUBSTRATE VARIANT (R452S) | CO-EVOLUTION, PROTEASE, HYDROLASE
3b60:A (ASP341) to (ALA368) CRYSTAL STRUCTURE OF MSBA FROM SALMONELLA TYPHIMURIUM WITH AMPPNP, HIGHER RESOLUTION FORM | ABC TRANSPORTER, MSBA, LIPID FLIPPASE, ATP-BINDING, HYDROLASE, INNER MEMBRANE, LIPID TRANSPORT, MEMBRANE, NUCLEOTIDE-BINDING, TRANSMEMBRANE, MEMBRANE PROTEIN
3b60:B (ASP341) to (ALA368) CRYSTAL STRUCTURE OF MSBA FROM SALMONELLA TYPHIMURIUM WITH AMPPNP, HIGHER RESOLUTION FORM | ABC TRANSPORTER, MSBA, LIPID FLIPPASE, ATP-BINDING, HYDROLASE, INNER MEMBRANE, LIPID TRANSPORT, MEMBRANE, NUCLEOTIDE-BINDING, TRANSMEMBRANE, MEMBRANE PROTEIN
3b60:C (ASP341) to (ALA368) CRYSTAL STRUCTURE OF MSBA FROM SALMONELLA TYPHIMURIUM WITH AMPPNP, HIGHER RESOLUTION FORM | ABC TRANSPORTER, MSBA, LIPID FLIPPASE, ATP-BINDING, HYDROLASE, INNER MEMBRANE, LIPID TRANSPORT, MEMBRANE, NUCLEOTIDE-BINDING, TRANSMEMBRANE, MEMBRANE PROTEIN
3b60:D (ASP341) to (ALA368) CRYSTAL STRUCTURE OF MSBA FROM SALMONELLA TYPHIMURIUM WITH AMPPNP, HIGHER RESOLUTION FORM | ABC TRANSPORTER, MSBA, LIPID FLIPPASE, ATP-BINDING, HYDROLASE, INNER MEMBRANE, LIPID TRANSPORT, MEMBRANE, NUCLEOTIDE-BINDING, TRANSMEMBRANE, MEMBRANE PROTEIN
2adz:A (PRO7) to (ALA35) SOLUTION STRUCTURE OF THE JOINED PH DOMAIN OF ALPHA1- SYNTROPHIN | PROTEIN BINDING
2aeg:B (GLN36) to (ARG55) X-RAY CRYSTAL STRUCTURE OF PROTEIN ATU5096 FROM AGROBACTERIUM TUMEFACIENS. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ATR63. | ALPHA-BETA PROTEIN., STRUCTURAL GENOMICS, PSI, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, UNKNOWN FUNCTION
2aey:A (ASN18) to (TYR42) CRYSTAL STRUCTURE OF FRUCTAN 1-EXOHYDROLASE IIA FROM CICHORIUM INTYBUS IN COMPLEX WITH 2,5 DIDEOXY-2,5-IMMINO-D-MANNITOL | FIVE FOLD BETA PROPELLER, HYDROLASE
3mdu:A (SER2) to (GLU22) THE STRUCTURE OF N-FORMIMINO-L-GLUTAMATE IMINOHYDROLASE FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH N-GUANIDINO-L-GLUTAMATE | AMONOHYDRALASE FAMILY, N-FORMIMINO-L-GLUTAMATE IMINOHYDROLASE, N- GUANIDINO-L-GLUTAMATE, HYDROLASE
4qlo:A (ASN3) to (ARG28) CRYSTAL STRUCTURE OF HOMOSERINE O-ACETYLTRANSFERASE FROM STAPHYLOCOCCUS AUREUS | ROSSMANN FOLD, ACETYLTRANSFERASE, ACETYLCO-A BINDING, TRANSFERASE
3b80:A (ARG57) to (GLY78) HIV-1 PROTEASE MUTANT I54V COMPLEXED WITH GEM-DIOL-AMINE INTERMEDIATE NLLTQI | HYDROLASE-HYDROLASE SUBSTRATE COMPLEX, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3mdw:A (ALA3) to (SER24) THE STRUCTURE OF N-FORMIMINO-L-GLUTAMATE IMINOHYDROLASE FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH N-FORMIMINO-L-ASPARTATE | AMINOHYDROLASE FAMILY, N-FORMIMINO-L-GLUTAMATE IMINOHYDROLASE, HYDROLASE
3mdw:C (ALA3) to (GLU22) THE STRUCTURE OF N-FORMIMINO-L-GLUTAMATE IMINOHYDROLASE FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH N-FORMIMINO-L-ASPARTATE | AMINOHYDROLASE FAMILY, N-FORMIMINO-L-GLUTAMATE IMINOHYDROLASE, HYDROLASE
3mdw:D (ALA3) to (SER24) THE STRUCTURE OF N-FORMIMINO-L-GLUTAMATE IMINOHYDROLASE FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH N-FORMIMINO-L-ASPARTATE | AMINOHYDROLASE FAMILY, N-FORMIMINO-L-GLUTAMATE IMINOHYDROLASE, HYDROLASE
3b96:A (ASP217) to (VAL243) STRUCTURAL BASIS FOR SUBSTRATE FATTY-ACYL CHAIN SPECIFICITY: CRYSTAL STRUCTURE OF HUMAN VERY-LONG-CHAIN ACYL-COA DEHYDROGENASE | ACYL-COA, FATTY ACID BETA-OXIDATION, DEHYDROGENASE, VERY LONG CHAIN, MITOCHONDRIA, MEMBRANE, ACETYLATION, ALTERNATIVE SPLICING, CARDIOMYOPATHY, DISEASE MUTATION, FAD, FATTY ACID METABOLISM, FLAVOPROTEIN, LIPID METABOLISM, MITOCHONDRION, OXIDOREDUCTASE, POLYMORPHISM, TRANSIT PEPTIDE, UBL CONJUGATION
4qo9:A (LEU23) to (ARG45) MST3 IN COMPLEX WITH DANUSERTIB | PROTEIN KINASE, MST3, STK24, STERILE 20-LIKE KINASE, ATP-BINDING, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
3bce:A (THR706) to (LEU728) CRYSTAL STRUCTURE OF THE ERBB4 KINASE | ACTIVE CONFORMATION, ATP-BINDING, GLYCOPROTEIN, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHORYLATION, RECEPTOR, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE
4qqc:A (GLY479) to (MET504) CRYSTAL STRUCTURE OF FGF RECEPTOR (FGFR) 4 KINASE DOMAIN IN COMPLEX WITH FIIN-2, AN IRREVERSIBLE TYROSINE KINASE INHIBITOR CAPABLE OF OVERCOMING FGFR KINASE GATE-KEEPER MUTATIONS | KINASE DOMAIN FOLD, CELL SIGNALING, PHOSPHOTRANSFERASE, PLASMAMEMBRANE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
4qqt:A (GLY479) to (MET504) CRYSTAL STRUCTURE OF FGF RECEPTOR (FGFR) 4 TYROSINE KINASE DOMAIN | KINASE DOMAIN FOLD, CELL SIGNALING, PHOSPHOTRANSFERASE, PLASMAMEMBRANE, TRANSFERASE
3ml4:A (LEU6) to (ARG27) CRYSTAL STRUCTURE OF A COMPLEX BETWEEN DOK7 PH-PTB AND THE MUSK JUXTAMEMBRANE REGION | TYROSINE PHOSPHORYLATION, ADAPTER PROTEIN, DIMERIZATION, SIGNALING PROTEIN
3ml4:C (LEU6) to (LYS28) CRYSTAL STRUCTURE OF A COMPLEX BETWEEN DOK7 PH-PTB AND THE MUSK JUXTAMEMBRANE REGION | TYROSINE PHOSPHORYLATION, ADAPTER PROTEIN, DIMERIZATION, SIGNALING PROTEIN
3ml4:D (LEU6) to (LYS28) CRYSTAL STRUCTURE OF A COMPLEX BETWEEN DOK7 PH-PTB AND THE MUSK JUXTAMEMBRANE REGION | TYROSINE PHOSPHORYLATION, ADAPTER PROTEIN, DIMERIZATION, SIGNALING PROTEIN
4qra:A (GLY295) to (ILE328) STRUCTURE AND SPECIFICITY OF L-D-TRANSPEPTIDASE FROM MYCOBACTERIUM TUBERCULOSIS AND ANTIBIOTIC RESISTANCE: CALCIUM BINDING PROMOTES DIMER FORMATION | STRUCTURAL GENOMICS, ENZYME FUNCTION INITIATIVE, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, L-D- TRANSPEPTIDASE; D-D-TRANSPEPTIDASE; SINGLE ANOMALOUS DIFFRACTION; IMIPENEM; MEROPENEM;, HYDROLASE
3bh4:A (ASP160) to (GLY178) HIGH RESOLUTION CRYSTAL STRUCTURE OF BACILLUS AMYLOLIQUEFACIENS ALPHA-AMYLASE | CRYSTAL STRUCTURE ALPHA-AMYLASE, CALCIUM, CARBOHYDRATE METABOLISM, GLYCOSIDASE, HYDROLASE, METAL-BINDING, SECRETED
5ew5:A (ASN183) to (GLY202) CRYSTAL STRUCTURE OF COLICIN E9 IN COMPLEX WITH ITS IMMUNITY PROTEIN IM9 | COLICIN, COMPLEX, TOXIN, HYDROLASE
5ew5:B (ASN183) to (GLY202) CRYSTAL STRUCTURE OF COLICIN E9 IN COMPLEX WITH ITS IMMUNITY PROTEIN IM9 | COLICIN, COMPLEX, TOXIN, HYDROLASE
3bm3:A (TYR119) to (PRO142) RESTRICTION ENDONUCLEASE PSPGI-SUBSTRATE DNA COMPLEX | ENDONUCLEASE-DNA COMPLEX, RESTRICTION ENZYME, PSPGI, BASE FLIPPING, HYDROLASE-DNA COMPLEX
3mv5:A (GLU149) to (ALA171) CRYSTAL STRUCTURE OF AKT-1-INHIBITOR COMPLEXES | KINASE INHIBITOR, TRANSFERASE
3mws:A (GLY52) to (GLY78) CRYSTAL STRUCTURE OF GROUP N HIV-1 PROTEASE | HIV-1, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3bto:C (LYS5) to (PRO30) HORSE LIVER ALCOHOL DEHYDROGENASE COMPLEXED TO NADH AND (1S, 3S)3-BUTYLTHIOLANE 1-OXIDE | DEHYDROGENASE, ALCOHOL, NICOTINAMIDE COENZYME, SULFOXIDE, OXIDOREDUCTASE
3bto:D (LYS5) to (PRO30) HORSE LIVER ALCOHOL DEHYDROGENASE COMPLEXED TO NADH AND (1S, 3S)3-BUTYLTHIOLANE 1-OXIDE | DEHYDROGENASE, ALCOHOL, NICOTINAMIDE COENZYME, SULFOXIDE, OXIDOREDUCTASE
3bu3:A (GLY1008) to (VAL1032) CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH IRS2 KRLB PEPTIDE | IRK, KRLB, IRS2, INSULIN RECEPTOR, PEPTIDE, SUBSTRATE, ALTERNATIVE SPLICING, ATP-BINDING, CARBOHYDRATE METABOLISM, CLEAVAGE ON PAIR OF BASIC RESIDUES, DIABETES MELLITUS, DISEASE MUTATION, GLYCOPROTEIN, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE, TRANSDUCER
3bu6:A (GLY1008) to (VAL1032) CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH IRS2 KRLB PHOSPHOPEPTIDE | IR, IRK, IRS-2, KRLB, INSULIN RECEPTOR, PHOSPHOPEPTIDE, ALTERNATIVE SPLICING, ATP-BINDING, CARBOHYDRATE METABOLISM, CLEAVAGE ON PAIR OF BASIC RESIDUES, DIABETES MELLITUS, DISEASE MUTATION, GLYCOPROTEIN, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE, TRANSDUCER
3bvq:A (VAL134) to (GLU165) CRYSTAL STRUCTURE OF APO NOTI RESTRICTION ENDONUCLEASE | RESTRICTION ENZYME FOLD, PD-(D/E)-XK, RESTRICTION ENDONUCLEASE, RARE- CUTTING, FE-CYS4 MOTIF, IRON-SULFUR PROTEIN, HYDROLASE
3bvq:B (VAL134) to (GLU165) CRYSTAL STRUCTURE OF APO NOTI RESTRICTION ENDONUCLEASE | RESTRICTION ENZYME FOLD, PD-(D/E)-XK, RESTRICTION ENDONUCLEASE, RARE- CUTTING, FE-CYS4 MOTIF, IRON-SULFUR PROTEIN, HYDROLASE
3bxr:A (ARG57) to (GLY78) CRYSTAL STRUCTURES OF HIGHLY CONSTRAINED SUBSTRATE AND HYDROLYSIS PRODUCTS BOUND TO HIV-1 PROTEASE. IMPLICATIONS FOR CATALYTIC MECHANISM | HIV PROTEASE, HIVPR, SUBSTRATE, PRODUCT, MECHANISM, AIDS, ASPARTYL PROTEASE, CAPSID MATURATION, CORE PROTEIN, CYTOPLASM, DNA INTEGRATION, DNA RECOMBINATION, DNA-DIRECTED DNA POLYMERASE, ENDONUCLEASE, HYDROLASE, LIPOPROTEIN, MAGNESIUM, MEMBRANE, METAL-BINDING, MULTIFUNCTIONAL ENZYME, MYRISTATE, NUCLEASE, NUCLEOTIDYLTRANSFERASE, NUCLEUS, PHOSPHOPROTEIN, RNA-BINDING, RNA-DIRECTED DNA POLYMERASE, TRANSFERASE, VIRAL NUCLEOPROTEIN, VIRION, ZINC, ZINC-FINGER
3bxs:A (ARG57) to (GLY78) CRYSTAL STRUCTURES OF HIGHLY CONSTRAINED SUBSTRATE AND HYDROLYSIS PRODUCTS BOUND TO HIV-1 PROTEASE. IMPLICATIONS FOR CATALYTIC MECHANISM | HIV PROTEASE, HIVPR, SUBSTRATE, PRODUCT, MECHANISM, AIDS, ASPARTYL PROTEASE, CAPSID MATURATION, CORE PROTEIN, CYTOPLASM, DNA INTEGRATION, DNA RECOMBINATION, DNA-DIRECTED DNA POLYMERASE, ENDONUCLEASE, HYDROLASE, LIPOPROTEIN, MAGNESIUM, MEMBRANE, METAL-BINDING, MULTIFUNCTIONAL ENZYME, MYRISTATE, NUCLEASE, NUCLEOTIDYLTRANSFERASE, NUCLEUS, PHOSPHOPROTEIN, RNA-BINDING, RNA-DIRECTED DNA POLYMERASE, TRANSFERASE, VIRAL NUCLEOPROTEIN, VIRION, ZINC, ZINC-FINGER
3bxy:A (SER231) to (ASP257) CRYSTAL STRUCTURE OF TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE FROM E. COLI | LEFT-HANDED BETA-HELIX, STRUCTURAL GENOMICS, CIHR, CANADIAN INSTITUTES OF HEALTH RESEARCH, MONTREAL-KINGSTON BACTERIAL STRUCTURAL GENOMICS INITIATIVE, BSGI, ACYLTRANSFERASE, AMINO-ACID BIOSYNTHESIS, DIAMINOPIMELATE BIOSYNTHESIS, LYSINE BIOSYNTHESIS, TRANSFERASE
5f9z:B (LYS322) to (SER356) CRYSTAL STRUCTURE OF PROLYL-TRNA SYNTHETASE FROM CRYPTOSPORIDIUM PARVUM COMPLEXED WITH HALOFUGINONE AND AMPPNP | SSGCID, PROLYL-TRNA LIGASE, CRYPTOSPORIDIUM PARVUM, ATP BINDING, AMINOACYLATION, HALOFUGINONE, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, PRORS, LIGASE
3bzw:B (PHE130) to (PRO155) CRYSTAL STRUCTURE OF A PUTATIVE LIPASE FROM BACTEROIDES THETAIOTAOMICRON | CRYSTAL STRUCTURE, LIPASE, PROTEIN STRUCTURE INITIATIVE II, (PSI-II), NYSGXRC, 12063B, STRUCTURAL GENOMICS, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, HYDROLASE
3bzw:D (PHE130) to (PRO155) CRYSTAL STRUCTURE OF A PUTATIVE LIPASE FROM BACTEROIDES THETAIOTAOMICRON | CRYSTAL STRUCTURE, LIPASE, PROTEIN STRUCTURE INITIATIVE II, (PSI-II), NYSGXRC, 12063B, STRUCTURAL GENOMICS, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, HYDROLASE
3c25:A (VAL134) to (GLU165) CRYSTAL STRUCTURE OF NOTI RESTRICTION ENDONUCLEASE BOUND TO COGNATE DNA | PROTEIN-DNA COMPLEX, RESTRICTION ENZYME FOLD, PD-(D/E)-XK, RESTRICTION ENDONUCLEASE, RARE-CUTTING, FE-CYS4 MOTIF, IRON-SULFUR PROTEIN, HYDROLASE-DNA COMPLEX
4r28:A (GLU185) to (SER212) MSPJI RESTRICTION ENDONUCLEASE IN COMPLEX WITH 27-MER OLIGONUCLEOTIDE | ENDONUCLEASE, DNA METHYLATION DEPENDENT, SRA DOMAIN, EPIGENETICS TOOL, CYTOSINE METHYLATION-DEPENDENT ENDONUCLEASE, TETRAMERIC ENDONUCLEASE, HYDROLASE, HYDROLASE-DNA COMPLEX
4r3a:A (GLU80) to (PRO103) ERYTHROBACTER LITORALIS EL346 BLUE-LIGHT ACTIVATED HISTIDINE KINASE | LIGHT-ACTIVATED, LOV DOMAIN, HISTIDINE KINASE, BERGERAT FOLD, SIGNAL TRANSDUCTION, SENSORY TRANSDUCTION, PHOTORECEPTOR, CELL SIGNALING, REGULATION, TWO-COMPONENT SYSTEM, SIGNALING PROTEIN
4bxs:V (GLN2) to (GLU43) CRYSTAL STRUCTURE OF THE PROTHROMBINASE COMPLEX FROM THE VENOM OF PSEUDONAJA TEXTILIS | BLOOD CLOTTING, BLOOD COAGULATION, PROTHROMBINASE, HYDROLASE
4r5q:A (ASN106) to (LYS127) CRYSTAL STRUCTURE AND NUCLEASE ACTIVITY OF THE CRISPR-ASSOCIATED CAS4 PROTEIN PCAL_0546 FROM PYROBACULUM CALIDIFONTIS CONTAINING A [2FE-2S] CLUSTER | MCSG, STRUCTURAL GENOMICS, PSI-BIOLOGY, EXONUCLEASE, HYDROLASE, MIDWEST CENTER FOR STRUCTURAL GENOMICS
3c5o:C (GLY29) to (PRO62) CRYSTAL STRUCTURE OF THE CONSERVED PROTEIN OF UNKNOWN FUNCTION RPA1785 FROM RHODOPSEUDOMONAS PALUSTRIS | BETA-BARRELS, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, UNKNOWN FUNCTION
5fi3:A (LYS16) to (ARG37) HETEROYOHIMBINE SYNTHASE THAS1 FROM CATHARANTHUS ROSEUS - COMPLEX WITH NADP+ | HETEROYOHIMBINE SYNTHASE, MEDIUM CHAIN DEHYDROGENASE/REDUCTASE, NADP+ DEPENDENT ENZYME, ZINC BINDING SITE, OXIDOREDUCTASE
5fi3:B (LYS16) to (ARG37) HETEROYOHIMBINE SYNTHASE THAS1 FROM CATHARANTHUS ROSEUS - COMPLEX WITH NADP+ | HETEROYOHIMBINE SYNTHASE, MEDIUM CHAIN DEHYDROGENASE/REDUCTASE, NADP+ DEPENDENT ENZYME, ZINC BINDING SITE, OXIDOREDUCTASE
4bz4:E (GLY120) to (PHE146) CORA IS A SURFACE-ASSOCIATED COPPER-BINDING PROTEIN IMPORTANT IN METHYLOMICROBIUM ALBUM BG8 COPPER ACQUISITION | COPPER-BINDING PROTEIN, COPPER ACQUISITION, METHANOTROPH
3c9x:A (ASP83) to (ALA104) CRYSTAL STRUCTURE OF TRICHODERMA REESEI ASPARTIC PROTEINASE | ASPARTIC PROTEINASE, ASPARTYL PROTEASE, HYDROLASE, PROTEASE
4c0d:B (TYR494) to (GLU517) STRUCTURE OF THE NOT MODULE OF THE HUMAN CCR4-NOT COMPLEX (CNOT1-CNOT2-CNOT3) | GENE REGULATION, DEADENYLATION, MRNA DECAY, CCR4-NOT, HYDROLASE, TRANSCRIPTION
4c0g:A (PHE719) to (GLU743) STRUCTURE OF THE NOT-BOX DOMAIN OF HUMAN CNOT3 | GENE REGULATION, DEADENYLATION, MRNA DECAY, CCR4-NOT, HYDROLASE, TRANSCRIPTION
4c0g:B (PHE719) to (GLU743) STRUCTURE OF THE NOT-BOX DOMAIN OF HUMAN CNOT3 | GENE REGULATION, DEADENYLATION, MRNA DECAY, CCR4-NOT, HYDROLASE, TRANSCRIPTION
4c0g:C (PHE719) to (GLU743) STRUCTURE OF THE NOT-BOX DOMAIN OF HUMAN CNOT3 | GENE REGULATION, DEADENYLATION, MRNA DECAY, CCR4-NOT, HYDROLASE, TRANSCRIPTION
4c0g:D (PHE719) to (TYR744) STRUCTURE OF THE NOT-BOX DOMAIN OF HUMAN CNOT3 | GENE REGULATION, DEADENYLATION, MRNA DECAY, CCR4-NOT, HYDROLASE, TRANSCRIPTION
4c0g:E (PHE719) to (GLU743) STRUCTURE OF THE NOT-BOX DOMAIN OF HUMAN CNOT3 | GENE REGULATION, DEADENYLATION, MRNA DECAY, CCR4-NOT, HYDROLASE, TRANSCRIPTION
4c0g:F (PHE719) to (GLU743) STRUCTURE OF THE NOT-BOX DOMAIN OF HUMAN CNOT3 | GENE REGULATION, DEADENYLATION, MRNA DECAY, CCR4-NOT, HYDROLASE, TRANSCRIPTION
4r8x:B (TYR13) to (GLU52) CRYSTAL STRUCTURE OF A URICASE FROM BACILLUS FASTIDIOUS | BACILLUS FASTIDIOUS URICASE, FOLD, STABILITY, HYDROLASE
4r8x:C (TYR13) to (GLU52) CRYSTAL STRUCTURE OF A URICASE FROM BACILLUS FASTIDIOUS | BACILLUS FASTIDIOUS URICASE, FOLD, STABILITY, HYDROLASE
3nbv:A (GLY10) to (ASN42) X-RAY STRUCTURE OF KETOHEXOKINASE IN COMPLEX WITH AMP-PNP AND FRUCTOSE | KETOHEXOKINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
3nca:A (GLY10) to (ASN42) X-RAY STRUCTURE OF KETOHEXOKINASE IN COMPLEX WITH A THIENO PYRIDINOL COMPOUND | KETOHEXOKINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
4rdv:A (SER2) to (SER24) THE STRUCTURE OF N-FORMIMINO-L-GLUTAMATE IMINOHYDROLASE FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH N-FORMIMINO-L-ASPARTATE | AMIDOHYDROLASE FOLD, N-FORMIMINO-L-GLUTAMATE IMINOHYDROLASE, N- FORMIMINO-L-ASPARTATE, HYDROLASE
4rdv:B (SER2) to (SER24) THE STRUCTURE OF N-FORMIMINO-L-GLUTAMATE IMINOHYDROLASE FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH N-FORMIMINO-L-ASPARTATE | AMIDOHYDROLASE FOLD, N-FORMIMINO-L-GLUTAMATE IMINOHYDROLASE, N- FORMIMINO-L-ASPARTATE, HYDROLASE
4rdv:C (SER2) to (GLU22) THE STRUCTURE OF N-FORMIMINO-L-GLUTAMATE IMINOHYDROLASE FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH N-FORMIMINO-L-ASPARTATE | AMIDOHYDROLASE FOLD, N-FORMIMINO-L-GLUTAMATE IMINOHYDROLASE, N- FORMIMINO-L-ASPARTATE, HYDROLASE
4rdv:D (SER2) to (SER24) THE STRUCTURE OF N-FORMIMINO-L-GLUTAMATE IMINOHYDROLASE FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH N-FORMIMINO-L-ASPARTATE | AMIDOHYDROLASE FOLD, N-FORMIMINO-L-GLUTAMATE IMINOHYDROLASE, N- FORMIMINO-L-ASPARTATE, HYDROLASE
4rdw:A (SER2) to (GLU22) THE STRUCTURE OF N-FORMIMINO-L-GLUTAMATE IMINOHYDROLASE FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH N-GUANIDINO-L-GLUTARIC ACID | AMIDOHYDRALASE FOLD, N-FORMIMINO-L-GLUTAMATE IMINOHYDROLASE, N- GUANIDINO-L-GLUTARIC ACID, HYDROLASE
3ndi:A (PHE23) to (ARG53) X-RAY STRUCTURE OF A C-3'-METHYLTRANSFERASE IN COMPLEX WITH S- ADENOSYLMETHIONINE AND DTMP | S-ADENOSYLMETHIONINE, KIJANOSE, TETRONITROSE, TETRADEOXYSUGAR, MICROMONOSPORA CHALCEA, TCAB9, C-3'-METHYLTRANSFERASE, SUGAR METHYLATION, TRANSFERASE
5fl4:D (TYR192) to (PHE213) THREE DIMENSIONAL STRUCTURE OF HUMAN CARBONIC ANHYDRASE IX IN COMPLEX WITH 5-(1-NAPHTHALEN-1-YL-1,2,3-TRIAZOL-4-YL) THIOPHENE-2-SULFONAMIDE | LYASE
5fl5:C (TYR192) to (PHE213) THREE DIMENSIONAL STRUCTURE OF HUMAN CARBONIC ANHYDRASE IX IN COMPLEX WITH 5-(1-(4-METHOXYPHENYL)-1H-1,2,3-TRIAZOL-4- YL)THIOPHENE-2-SULFONAMIDE | LYASE, CARBONIC ANHYDRASE IX, CARBONIC ANHYDRASE 9, CA IX, CA 9
5fl6:C (TYR192) to (PHE213) THREE DIMENSIONAL STRUCTURE OF HUMAN CARBONIC ANHYDRASE IX IN COMPLEX WITH 5-(1-(4-METHYLPHENYL)-1H-1,2,3-TRIAZOL-4-YL) THIOPHENE-2-SULFONAMIDE | LYASE, CARBONIC ANHYDRASE IX, CARBONIC ANHYDRASE 9, CA IX, CA 9
3cik:A (ILE560) to (PRO585) HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS | PROTEIN KINASE, COMPLEX, G PROTEIN, RECEPTOR, WD40 REPEAT, ATP- BINDING, NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, TRANSDUCER, WD REPEAT, LIPOPROTEIN, MEMBRANE, PHOSPHOPROTEIN, PRENYLATION, TRANSFERASE-SIGNALING PROTEIN COMPLEX
4c47:C (ILE138) to (PRO180) SALMONELLA ENTERICA TRIMERIC LIPOPROTEIN SADB | CELL ADHESION, BACTERIAL ADHESION, MEMBRANE TRAFFICKING, MEMBRANE INSERTION, AUTOTRANSPORT, POLAR CORE RESIDUES
5fmz:E (PRO177) to (THR213) CRYSTAL STRUCTURE OF INFLUENZA B POLYMERASE WITH BOUND 5' VRNA | TRANSCRIPTION, INFLUENZA B VIRUS RNA-DEPENDENT RNA POLYMERASE, HETEROTRIMER, VIRAL RNA, VRNA 5' END.
3npe:A (VAL425) to (ASP456) STRUCTURE OF VP14 IN COMPLEX WITH OXYGEN | DIOXYGENASE, SEVEN BLADE BETA PROPELLER, ABSCISIC ACID, NON HEME IRON, OXIDOREDUCTASE
3nsu:B (ILE470) to (PRO494) A SYSTEMATIC SCREEN FOR PROTEIN-LIPID INTERACTIONS IN SACCHAROMYCES CEREVISIAE | PLECKSTRIN HOMOLOGY DOMAIN, SIGNALING PROTEIN
4ro1:B (GLU530) to (ALA564) AN 3'-5'-EXORIBONUCLEASE THAT SPECIFICALLY RECOGNIZES RNAS. | OB-FOLDS AND RNB, RNA DIGESTION, HYDROLASE
5fu7:C (PHE719) to (GLU743) DROSOPHILA NANOS NBR PEPTIDE BOUND TO THE NOT MODULE OF THE HUMAN CCR4-NOT COMPLEX | GENE REGULATION, DEADENYLATION, MRNA DECAY, CCR4-NOT, TRANSCRIPTION, TRANSLATIONAL REPRESSION
5fu7:G (PHE719) to (GLU743) DROSOPHILA NANOS NBR PEPTIDE BOUND TO THE NOT MODULE OF THE HUMAN CCR4-NOT COMPLEX | GENE REGULATION, DEADENYLATION, MRNA DECAY, CCR4-NOT, TRANSCRIPTION, TRANSLATIONAL REPRESSION
4rqt:A (GLN6) to (PRO31) ALCOHOL DEHYDROGENASE CRYSTAL STRUCTURE | ROSSMANN FOLD, ALCOHOL DEHYDROGENASE, OXIDOREDUCTASE
3csn:A (ASN653) to (TYR676) STRUCTURE OF THE SERRATIA MARCESCENS HEMOPHORE RECEPTOR HASR IN COMPLEX WITH ITS HEMOPHORE HASA | OUTER MEMBRANE PROTEIN, BETA-BARREL, HEMOPHORE RECEPTOR, TONB BOX, HEME, IRON, METAL-BINDING, SECRETED, MEMBRANE PROTEIN-HEME BINDING PROTEIN COMPLEX
3csn:B (ASN653) to (TYR676) STRUCTURE OF THE SERRATIA MARCESCENS HEMOPHORE RECEPTOR HASR IN COMPLEX WITH ITS HEMOPHORE HASA | OUTER MEMBRANE PROTEIN, BETA-BARREL, HEMOPHORE RECEPTOR, TONB BOX, HEME, IRON, METAL-BINDING, SECRETED, MEMBRANE PROTEIN-HEME BINDING PROTEIN COMPLEX
4rs4:C (ALA149) to (LYS183) CRYSTAL STRUCTURE AND MUTATIONAL ANALYSIS OF THE ENDORIBONUCLEASE FROM HUMAN CORONAVIRUS 229E | ENDORIBONUCLEASE, HYDROLASE
3nwq:B (ARG57) to (GLY78) X-RAY STRUCTURE OF ESTER CHEMICAL ANALOGUE [O-ILE50,O-ILE50']HIV-1 PROTEASE COMPLEXED WITH MVT-101 | BETA-BARREL, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3nxe:A (ARG57) to (GLY78) X-RAY STRUCTURE OF ESTER CHEMICAL ANALOGUE 'COVALENT DIMER' [ILE50,O- ILE50']HIV-1 PROTEASE COMPLEXED WITH MVT-101 INHIBITOR | BETA-BARREL, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4rt7:A (GLY622) to (MET645) CRYSTAL STRUCTURE OF FLT3 WITH A SMALL MOLECULE INHIBITOR | KINASE, TRANSFERASE, TRANSFERASE INHIBITOR, COMPLEX, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX
4rvx:B (ARG57) to (GLY78) CRYSTAL STRUCTURE OF MULTIDRUG-RESISTANT CLINICAL ISOLATE A02 HIV-1 PROTEASE IN COMPLEX WITH NON-PEPTIDIC INHIBITOR, GRL079 | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX, HIV-1 PROTEASE- INHIBITOR COMPLEX, GRL079, NON-PEPTIDIC PROTEASE INHIBITOR
4ckm:B (THR137) to (ARG160) STRUCTURE OF THE N-TERMINAL DOMAIN OF LEISHMANIA SAS-6 | STRUCTURAL PROTEIN, BASAL BODY, CENTRIOLE, CARTWHEEL, TRYPANOSOMATIDS
4ckp:C (THR137) to (ARG160) STRUCTURE OF AN N-TERMINAL FRAGMENT OF LEISHMANIA SAS-6 THAT CONTAINS PART OF ITS COILED COIL DOMAIN | STRUCTURAL PROTEIN, BASAL BODY, CENTRIOLE, CARTWHEEL, TRYPANOSOMATIDS
4ckp:D (THR137) to (ARG160) STRUCTURE OF AN N-TERMINAL FRAGMENT OF LEISHMANIA SAS-6 THAT CONTAINS PART OF ITS COILED COIL DOMAIN | STRUCTURAL PROTEIN, BASAL BODY, CENTRIOLE, CARTWHEEL, TRYPANOSOMATIDS
4ckp:E (THR137) to (ARG160) STRUCTURE OF AN N-TERMINAL FRAGMENT OF LEISHMANIA SAS-6 THAT CONTAINS PART OF ITS COILED COIL DOMAIN | STRUCTURAL PROTEIN, BASAL BODY, CENTRIOLE, CARTWHEEL, TRYPANOSOMATIDS
4cku:B (TRP193) to (SER215) THREE DIMENSIONAL STRUCTURE OF PLASMEPSIN II IN COMPLEX WITH HYDROXYETHYLAMINE-BASED INHIBITOR | HYDROLASE, MALARIA, DRUG DESIGN
4cku:C (TRP193) to (SER215) THREE DIMENSIONAL STRUCTURE OF PLASMEPSIN II IN COMPLEX WITH HYDROXYETHYLAMINE-BASED INHIBITOR | HYDROLASE, MALARIA, DRUG DESIGN
4cku:D (TRP193) to (SER215) THREE DIMENSIONAL STRUCTURE OF PLASMEPSIN II IN COMPLEX WITH HYDROXYETHYLAMINE-BASED INHIBITOR | HYDROLASE, MALARIA, DRUG DESIGN
4cku:F (TRP193) to (SER215) THREE DIMENSIONAL STRUCTURE OF PLASMEPSIN II IN COMPLEX WITH HYDROXYETHYLAMINE-BASED INHIBITOR | HYDROLASE, MALARIA, DRUG DESIGN
3o23:A (MET1012) to (VAL1035) HUMAN UNPHOSPHORYLATED IGF1-R KINASE DOMAIN IN COMPLEX WITH AN HYDANTOIN INHIBITOR | PROTEIN KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
5fxr:A (MET1012) to (VAL1035) IGFR-1R COMPLEX WITH A PYRIMIDINE INHIBITOR. | TRANSFERASE
4rzb:A (SER2) to (SER24) THE STRUCTURE OF N-FORMIMINO-L-GLUTAMATE IMINOHYDROLASE FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH N-FORMIMINO-L-ASPARTATE, SOAKED WITH MERCURY | AMIDOHYDROLASE FOLD, N-FORMIMINO-L-GLUTAMATE IMINOHYDROLASE, N- FORMIMINO-L-ASPARTATE, HYDROLASE
4rzb:B (SER2) to (SER24) THE STRUCTURE OF N-FORMIMINO-L-GLUTAMATE IMINOHYDROLASE FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH N-FORMIMINO-L-ASPARTATE, SOAKED WITH MERCURY | AMIDOHYDROLASE FOLD, N-FORMIMINO-L-GLUTAMATE IMINOHYDROLASE, N- FORMIMINO-L-ASPARTATE, HYDROLASE
4cns:D (ASP408) to (GLN449) CRYSTAL STRUCTURE OF TRUNCATED HUMAN CRMP-4 | SIGNALING PROTEIN, NEUROGENESIS, AXONAL OUTGROWTH, DEVELOPMENTAL PROTEIN
3d20:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF HIV-1 MUTANT I54V AND INHIBITOR DARUNAVIA | DRUG RESISTANCE; HIV-1, I54V, FLAP MUTANT, AIDS, ASPARTYL PROTEASE, CAPSID MATURATION, CAPSID PROTEIN, DNA INTEGRATION, DNA RECOMBINATION, DNA-DIRECTED DNA POLYMERASE, ENDONUCLEASE, HYDROLASE, LIPOPROTEIN, MAGNESIUM, MEMBRANE, METAL-BINDING, MULTIFUNCTIONAL ENZYME, MYRISTATE, NUCLEASE, NUCLEOTIDYLTRANSFERASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, RNA-BINDING, RNA-DIRECTED DNA POLYMERASE, TRANSFERASE, VIRAL NUCLEOPROTEIN, VIRION, ZINC-FINGER
4s1t:A (PRO148) to (LYS183) CRYSTAL STRUCTURE OF THE MUTANT I26A/N52A OF THE ENDORIBONUCLEASE FROM HUMAN CORONAVIRUS 229E | HCOV-229E, ENDORIBONUCLEASE, TRIMERIC NSP15, DOUBLE MUTATION, HYDROLASE
4s1t:D (ALA149) to (LYS183) CRYSTAL STRUCTURE OF THE MUTANT I26A/N52A OF THE ENDORIBONUCLEASE FROM HUMAN CORONAVIRUS 229E | HCOV-229E, ENDORIBONUCLEASE, TRIMERIC NSP15, DOUBLE MUTATION, HYDROLASE
3d3t:B (ARG57) to (GLY78) CRYSTAL STRUCTURE OF HIV-1 CRF01_AE IN COMPLEX WITH THE SUBSTRATE P1- P6 | HIV-1 PROTEASE, NON-B CLADES, CRF01_AE, P1-P6 SUBSTRATE, AIDS, ASPARTYL PROTEASE, HYDROLASE
3o99:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH KD13 | HIV-1 PROTEASE, DRUG RESISTANCE, DRUG DESIGN, PROTEASE INHIBITORS, AIDS, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3o9a:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH KD14 | HIV-1 PROTEASE, DRUG RESISTANCE, DRUG DESIGN, PROTEASE INHIBITORS, AIDS, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3o9b:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH KD25 | HIV-1 PROTEASE, DRUG RESISTANCE, DRUG DESIGN, PROTEASE INHIBITORS, AIDS, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3o9d:B (GLY52) to (GLY78) CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH KD19 | HIV-1 PROTEASE, DRUG RESISTANCE, DRUG DESIGN, PROTEASE INHIBITORS, AIDS, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3o9e:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH AF60 | HIV-1 PROTEASE, DRUG RESISTANCE, DRUG DESIGN, PROTEASE INHIBITORS, AIDS, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3o9g:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH AF53 | HIV-1 PROTEASE, DRUG RESISTANCE, DRUG DESIGN, PROTEASE INHIBITORS, AIDS, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3d91:B (SER71) to (ASP95) HUMAN RENIN IN COMPLEX WITH REMIKIREN | RENIN, REMIKIREN, ALTERNATIVE SPLICING, ASPARTYL PROTEASE, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISEASE MUTATION, GLYCOPROTEIN, HYDROLASE, MEMBRANE, POLYMORPHISM, PROTEASE, SECRETED, ZYMOGEN
3da2:A (VAL94) to (ASN125) X-RAY STRUCTURE OF HUMAN CARBONIC ANHYDRASE 13 IN COMPLEX WITH INHIBITOR | CARBONIC ANHYDRASE, SULFONAMIDE, SGC, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, LYASE, METAL-BINDING
3dcr:B (ARG57) to (GLY78) X-RAY STRUCTURE OF HIV-1 PROTEASE AND HYDRATED FORM OF KETOMETHYLENE ISOSTERE INHIBITOR | HIV-1 PROTEASE, HOMODIMER, BETA-TURN, BETA-STRAND, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3ddr:A (TYR654) to (TYR676) STRUCTURE OF THE SERRATIA MARCESCENS HEMOPHORE RECEPTOR HASR-ILE671GLY MUTANT IN COMPLEX WITH ITS HEMOPHORE HASA AND HEME | OUTER MEMBRANE PROTEIN, BETA-BARREL, HEMOPHORE RECEPTOR, MEMBRANE, OUTER MEMBRANE, TONB BOX, HEME, IRON, METAL-BINDING, SECRETED, MEMBRANE PROTEIN-HEME BINDING PROTEIN COMPLEX
3ddr:B (TYR654) to (TYR676) STRUCTURE OF THE SERRATIA MARCESCENS HEMOPHORE RECEPTOR HASR-ILE671GLY MUTANT IN COMPLEX WITH ITS HEMOPHORE HASA AND HEME | OUTER MEMBRANE PROTEIN, BETA-BARREL, HEMOPHORE RECEPTOR, MEMBRANE, OUTER MEMBRANE, TONB BOX, HEME, IRON, METAL-BINDING, SECRETED, MEMBRANE PROTEIN-HEME BINDING PROTEIN COMPLEX
3ogp:B (GLY61) to (ASP94) CRYSTAL STRUCTURE OF 6S-98S FIV PROTEASE WITH DARUNAVIR BOUND | ASPARTYL PROTEASE, HIV-LIKE FIV CHIMERA, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3ogs:A (ARG468) to (ALA489) COMPLEX STRUCTURE OF BETA-GALACTOSIDASE FROM TRICHODERMA REESEI WITH IPTG | TIM BARREL DOMAIN, GLYCOSIDE HYDROLASE, FAMILY 35, GLYCOPROTEIN, HYDROLASE
3ohn:A (GLY327) to (GLY358) CRYSTAL STRUCTURE OF THE FIMD TRANSLOCATION DOMAIN | BETA-BARREL, PROTEIN TRANSLOCATION, OUTER MEMBRANE, MEMBRANE PROTEIN
4ttu:A (GLN2491) to (ASN2518) N-TERMINALLY TRUNCATED DEXTRANSUCRASE DSR-E FROM LEUCONOSTOC MESENTEROIDES NRRL B-1299 IN COMPLEX WITH ISOMALTOTRIOSE | ALPHA-1, 2-BRANCHING-SUCRASE, GLUCAN BINDING DOMAIN, ISOMALTOTRIOSE, GLUCANSUCRASE, TRANSFERASE
4tvc:A (GLN2491) to (ASN2518) N-TERMINALLY TRUNCATED DEXTRANSUCRASE DSR-E FROM LEUCONOSTOC MESENTEROIDES NRRL B-1299 IN COMPLEX WITH GLUCO-OLIGOSACCHARIDES | ALPHA-1, 2-BRANCHING-SUCRASE, GLUCAN BINDING DOMAIN, GLUCO- OLIGOSACCHARIDES, GLUCANSUCRASE, TRANSFERASE
4tvd:A (GLN2491) to (ASN2518) N-TERMINALLY TRUNCATED DEXTRANSUCRASE DSR-E FROM LEUCONOSTOC MESENTEROIDES NRRL B-1299 IN COMPLEX WITH D-GLUCOSE | ALPHA-1, 2-BRANCHING-SUCRASE, GLUCAN-BINDING DOMAIN, GLUCANSUCRASE, D-GLUCOSE, TRANSFERASE
4tvh:A (ARG57) to (GLY78) HIV PROTEASE (PR) DIMER IN CLOSED FORM WITH TL-3 IN ACTIVE SITE AND FRAGMENT AK-2097 IN THE OUTSIDE/TOP OF FLAP | HIV PROTEASE, ALLOSTERY, FRAGMENT BINDING, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4twm:B (ALA174) to (MET196) CRYSTAL STRUCTURE OF DIOSCORIN FROM DIOSCOREA JAPONICA | STORAGE PROTEIN, CARBONIC ANHYDRASE ACTIVITY, DEHYDROASCORBATE REDUCTASE ACTIVITY, PLANT PROTEIN
3dnx:A (GLY25) to (GLY46) SPO1766 PROTEIN OF UNKNOWN FUNCTION FROM SILICIBACTER POMEROYI. | STRUCTURAL GENOMICS, APC88088, PROTEIN OF UNKNOWN FUNCTION, PSI-2, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, UNKNOWN FUNCTION
4tye:A (GLY479) to (MET504) STRUCTURAL ANALYSIS OF THE HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE | FIBROBLAST GROWTH FACTOR RECEPTOR, KINASE, TRANSFERASE, DOVITINIB, PONATINB, PROTEROS BIOSTRUCTURES GMBH
5h8j:E (ILE90) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) IN COMPLEX WITH CADAVERINE | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, PUTRESCINE BIOSYNTHESIS, HYDROLASE
5h8j:F (VAL89) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) IN COMPLEX WITH CADAVERINE | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, PUTRESCINE BIOSYNTHESIS, HYDROLASE
5h8j:G (ILE90) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) IN COMPLEX WITH CADAVERINE | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, PUTRESCINE BIOSYNTHESIS, HYDROLASE
5h8j:H (VAL89) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) IN COMPLEX WITH CADAVERINE | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, PUTRESCINE BIOSYNTHESIS, HYDROLASE
5h8j:K (ILE90) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) IN COMPLEX WITH CADAVERINE | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, PUTRESCINE BIOSYNTHESIS, HYDROLASE
5h8l:A (VAL89) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) C158S MUTANT IN COMPLEX WITH PUTRESCINE | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, HYDROLASE
5h8l:B (ILE90) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) C158S MUTANT IN COMPLEX WITH PUTRESCINE | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, HYDROLASE
5h8l:C (ILE90) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) C158S MUTANT IN COMPLEX WITH PUTRESCINE | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, HYDROLASE
5h8l:E (ILE90) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) C158S MUTANT IN COMPLEX WITH PUTRESCINE | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, HYDROLASE
5h8l:F (ILE90) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) C158S MUTANT IN COMPLEX WITH PUTRESCINE | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, HYDROLASE
5h8l:G (ILE90) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) C158S MUTANT IN COMPLEX WITH PUTRESCINE | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, HYDROLASE
5h8l:H (ILE90) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) C158S MUTANT IN COMPLEX WITH PUTRESCINE | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, HYDROLASE
5h8l:K (ILE90) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) C158S MUTANT IN COMPLEX WITH PUTRESCINE | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, HYDROLASE
4u2j:D (ARG27) to (GLY52) N-TERMINAL DOMAIN OF C. REINHARDTII SAS-6 HOMOLOG BLD12P VARIANT Q93E F145W (NN27) | HOMODIMER, STABILIZATION, MUTATION, CENTRIOLE, SAS-6, CARTWHEEL, STRUCTURAL PROTEIN, BETA-SANDWICH, ALPHA-BETA PROTEIN, CENTRIOLAR
4dap:A (SER105) to (ASP127) THE STRUCTURE OF ESCHERICHIA COLI SFSA | OB FOLD, PD-(D/E)XK DOMAIN, NUCLEASE, DNA BINDING PROTEIN
5hc1:D (ALA156) to (ASP177) STRUCTURE OF EAV NSP11 H141A MUTANT AT 3.10A | NSP11, EQUINE ARTERITIS VIRUS, ENDORIBONUCLEASE, NONSTRUCTURAL PROTEIN 11, NIDOVIRUS, NF-KAPPAB, HYDROLASE
5hcb:A (ASN124) to (ASN143) GLOBULAR DOMAIN OF THE ENTAMOEBA HISTOLYTICA CALRETICULIN IN COMPLEX WITH GLUCOSE | CHAPERONE, LEGUME LECTIN DOMAIN, SUGAR BINDING PROTEIN, FUSION PROTEIN
5hct:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH BIACYLHYDRAZONE | HYDROLASE, INHIBITION
4dea:A (ASP132) to (GLN154) AURORA A IN COMPLEX WITH YL1-038-18 | PROTEIN KINASE, AURORA A, INHIBITOR, DFG-IN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
4deb:A (ASP132) to (GLN154) AURORA A IN COMPLEX WITH RK2-17-01 | PROTEIN KINASE, AURORA A, INHIBITOR, DFG-IN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
3oxv:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF HIV-1 I50V, A71 PROTEASE IN COMPLEX WITH THE PROTEASE INHIBITOR AMPRENAVIR. | HIV-1 PROTEASE, INHIBITOR RESISTANCE, AIDS, ASPARTYL PROTEASE, DRUG RESISTANCE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3oxw:D (ARG57) to (GLY78) CRYSTAL STRUCTURE OF HIV-1 I50V, A71V PROTEASE IN COMPLEX WITH THE PROTEASE INHIBITOR DARUNAVIR | HIV-1 PROTEASE, INHIBITOR RESISTANCE, AIDS, ASPARTYL PROTEASE, DRUG RESISTANCE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3oxx:B (ARG57) to (GLY78) CRYSTAL STRUCTURE OF HIV-1 I50V, A71V PROTEASE IN COMPLEX WITH THE PROTEASE INHIBITOR ATAZANAVIR | HIV-1 PROTEASE, INHIBITOR RESISTANCE, AIDS, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3oxx:D (ARG57) to (GLY78) CRYSTAL STRUCTURE OF HIV-1 I50V, A71V PROTEASE IN COMPLEX WITH THE PROTEASE INHIBITOR ATAZANAVIR | HIV-1 PROTEASE, INHIBITOR RESISTANCE, AIDS, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3oy4:B (ARG57) to (GLY78) CRYSTAL STRUCTURE OF HIV-1 L76V PROTEASE IN COMPLEX WITH THE PROTEASE INHIBITOR DARUNAVIR. | HIV-1 PROTEASE, INHIBITOR RESISTANCE, AIDS, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4dfg:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE WITH CYCLOPENTYLTETRAHYDRO- FURANYL URETHANES AS P2-LIGAND, GRL-0249A | ASPARTIC ACID PROTEASE, HIV-1 PROTEASE INHIBITOR GRL-0249A, CYCLOPENTYLTETRAHYDRO- FURANYL URETHANES P2-LIGANDS, WILD-TYPE HIV-1 PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4dip:A (ASP46) to (THR78) CRYSTAL STRUCTURE OF HUMAN PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP14 | STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, PEPTIDYL- PROLYL CIS-TRANS ISOMERASE, ISOMERASE
4dip:C (ASP46) to (THR78) CRYSTAL STRUCTURE OF HUMAN PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP14 | STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, PEPTIDYL- PROLYL CIS-TRANS ISOMERASE, ISOMERASE
4dip:D (ASP46) to (THR78) CRYSTAL STRUCTURE OF HUMAN PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP14 | STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, PEPTIDYL- PROLYL CIS-TRANS ISOMERASE, ISOMERASE
4dip:E (ASP46) to (THR78) CRYSTAL STRUCTURE OF HUMAN PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP14 | STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, PEPTIDYL- PROLYL CIS-TRANS ISOMERASE, ISOMERASE
4dip:F (ASP46) to (THR78) CRYSTAL STRUCTURE OF HUMAN PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP14 | STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, PEPTIDYL- PROLYL CIS-TRANS ISOMERASE, ISOMERASE
4dip:H (ASP46) to (THR78) CRYSTAL STRUCTURE OF HUMAN PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP14 | STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, PEPTIDYL- PROLYL CIS-TRANS ISOMERASE, ISOMERASE
4dip:I (ASP46) to (THR78) CRYSTAL STRUCTURE OF HUMAN PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP14 | STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, PEPTIDYL- PROLYL CIS-TRANS ISOMERASE, ISOMERASE
4dip:J (ASP46) to (THR78) CRYSTAL STRUCTURE OF HUMAN PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP14 | STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, PEPTIDYL- PROLYL CIS-TRANS ISOMERASE, ISOMERASE
4djp:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH MKP73 | HIV-1 PROTEASE, DRUG RESISTANCE, DRUG DESIGN, PROTEASE INHIBITORS, AIDS, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4djq:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH MKP86 | HIV-1 PROTEASE, DRUG RESISTANCE, DRUG DESIGN, PROTEASE INHIBITORS, AIDS, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4dlp:B (ASP117) to (ARG167) CRYSTAL STRUCTURE OF METHIONYL-TRNA SYNTHETASE METRS FROM BRUCELLA MELITENSIS BOUND TO SELENOMETHIONINE | STRUCTURAL GENOMICS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, CLASS IA AMINOACYL-TRNA SYNTHETASE, SELENOMETHIONINE, ANOMALOUS SIGNAL, PROTEIN SYNTHESIS, ATP- DEPENDENT, LIGASE
4dqf:B (ARG57) to (GLY78) CRYSTAL STRUCTURE OF (G16A/L38A) HIV-1 PROTEASE IN COMPLEX WITH DRV | HIV-1 PROTEASE, DRUG RESISTANCE, DRUG DESIGN, PROTEASE INHIBITORS, AIDS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5htg:B (ASP24) to (THR53) STRUCTURE OF APO P1 FORM OF CANDIDA ALBICANS FKBP12 | FKBP12, PATHOGENIC FUNGI, CALCINEURIN, ISOMERASE
3pa7:A (ASN37) to (HIS67) CRYSTAL STRUCTURE OF FKBP FROM PLASMODIUM VIVAX IN COMPLEX WITH TETRAPEPTIDE ALPF | PLASMODIUM VIVAX, FKBP35, ISOMERASE, PPIASE, FK506 BINDING PROTEIN
5hvp:B (ARG257) to (GLY278) CRYSTALLOGRAPHIC ANALYSIS OF A COMPLEX BETWEEN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE AND ACETYL-PEPSTATIN AT 2.0-ANGSTROMS RESOLUTION | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3pbz:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3pcw:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3pcz:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH BENZAMIDINE | HYDROLASE
5hzn:B (GLY1008) to (VAL1032) STRUCTURE OF NVP-AEW541 IN COMPLEX WITH IGF-1R KINASE | INHIBITOR, KINASE, TRANSFERASE
5hzn:E (MET1009) to (VAL1032) STRUCTURE OF NVP-AEW541 IN COMPLEX WITH IGF-1R KINASE | INHIBITOR, KINASE, TRANSFERASE
5hzn:F (GLY1008) to (VAL1032) STRUCTURE OF NVP-AEW541 IN COMPLEX WITH IGF-1R KINASE | INHIBITOR, KINASE, TRANSFERASE
5i2k:B (LYS41) to (GLY66) STRUCTURE OF THE HUMAN GLUN1/GLUN2A LBD IN COMPLEX WITH 7-{[ETHYL(4- FLUOROPHENYL)AMINO]METHYL}-N,2-DIMETHYL-5-OXO-5H-[1,3]THIAZOLO[3,2- A]PYRIMIDINE-3-CARBOXAMIDE (COMPOUND 19) | GLUN1, GLUN2A, RECEPTOR, NMDA, TRANSPORT PROTEIN
3phv:A (ILE54) to (GLY78) X-RAY ANALYSIS OF HIV-1 PROTEINASE AT 2.7 ANGSTROMS RESOLUTION CONFIRMS STRUCTURAL HOMOLOGY AMONG RETROVIRAL ENZYMES | HYDROLASE, ASPARTIC PROTEINASE
4uj1:A (GLU44) to (GLU64) PROTEIN KINASE A IN COMPLEX WITH AN INHIBITOR | TRANSFERASE-INHIBITOR COMPLEX, PROTEIN KINASE A,
4dyk:A (LEU10) to (ASP36) CRYSTAL STRUCTURE OF AN ADENOSINE DEAMINASE FROM PSEUDOMONAS AERUGINOSA PAO1 (TARGET NYSGRC-200449) WITH BOUND ZN | AMIDOHYDROLASE, ADENOSINE DEAMINASE, NYSGRC, STRUCTURAL GENOMICS, PSI-BIOLOGY, NEW YORK STRUCTURAL GENOMICS RESEARCH CONSORTIUM, HYDROLASE
4dyk:B (LEU10) to (ASP36) CRYSTAL STRUCTURE OF AN ADENOSINE DEAMINASE FROM PSEUDOMONAS AERUGINOSA PAO1 (TARGET NYSGRC-200449) WITH BOUND ZN | AMIDOHYDROLASE, ADENOSINE DEAMINASE, NYSGRC, STRUCTURAL GENOMICS, PSI-BIOLOGY, NEW YORK STRUCTURAL GENOMICS RESEARCH CONSORTIUM, HYDROLASE
3pld:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3pls:A (GLY1094) to (SER1115) RON IN COMPLEX WITH LIGAND AMP-PNP | PROTEIN KINASE, CIS AUTOPHOSPHORYLATION CONFORMATION, RECEPTOR TYROSINE KINASE, AMP-PNP, UNPHOSPHORYLATED, SINGLE-SPAN TRANSMEMBRANE RECEPTOR, TRANSFERASE
3pmu:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3pmy:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4e2s:D (ASP68) to (PRO96) CRYSTAL STRUCTURE OF (S)-UREIDOGLYCINE AMINOHYDROLASE FROM ARABIDOPSIS THALIANA IN COMPLEX WITH ITS SUBSTRATE, (S)-UREIDOGLYCINE | BI-CUPIN, (S)-UREIDOGLYCINE AMINOHYDROLASE, MANGANESE BINDING, ENDOPLASMIC RETICULUMN, HYDROLASE
4e2s:F (ASP68) to (PRO96) CRYSTAL STRUCTURE OF (S)-UREIDOGLYCINE AMINOHYDROLASE FROM ARABIDOPSIS THALIANA IN COMPLEX WITH ITS SUBSTRATE, (S)-UREIDOGLYCINE | BI-CUPIN, (S)-UREIDOGLYCINE AMINOHYDROLASE, MANGANESE BINDING, ENDOPLASMIC RETICULUMN, HYDROLASE
4e2w:A (PHE23) to (ARG53) X-RAY STRUCTURE OF THE H181N MUTANT OF TCAB9, A C-3'- METHYLTRANSFERASE, IN COMPLEX WITH S-ADENOSYL-L-HOMOCYSTEINE AND SUGAR PRODUCT | KIJANOSE, TETRONITROSE, TETRADEOXY SUGAR, KETO SUGAR, SUGAR METHYLATION, TRANSFERASE
4e2x:A (PHE23) to (ARG53) X-RAY STRUCTURE OF THE Y222F MUTANT OF TCAB9, A C-3'- METHYLTRANSFERASE, IN COMPLEX WITH S-ADENOSYL-L-HOMOCYSTEINE AND DTDP | KIJANOSE, TETRONITROSE, TETRADEOXY SUGAR, SUGAR METHYLATION, TRANSFERASE
4e31:A (PHE23) to (ARG53) X-RAY STRUCTURE OF THE Y76F MUTANT OF TCAB9, A C-3'-METHYLTRANSFERASE, IN COMPLEX WITH S-ADENOSYL-L-HOMOCYSTEINE AND SUGAR PRODUCT | KIJANOSE, TETRONITROSE, TETRADEOXY SUGAR, KETO SUGAR, SUGAR METHYLATION, TRANSFERASE
4e33:A (PHE23) to (ARG53) X-RAY STRUCTURE OF THE C-3'-METHYLTRANSFERASE TCAB9 IN COMPLEX WITH S- ADENOSYL-L-HOMOCYSTEINE AND REDUCED DTDP-SUGAR SUBSTRATE | KIJANOSE, TETRONITROSE, TETRADEOXY SUGAR, SUGAR METHYLATION, TRANSFERASE
4e4l:E (LEU875) to (PRO896) JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 30 | O-PHOSPHOTYROSINE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
4utd:A (ASP132) to (GLN154) STRUCTURE OF DEPHOSPHORYLATED AURORA A (122-403) BOUND TO AMPPCP IN AN ACTIVE CONFORMATION | TRANSFERASE, ACTIVATION, CELL CYCLE, CANCER
3pro:A (THR115) to (ASN135) ALPHA-LYTIC PROTEASE COMPLEXED WITH C-TERMINAL TRUNCATED PRO REGION | PRO REGION, FOLDASE, PROTEIN FOLDING, SERINE PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
3pro:B (THR115) to (ASN135) ALPHA-LYTIC PROTEASE COMPLEXED WITH C-TERMINAL TRUNCATED PRO REGION | PRO REGION, FOLDASE, PROTEIN FOLDING, SERINE PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
3prs:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH RITONAVIR | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3psy:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH AN INHIBITOR BASED ON THE GEWALD REACTION | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ehz:B (LEU875) to (PRO896) THE JAK1 KINASE DOMAIN IN COMPLEX WITH INHIBITOR | KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
3pww:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH SAQUINAVIR | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4eku:A (ASP261) to (GLY282) CRYSTAL STRUCTURE OF FERM DOMAIN OF PROLINE-RICH TYROSINE KINASE 2 | PROLINE-RICH TYROSINE KINASE 2; FERM DOMAIN, TRANSFERASE
4emo:B (MSE22) to (LEU46) CRYSTAL STRUCTURE OF THE PH DOMAIN OF SHARPIN | PLECKSTRIN HOMOLOGY (PH) DOMAIN, LUBAC, SIPL1, LINEAR UBIQUITIN, HOIL-1L, HOIP, PROTEIN BINDING
3q2u:A (TYR147) to (PRO177) STRUCTURE OF HUMAN GLIOMA PATHOGENESIS-RELATED PROTEIN 1 REVEALS UNIQUE LOOPS AND SURFACE MOTIFS. | CRISP, HUMAN GLIOMA PATHOGENESIS-RELATED PROTEIN 1 (GLIPR1), RTVP1, MEMBRANE PROTEIN
4ep2:A (ARG157) to (GLY178) CRYSTAL STRUCTURE OF INACTIVE SINGLE CHAIN WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH THE SUBSTRATE RT-RH | HIV-1 PROTEASE, SPECIFICITY DESIGN, DRUG DESIGN, PROTEASE INHIBITORS, AIDS, ASPARTYL PROTEASE, HYDROLASE, HYDROLASE-HYDROLASE SUBSTRATE COMPLEX
4epj:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF INACTIVE SINGLE CHAIN WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH THE SUBSTRATE P2-NC | HIV-1 PROTEASE, SPECIFICITY DESIGN, DRUG DESIGN, PROTEASE INHIBITORS, AIDS, ASPARTYL PROTEASE, HYDROLASE, HYDROLASE-HYDROLASE SUBSTRATE COMPLEX
4eq0:A (GLY52) to (GLY78) CRYSTAL STRUCTURE OF INACTIVE SINGLE CHAIN VARIANT OF HIV-1 PROTEASE IN COMPLEX WITH THE SUBSTRATE P2-NC | HIV-1 PROTEASE, SPECIFICITY DESIGN, DRUG DESIGN, PROTEASE INHIBITORS, AIDS, ASPARTYL PROTEASE, HYDROLASE, HYDROLASE-HYDROLASE SUBSTRATE COMPLEX
4eqj:A (GLY152) to (GLY178) CRYSTAL STRUCTURE OF INACTIVE SINGLE CHAIN VARIANT OF HIV-1 PROTEASE IN COMPLEX WITH THE SUBSTRATE RT-RH | HIV-1 PROTEASE, SPECIFICITY DESIGN, DRUG DESIGN, PROTEASE INHIBITORS, AIDS, ASPARTYL PROTEASE, HYDROLASE, HYDROLASE-HYDROLASE SUBSTRATE COMPLEX
5it9:c (GLY24) to (LYS45) STRUCTURE OF THE YEAST KLUYVEROMYCES LACTIS SMALL RIBOSOMAL SUBUNIT IN COMPLEX WITH THE CRICKET PARALYSIS VIRUS IRES. | IRES, RIBOSOME, SMALL, SUBUNIT
4er1:E (ASP83) to (ALA104) THE ACTIVE SITE OF ASPARTIC PROTEINASES | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4er2:E (ASP83) to (ALA104) THE ACTIVE SITE OF ASPARTIC PROTEINASES | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4er4:E (ASP83) to (ALA104) HIGH-RESOLUTION X-RAY ANALYSES OF RENIN INHIBITOR-ASPARTIC PROTEINASE COMPLEXES | HYDROLASE, ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3q6y:A (ASP88) to (LYS110) ENDOTHIAPEPSIN IN COMPLEX WITH A PYRROLIDINE BASED INHIBITOR | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3q8c:A (LEU255) to (ARG297) CRYSTAL STRUCTURE OF PROTECTIVE ANTIGEN W346F (PH 5.5) | PROTECTIVE ANTIGEN; ANTHRAX; PH STABILITY, TOXIN
3qa2:A (GLY10) to (ASN42) X-RAY STRUCTURE OF KETOHEXOKINASE IN COMPLEX WITH A PYRIMIDOPYRIMIDINE ANALOG 2 | KETOHEXOKINASE, ATP BINDING, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
3qed:A (GLY100) to (ASP124) THE STRUCTURE AND FUNCTION OF AN ARABINAN-SPECIFIC ALPHA-1,2- ARABINOFURANOSIDASE IDENTIFIED FROM SCREENING THE ACTIVITIES OF BACTERIAL GH43 GLYCOSIDE HYDROLASES | 5-BLADED BETA PROPELLER, HYDROLASE
3qed:B (GLY100) to (ASP124) THE STRUCTURE AND FUNCTION OF AN ARABINAN-SPECIFIC ALPHA-1,2- ARABINOFURANOSIDASE IDENTIFIED FROM SCREENING THE ACTIVITIES OF BACTERIAL GH43 GLYCOSIDE HYDROLASES | 5-BLADED BETA PROPELLER, HYDROLASE
4f0q:A (GLU185) to (VAL211) MSPJI RESTRICTION ENDONUCLEASE - P21 FORM | CYTOSINE METHYLATION-DEPENDENT ENDONUCLEASE, HYDROLASE
4f0r:A (LYS8) to (ASP34) CRYSTAL STRUCTURE OF AN ADENOSINE DEAMINASE HOMOLOG FROM CHROMOBACTERIUM VIOLACEUM (TARGET NYSGRC-019589) BOUND ZN AND 5'- METHYLTHIOADENOSINE (UNPRODUCTIVE COMPLEX) | STRUCTURAL GENOMICS, PSI-BIOLOGY, PROTEIN STRUCTURE INITIATIVE, NEW YORK STRUCTURAL GENOMICS RESEARCH CONSORTIUM, NYSGRC, HYDROLASE
4f14:A (GLY990) to (PRO1006) STRUCTURE OF THE SH3 DOMAIN OF HUMAN NEBULETTE IN COMPLEX WITH A PEPTIDE OF XIRP2 | SH3 DOMAIN, HEART MUSCLE, ACTIN-BINDING PROTEIN-PEPTIDE COMPLEX
3qj5:A (GLU3) to (PRO28) S-NITROSOGLUTATHIONE REDUCTASE (GSNOR) IN COMPLEX WITH N6022 | S-NITROSOGLUTATHIONE REDUCTASE, OXIDOREDUCTASE-OXIDOREDUCTASE INHIBITOR COMPLEX
3qj5:B (GLU3) to (PRO28) S-NITROSOGLUTATHIONE REDUCTASE (GSNOR) IN COMPLEX WITH N6022 | S-NITROSOGLUTATHIONE REDUCTASE, OXIDOREDUCTASE-OXIDOREDUCTASE INHIBITOR COMPLEX
5j6e:B (PHE22) to (THR49) STRUCTURE OF DISULFIDE CROSSLINKED A. FUMIGATUS FKBP12(V91C) | FKBP12, DISULFIDE TRAPPING, CROSSLINKED DIMER, ISOMERASE
4f74:B (ARG57) to (GLY78) CRYSTAL STRUCTURE OF ACTIVE HIV-1 PROTEASE IN COMPLEX WITH THE N TERMINAL PRODUCT OF THE SUBSTRATE MA-CA. | HIV-1 PROTEASE, SUBSTRATE COMPLEX, AIDS, PRODUCT COMPLEX, ASPARTYL PROTEASE, HYDROLASE, HYDROLASE-HYDROLASE PRODUCT COMPLEX
3qkk:A (GLU149) to (ALA171) SPIROCHROMANE AKT INHIBITORS | KINASE DOMAIN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
4uwy:B (GLY490) to (MET515) FGFR1 APO STRUCTURE | TRANSFERASE, INHIBITOR, DRUG, CANCER, FGF, RECEPTORS, GROWTH FACTORS, SIGNALLING
4fap:A (GLN20) to (MET49) ATOMIC STRUCTURES OF THE RAPAMYCIN ANALOGS IN COMPLEX WITH BOTH HUMAN FKBP12 AND FRB DOMAIN OF FRAP | FKBP12, FRAP, RAPAMYCIN, COMPLEX, GENE THERAPY, CELL CYCLE
4fbd:B (LEU99) to (PHE119) 2.35 ANGSTROM CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN FROM TOXOPLASMA GONDII ME49. | CONSERVED HYPOTHETICAL, STRUCTURAL GENOMICS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, UNKNOWN FUNCTION
4v2w:B (ASP64) to (VAL94) JMJD2A COMPLEXED WITH NI(II), NOG AND HISTONE H3K27ME3 PEPTIDE (16-35) | JMJD2A, OXIDOREDUCTASE, NON-HEME, IRON, 2-OXOGLUTARATE, DIOXYGENASE, OXYGENASE, DOUBLE-STRANDED BETA HELIX, DSBH, FACIAL TRIAD, DEMETHYLASE, HISTONE, JMJC DOMAIN, METAL BINDING PROTEIN, EPIGENETIC AND TRANSCRIPTION REGULATION, CHROMATIN REGULATOR, HYDROXYLATION
3qvi:A (TRP190) to (SER216) CRYSTAL STRUCTURE OF KNI-10395 BOUND HISTO-ASPARTIC PROTEASE (HAP) FROM PLASMODIUM FALCIPARUM | HISTO-ASPARTIC PROTEASE, HAP, PLASMEPSIN, ASPARTIC PROTEASE, MALARIA, KNI, KNI-10395, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3qvi:C (TRP190) to (SER216) CRYSTAL STRUCTURE OF KNI-10395 BOUND HISTO-ASPARTIC PROTEASE (HAP) FROM PLASMODIUM FALCIPARUM | HISTO-ASPARTIC PROTEASE, HAP, PLASMEPSIN, ASPARTIC PROTEASE, MALARIA, KNI, KNI-10395, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3qvi:D (TRP190) to (SER216) CRYSTAL STRUCTURE OF KNI-10395 BOUND HISTO-ASPARTIC PROTEASE (HAP) FROM PLASMODIUM FALCIPARUM | HISTO-ASPARTIC PROTEASE, HAP, PLASMEPSIN, ASPARTIC PROTEASE, MALARIA, KNI, KNI-10395, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3qzr:B (SER95) to (GLN121) HUMAN ENTEROVIRUS 71 3C PROTEASE MUTANT E71A IN COMPLEX WITH RUPINTRIVIR | CHYMOTRYPSIN-FOLD, BETA-RIBBON, HYDROLYSIS, NUCLEUS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
3r4b:B (ARG57) to (GLY78) CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH TMC310911 | DRUG RESISTANCE, DRUG DESIGN, PROTEASE INHIBITORS, AIDS, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4fk6:B (LEU875) to (PRO896) JAK1 KINASE (JH1 DOMAIN) IN COMPLEX WITH COMPOUND 72 | PROTEIN KINASE, PHOSPHO TRANSFER, PHOSPHO TYROSINE, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX
3r6j:A (GLY330) to (ALA353) CRYSTAL STRUCTURE OF THE CAPSID P DOMAIN FROM NORWALK VIRUS STRAIN HIROSHIMA/1999 | NOROVIRUS, P-DOMAIN, CAPSID, RECEPTOR, HISTO BLOOD GROUP ANTIGEN (HBGA), VIRAL PROTEIN
3ref:A (THR52) to (GLY77) CRYSTAL STRUCTURE OF EHRHO1 BOUND TO GDP AND MAGNESIUM | CYTOSKELETON, NUCLEOTIDE-BINDING, GTP-BINDING, SIGNALING PROTEIN, LIPOPROTEIN, PRENYLATION
3rfy:A (GLU287) to (PRO350) CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CYCLOPHILIN 38 (ATCYP38) | CYCLOPHILIN, CYP38, PEPTIDYL PROLYL ISOMERASE, PPIASE, TLP, ISOMERASE
3rfz:E (GLY327) to (PRO360) CRYSTAL STRUCTURE OF THE FIMD USHER BOUND TO ITS COGNATE FIMC:FIMH SUBSTRATE | BETA-BARREL, PILUS ASSEMBLY, OUTER-MEMBRANE, CELL ADHESION-TRANSPORT PROTEIN-CHAPERONE COMPLEX, CELL ADHESION-TRANSPORT-CHAPERONE COMPLEX
5jlj:B (ARG154) to (PHE178) CRYSTAL STRUCTURE OF KPT8602 IN COMPLEX WITH CRM1-RAN-RANBP1 | HEAT REPEAT, EXPORTIN-1, NUCLEAR TRANSPORT, TRANSPORT RECEPTOR- INHIBITOR COMPLEX, PROTEIN TRANSPORT
4frt:B (THR105) to (ASN138) CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA OCCK7 (OPDD) | BETA-BARREL, TRANSPORTER (PORIN), OUTER MEMBRANE, TRANSPORT PROTEIN
3rhk:B (GLY1090) to (SER1111) CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF C-MET KINASE IN COMPLEX WITH ARQ 197 | KINASE, RECEPTOR TYROSINE KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
5jow:B (HIS412) to (LEU433) BACTEROIDES OVATUS XYLOGLUCAN PUL GH43A | GLYCOSIDE HYDROLASE, GH43, HYDROLASE
4fyg:A (SER389) to (GLN410) STRUCTURAL BASIS FOR SUBSTRATE RECOGNITION BY A NOVEL LEGIONELLA PHOSPHOINOSITIDE PHOSPHATASE | MIXED ALPHA-BETA, PHOSPHOINOSITIDE PHOSPHATASE, PHOSPHOINOSITIDES, MEMBRANE, HYDROLASE
5k69:A (GLY295) to (ILE328) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS L,D-TRANSPEPTIDASE 2 WITH CARBAPENEM DRUG T224 | PEPTIDASE, IGD_LIKE DOMAIN, YKUD DOMAIN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
5kbp:A (ALA459) to (GLU495) THE CRYSTAL STRUCTURE OF AN ALPHA-MANNOSIDASE FROM ENTEROCOCCUS FAECALIS V583 | STRUCTURAL GENOMICS, THE CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, HYDROLASE
4gb2:A (ARG57) to (GLY78) HIV-1 PROTEASE (MUTANT Q7K L33I L63I) IN COMPLEX WITH A BICYCLIC PYRROLIDINE INHIBITOR | DIMER, ASPARTYL PROTEASE, INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4gbd:B (LEU10) to (ASP36) CRYSTAL STRUCTURE OF ADENOSINE DEAMINASE FROM PSEUDOMONAS AERUGINOSA PAO1 WITH BOUND ZN AND METHYLTHIO-COFORMYCIN | DEAMINASE, METHYLTIHOADENOSINE, LYASE
5kcv:A (GLU149) to (ALA171) CRYSTAL STRUCTURE OF ALLOSTERIC INHIBITOR, ARQ 092, IN COMPLEX WITH AUTOINHIBITED FORM OF AKT1 | AKT, ALLOSTERIC INHIBITOR, KINASE INHIBITOR, TRANSFERASE-INHIBITOR COMPLEX
5ked:D (ALA162) to (VAL183) STRUCTURE OF THE 2.65 ANGSTROM P2(1) CRYSTAL OF K. PNEUMONIA MRKH | MRKH, BIOFILM, K. PNEUMONIA, TRANSFERASE
5ked:B (ASN161) to (VAL183) STRUCTURE OF THE 2.65 ANGSTROM P2(1) CRYSTAL OF K. PNEUMONIA MRKH | MRKH, BIOFILM, K. PNEUMONIA, TRANSFERASE
5ked:C (ASN161) to (VAL183) STRUCTURE OF THE 2.65 ANGSTROM P2(1) CRYSTAL OF K. PNEUMONIA MRKH | MRKH, BIOFILM, K. PNEUMONIA, TRANSFERASE
4gj8:A (SER63) to (ASP87) CRYSTAL STRUCTURE OF RENIN IN COMPLEX WITH PKF909-724 (COMPOUND 3) | RENIN INHIBITOR, FRAGMENT BASED SCREENING, 3,5-DISUBSTITUTED PIPERIDINES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4gjc:B (SER63) to (ASP87) CRYSTAL STRUCTURE OF RENIN IN COMPLEX WITH NVP-BCH965 (COMPOUND 9) | RENIN INHIBITOR, FRAGMENT BASED SCREENING, 3,5-DISUBSTITUTED PIPERIDINES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5kja:A (LYS314) to (ASP353) SYNECHOCYSTIS APOCAROTENOID OXYGENASE (ACO) MUTANT - TRP149ALA | IRON-COORDINATION, ACTIVE SITE, CAROTENOID BINDING, LIGAND INTERACTION, NON-HEME IRON, MUTAGENESIS, OXIDOREDUCTASE
5kja:B (LYS314) to (ASP353) SYNECHOCYSTIS APOCAROTENOID OXYGENASE (ACO) MUTANT - TRP149ALA | IRON-COORDINATION, ACTIVE SITE, CAROTENOID BINDING, LIGAND INTERACTION, NON-HEME IRON, MUTAGENESIS, OXIDOREDUCTASE
5kja:C (LYS314) to (ASP353) SYNECHOCYSTIS APOCAROTENOID OXYGENASE (ACO) MUTANT - TRP149ALA | IRON-COORDINATION, ACTIVE SITE, CAROTENOID BINDING, LIGAND INTERACTION, NON-HEME IRON, MUTAGENESIS, OXIDOREDUCTASE
5kja:D (LYS314) to (ASP353) SYNECHOCYSTIS APOCAROTENOID OXYGENASE (ACO) MUTANT - TRP149ALA | IRON-COORDINATION, ACTIVE SITE, CAROTENOID BINDING, LIGAND INTERACTION, NON-HEME IRON, MUTAGENESIS, OXIDOREDUCTASE
5kja:E (LYS314) to (ASP353) SYNECHOCYSTIS APOCAROTENOID OXYGENASE (ACO) MUTANT - TRP149ALA | IRON-COORDINATION, ACTIVE SITE, CAROTENOID BINDING, LIGAND INTERACTION, NON-HEME IRON, MUTAGENESIS, OXIDOREDUCTASE
4gn1:D (VAL268) to (GLU289) CRYSTAL STRUCTURE OF THE RA AND PH DOMAINS OF LAMELLIPODIN | RA-PH, COILED-COIL REGION, RAS-ASSOCIATION DOMAIN, PLECKSTRIN HOMOLOGY DOMAIN, CYTOSKELETAL PROTEIN, ENA/VASP BINDING, CELL MIGRATION, CELL ADHESION, SIGNALING PROTEIN
5oyq:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 1 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5oyr:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 2 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5oyu:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 5 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5oyy:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 9 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5oyz:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 10 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5oz1:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 12 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5oz2:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 13 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5oz5:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 16 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5oz6:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 17 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5oz8:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 19 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5oza:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 21 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozc:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 23 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozd:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 24 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5oze:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 25 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozf:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 26 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozh:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 28 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozi:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 29 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozk:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 31 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozl:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 32 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozm:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 33 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozn:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 34 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozo:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 35 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozp:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 36 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozr:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 38 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozs:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 39 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozt:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 40 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozu:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 41 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5ozz:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 46 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p00:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 47 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p02:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 49 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p03:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 50 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p04:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 51 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p06:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 53 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p07:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 54 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p08:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 55 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p09:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 56 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0b:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 58 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0c:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 59 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0d:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 60 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0f:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 62 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0g:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 63 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0h:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 64 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0i:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 65 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0j:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 66 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0k:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 67 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0l:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 68 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0m:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 69 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0n:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 70 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0o:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 71 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0p:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 72 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0q:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 73 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0r:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 74 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0s:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 75 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0t:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 76 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0u:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 77 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0v:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 78 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0x:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 80 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0y:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 81 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0z:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 82 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p10:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 83 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p11:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 84 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p12:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 85 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p14:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 87 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p15:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 88 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p16:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 89 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p17:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 90 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p18:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 91 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p19:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 92 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1a:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 93 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1b:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 94 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1d:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 96 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1e:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 97 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1f:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 98 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1g:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 99 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1i:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 101 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1j:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 102 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1k:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 103 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1l:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 104 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1m:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 105 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1p:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 108 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1r:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 110 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1s:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 111 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1u:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 113 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1w:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 115 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1x:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 116 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1y:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 117 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1z:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 118 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p20:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 119 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p22:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 120 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p23:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 121 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p24:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 122 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p25:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 123 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p26:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 124 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p27:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 125 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p28:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 126 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p29:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 127 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2b:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 129 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2d:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 131 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2f:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 133 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2g:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 134 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2h:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 135 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2k:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 138 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2l:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 139 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2m:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 140 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2n:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 141 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2o:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 142 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2q:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 143 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2r:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 144 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2t:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 146 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2u:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 147 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2v:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 148 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2w:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 149 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2x:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 150 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2z:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 152 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p30:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 153 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p31:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 154 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p32:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 155 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p33:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 156 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p34:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 157 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p35:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 158 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p36:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 159 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p37:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 160 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p38:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 161 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3b:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 164 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3c:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 165 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3d:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 166 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3e:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 167 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3g:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 169 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3i:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 171 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3j:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 172 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3k:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 173 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3l:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 174 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3m:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 175 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3n:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 176 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3o:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 177 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3p:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 178 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3q:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 179 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3r:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 180 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3s:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 181 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3t:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 182 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3u:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 183 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3v:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 184 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3w:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 185 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3x:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 186 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3y:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 187 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3z:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 188 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p40:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 189 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p41:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 190 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p42:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 191 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p43:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 192 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p44:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 193 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p45:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 194 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p46:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 195 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p47:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 196 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p48:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 197 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p49:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 198 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4a:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 199 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4b:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 200 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4c:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 201 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4d:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 202 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4e:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 203 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4f:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 204 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4g:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 205 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4h:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 206 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4i:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 207 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4j:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 208 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4k:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 209 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4l:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 210 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4m:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 211 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4o:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 213 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4p:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 214 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4q:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 215 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4r:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 216 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4s:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 217 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4t:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 218 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4v:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 220 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4w:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 221 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4y:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 223 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4z:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 224 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p53:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 228 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p54:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 229 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p55:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 230 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p56:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 231 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p58:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 233 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p59:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 234 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5a:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 235 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5c:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 237 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5d:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 238 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5e:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 239 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5f:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 240 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5g:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 241 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5h:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 242 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5i:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 243 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5j:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 244 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5k:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 245 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5l:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 246 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5m:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 247 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5n:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 248 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5o:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 249 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5q:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 251 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5r:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 252 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5s:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 253 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5t:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 254 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5u:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 255 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5v:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 256 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5w:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 257 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5x:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 258 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5y:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 259 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5z:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 260 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p61:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 262 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p62:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 263 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p63:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 264 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p64:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 265 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p65:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 266 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p66:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 267 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p68:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 269 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6a:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 271 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6c:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 273 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6d:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 274 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6e:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 275 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6g:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 277 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6h:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 278 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6i:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 279 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6j:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 280 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6k:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 281 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6l:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 282 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6m:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 283 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6n:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 284 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6o:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 285 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6p:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 286 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6q:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 287 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6r:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 288 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6s:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 289 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6t:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 290 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6u:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 291 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6v:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 292 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6w:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 293 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6x:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 294 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6y:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 295 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6z:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 296 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p70:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 297 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p71:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 298 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p72:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 299 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p75:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 302 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p76:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 303 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p77:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 304 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p78:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 305 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7a:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 307 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7b:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 308 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7c:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 309 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7d:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 310 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7e:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 311 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7i:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 315 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7j:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 316 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7m:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 319 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7o:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 321 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7p:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 322 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7q:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 323 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7r:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 324 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7t:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 326 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7u:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 327 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7v:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 328 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7w:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 329 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7x:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 330 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7y:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 331 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7z:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 332 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p80:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 333 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p81:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 334 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p82:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 335 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p83:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 336 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p84:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 337 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p85:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 338 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p86:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 339 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p87:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 340 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p88:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 341 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p89:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 342 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8a:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 343 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8b:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 344 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8c:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 345 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8d:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 346 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8e:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 347 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8f:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 348 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8h:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 350 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8j:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 352 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8k:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 353 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8l:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 354 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8m:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 355 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8n:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 356 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8o:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 357 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8p:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 358 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8r:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 360 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8s:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 361 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8t:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 362 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8u:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 363 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8v:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 364 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5pep:A (ILE83) to (SER104) X-RAY ANALYSES OF ASPARTIC PROTEASES. II. THREE-DIMENSIONAL STRUCTURE OF THE HEXAGONAL CRYSTAL FORM OF PORCINE PEPSIN AT 2.3 ANGSTROMS RESOLUTION | HYDROLASE(ACID PROTEINASE)
5t5i:B (MET1) to (GLY25) TUNGSTEN-CONTAINING FORMYLMETHANOFURAN DEHYDROGENASE FROM METHANOTHERMOBACTER WOLFEII, ORTHORHOMBIC FORM AT 1.9 A | CO2 FIXATION, METALLOHYDROLASE, FORMATE DEHYDROGENASE, TUNGSTOPTERIN, METHANOGENESIS, GREEN HOUSE GAS, METHANOTHERMOBACTER WOLFEII, IRON SULFUR CLUSTER, FERREDOXIN, BETA HELICOIDAL, CHANNEL, FORMATE, CO2, METHANOFURAN, FORMYLMETHANOFURAN, NANOMACHINE, BINUCLEAR CENTER, TUNGSTEN, GATE, COUPLING, ENZYME, ANAEROBIC, CARBOXYLYSINE, OXIDOREDUCTASE
5t5i:J (MET1) to (GLY25) TUNGSTEN-CONTAINING FORMYLMETHANOFURAN DEHYDROGENASE FROM METHANOTHERMOBACTER WOLFEII, ORTHORHOMBIC FORM AT 1.9 A | CO2 FIXATION, METALLOHYDROLASE, FORMATE DEHYDROGENASE, TUNGSTOPTERIN, METHANOGENESIS, GREEN HOUSE GAS, METHANOTHERMOBACTER WOLFEII, IRON SULFUR CLUSTER, FERREDOXIN, BETA HELICOIDAL, CHANNEL, FORMATE, CO2, METHANOFURAN, FORMYLMETHANOFURAN, NANOMACHINE, BINUCLEAR CENTER, TUNGSTEN, GATE, COUPLING, ENZYME, ANAEROBIC, CARBOXYLYSINE, OXIDOREDUCTASE
5t5m:B (MET1) to (GLY25) TUNGSTEN-CONTAINING FORMYLMETHANOFURAN DEHYDROGENASE FROM METHANOTHERMOBACTER WOLFEII, TRIGONAL FORM AT 2.5 A. | CO2 FIXATION, METALLOHYDROLASE, FORMATE DEHYDROGENASE, TUNGSTOPTERIN, METHANOGENESIS, GREEN HOUSE GAS, METHANOTHERMOBACTER WOLFEII, IRON SULFUR CLUSTER, FERREDOXIN, BETA HELICOIDAL, CHANNEL, FORMATE, CO2, METHANOFURAN, FORMYLMETHANOFURAN, NANOMACHINE, BINUCLEAR CENTER, TUNGSTEN, GATE, COUPLING, ENZYME, ANAEROBIC, CARBOXYLYSINE, OXIDOREDUCTASE
6adh:B (LYS5) to (PRO30) STRUCTURE OF TRICLINIC TERNARY COMPLEX OF HORSE LIVER ALCOHOL DEHYDROGENASE AT 2.9 ANGSTROMS RESOLUTION | OXIDOREDUCTASE (NAD(A)-CHOH(D))
6lpr:A (THR163) to (ASN184) STRUCTURAL BASIS FOR BROAD SPECIFICITY IN ALPHA-LYTIC PROTEASE MUTANTS | SERINE PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
7hvp:A (ARG57) to (GLY78) X-RAY CRYSTALLOGRAPHIC STRUCTURE OF A COMPLEX BETWEEN A SYNTHETIC PROTEASE OF HUMAN IMMUNODEFICIENCY VIRUS 1 AND A SUBSTRATE-BASED HYDROXYETHYLAMINE INHIBITOR | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
8adh:A (LYS5) to (PRO30) INTERDOMAIN MOTION IN LIVER ALCOHOL DEHYDROGENASE. STRUCTURAL AND ENERGETIC ANALYSIS OF THE HINGE BENDING MODE | OXIDOREDUCTASE(NAD(A)-CHOH(D))
8hvp:A (ARG57) to (GLY78) STRUCTURE AT 2.5-ANGSTROMS RESOLUTION OF CHEMICALLY SYNTHESIZED HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE COMPLEXED WITH A HYDROXYETHYLENE*-BASED INHIBITOR | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
8hvp:B (ARG57) to (GLY78) STRUCTURE AT 2.5-ANGSTROMS RESOLUTION OF CHEMICALLY SYNTHESIZED HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE COMPLEXED WITH A HYDROXYETHYLENE*-BASED INHIBITOR | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
8prk:A (TRP52) to (VAL80) THE R78K AND D117E ACTIVE SITE VARIANTS OF SACCHAROMYCES CEREVISIAE SOLUBLE INORGANIC PYROPHOSPHATASE: STRUCTURAL STUDIES AND MECHANISTIC IMPLICATIONS | ENZYME MECHANISM, IORGANIC PYROPHOSPHATASE, MUTANT STRUCTURES, 2-METAL ION MECHANISM, HYDROLASE
9lpr:A (THR163) to (ASN184) STRUCTURAL BASIS FOR BROAD SPECIFICITY IN ALPHA-LYTIC PROTEASE MUTANTS | SERINE PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
2al0:X (LEU79) to (THR107) CRYSTAL STRUCTURE OF NITROPHORIN 2 FERROUS AQUA COMPLEX | BETA BARREL, LIPOCALIN, FERROUS HEME, TRANSPORT PROTEIN
1adb:B (LYS5) to (PRO30) CRYSTALLOGRAPHIC STUDIES OF ISOSTERIC NAD ANALOGUES BOUND TO ALCOHOL DEHYDROGENASE: SPECIFICITY AND SUBSTRATE BINDING IN TWO TERNARY COMPLEXES | OXIDOREDUCTASE (NAD(A)-CHOH(D))
1nj8:A (LYS123) to (SER158) CRYSTAL STRUCTURE OF PROLYL-TRNA SYNTHETASE FROM METHANOCALDOCOCCUS JANASCHII | CLASS-II TRNA SYNTHETASE, LIGASE
1nj8:C (LYS123) to (SER158) CRYSTAL STRUCTURE OF PROLYL-TRNA SYNTHETASE FROM METHANOCALDOCOCCUS JANASCHII | CLASS-II TRNA SYNTHETASE, LIGASE
1nj8:D (ILE122) to (SER158) CRYSTAL STRUCTURE OF PROLYL-TRNA SYNTHETASE FROM METHANOCALDOCOCCUS JANASCHII | CLASS-II TRNA SYNTHETASE, LIGASE
3ekx:B (ARG57) to (GLY78) CRYSTAL STRUCTURE OF THE WILD-TYPE HIV-1 PROTEASE WITH THE INHIBITOR, NELFINAVIR | HIV PROTEASE, PROTEASE INHIBITORS, DRUG RESISTANCE, AMPRENAVIR, AIDS, PROTEASE, HYDROLASE
1bdr:B (ARG57) to (GLY78) HIV-1 (2: 31, 33-37) PROTEASE COMPLEXED WITH INHIBITOR SB203386 | HYDROLASE, AIDS, POLYPROTEIN, ASPARTYL PROTEASE, ACID PROTEASE, HYDROXYETHYLENE ISOSTERE INHIBITOR, SUBSTRATE ANALOGUE INHIBITOR
1bwa:B (ARG57) to (GLY78) HIV-1 PROTEASE (V82F/I84V) DOUBLE MUTANT COMPLEXED WITH XV638 OF DUPONT PHARMACEUTICALS | HIV-1 PROTEASE, HYDROLASE
4xcu:A (GLN480) to (LEU505) CRYSTAL STRUCTURE OF FGFR4 WITH AN IRREVERSIBLE INHIBITOR | RECEPTOR TYROSINE KINASE, HEPATOCELLULAR CARCINOMA, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX
2bze:A (GLY399) to (GLY423) NMR STRUCTURE OF HUMAN RTF1 PLUS3 DOMAIN. | HUMAN RTF1 PLUS3 DOMAIN, TRANSCRIPTION, ELONGATION, PAF1 COMPLEX, HISTONE H3 METHYLATION, H2B UBIQUITINATION, CDC73, LEO1, CTR9, PLUS3 DOMAIN, TRANSCRIPTION REGULATION, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS
3seq:A (VAL90) to (HIS111) CRYSTAL STRUCTURE OF C176A MUTANT OF GLUTAMINE-DEPENDENT NAD+ SYNTHETASE FROM M. TUBERCULOSIS IN COMPLEX WITH AMPCPP AND NAAD+ | GLUTAMINE-AMIDOTRANSFERASE, GLUTAMINASE, GLUTAMINE-DEPENDENT NAD+ SYNTHETASE, LIGASE, AMMONIA TUNNELING, ATP BINDING, NAD, NUCLEOTIDE BINDING
3seq:D (VAL90) to (HIS111) CRYSTAL STRUCTURE OF C176A MUTANT OF GLUTAMINE-DEPENDENT NAD+ SYNTHETASE FROM M. TUBERCULOSIS IN COMPLEX WITH AMPCPP AND NAAD+ | GLUTAMINE-AMIDOTRANSFERASE, GLUTAMINASE, GLUTAMINE-DEPENDENT NAD+ SYNTHETASE, LIGASE, AMMONIA TUNNELING, ATP BINDING, NAD, NUCLEOTIDE BINDING
3fsm:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF A CHEMICALLY SYNTHESIZED 203 AMINO ACID 'COVALENT DIMER' [L-ALA51,D-ALA51'] HIV-1 PROTEASE MOLECULE | ASYMMETRIC DIMER, COVALENT DIMER, BETA-SHEET, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
2q1f:A (ALA806) to (LEU833) CRYSTAL STRUCTURE OF CHONDROITIN SULFATE LYASE ABC FROM BACTEROIDES THETAIOTAOMICRON WAL2926 | ALPHA PLUS BETA, LYASE
2q1f:B (ALA806) to (LEU833) CRYSTAL STRUCTURE OF CHONDROITIN SULFATE LYASE ABC FROM BACTEROIDES THETAIOTAOMICRON WAL2926 | ALPHA PLUS BETA, LYASE
3ftj:A (SER356) to (GLY381) CRYSTAL STRUCTURE OF THE PERIPLASMIC REGION OF MACB FROM ACTINOBACILLUS ACTINOMYCETEMCOMITANS | MACROLIDE-SPECIFIC PUMP, ABC-TYPE TRANSPORTER, HEAT STABLE EXOTOXIN II, MEMBRANE PROTEIN, PERIPLASMIC REGION, ANTIBIOTIC RESISTANCE, ATP-BINDING, CELL INNER MEMBRANE, CELL MEMBRANE, HYDROLASE, MEMBRANE, NUCLEOTIDE-BINDING, TRANSMEMBRANE, TRANSPORT
1d4s:A (ARG57) to (GLY78) HIV-1 PROTEASE V82F/I84V DOUBLE MUTANT/TIPRANAVIR COMPLEX | HYDROLASE, ACID PROTEASE, ASPARTYL PROTEASE
3t3c:A (ARG57) to (GLY78) STRUCTURE OF HIV PR RESISTANT PATIENT DERIVED MUTANT (COMPRISING 22 MUTATIONS) IN COMPLEX WITH DRV | PEPTIDASE, VIRAL PARTICLE, HYDROLASE
4ist:B (PRO568) to (GLU588) S177A KLUYVEROMYCES LACTIS ALLOPHANATE HYDROLASE | MIXED ALPHA AND BETA STRUCTURE, ALLOPHANATE BINDING, HYDROLASE
3ggx:A (ARG57) to (GLY78) HIV PROTEASE, PSEUDO-SYMMETRIC INHIBITORS | HIV PROTEASE, PSEUDO-SYMMETRIC INHIBITORS, HYDROLASE, PROTEASE
3ggx:B (ARG57) to (GLY78) HIV PROTEASE, PSEUDO-SYMMETRIC INHIBITORS | HIV PROTEASE, PSEUDO-SYMMETRIC INHIBITORS, HYDROLASE, PROTEASE
3ggx:E (ARG57) to (GLY78) HIV PROTEASE, PSEUDO-SYMMETRIC INHIBITORS | HIV PROTEASE, PSEUDO-SYMMETRIC INHIBITORS, HYDROLASE, PROTEASE
3ggx:G (ARG57) to (GLY78) HIV PROTEASE, PSEUDO-SYMMETRIC INHIBITORS | HIV PROTEASE, PSEUDO-SYMMETRIC INHIBITORS, HYDROLASE, PROTEASE
3ggx:H (ARG57) to (GLY78) HIV PROTEASE, PSEUDO-SYMMETRIC INHIBITORS | HIV PROTEASE, PSEUDO-SYMMETRIC INHIBITORS, HYDROLASE, PROTEASE
2qs8:A (SER7) to (ASP33) CRYSTAL STRUCTURE OF A XAA-PRO DIPEPTIDASE WITH BOUND METHIONINE IN THE ACTIVE SITE | AMIDOHYDROLASE, DIPEPTIDASE, TIM BARREL, PROTEIN STRUCTURE INITIATIVE, PSI-2, 9355E, NYSGXRC, STRUCTURAL GENOMICS, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, HYDROLASE
2qs8:B (ASP6) to (ASP33) CRYSTAL STRUCTURE OF A XAA-PRO DIPEPTIDASE WITH BOUND METHIONINE IN THE ACTIVE SITE | AMIDOHYDROLASE, DIPEPTIDASE, TIM BARREL, PROTEIN STRUCTURE INITIATIVE, PSI-2, 9355E, NYSGXRC, STRUCTURAL GENOMICS, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, HYDROLASE
3t6i:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH AN AZEPIN DERIVATIVE | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y39:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 75 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y3f:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 78 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
4y3g:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 285 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
4y3z:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 41 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y41:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 112 | FRAGMENT SCREENING, ASPARTIC PROTEASE, INHIBITION, HYDROLASE
4y4g:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B53 | FRAGMENT SCREENING, ASPARTIC PROTEASE INHIBITION, HYDROLASE
4y4x:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 51 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4y50:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 81 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
2db9:A (GLY68) to (GLY92) SOLUTION STRUCTURE OF THE PLUS-3 DOMAIN OF HUMAN KIAA0252 PROTEIN | PLUS-3 DOMAIN; STRUCTURAL GENOMICS, KIAA0252, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, STRUCTURAL GENOMICS, UNKNOWN FUNCTION
2r7d:A (GLU168) to (ALA201) CRYSTAL STRUCTURE OF RIBONUCLEASE II FAMILY PROTEIN FROM DEINOCOCCUS RADIODURANS, TRICLINIC CRYSTAL FORM. NORTHEAST STRUCTURAL GENOMICS TARGET DRR63 | RIBONUCLEASE II FAMILY PROTEIN, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, HYDROLASE
1qbs:A (ARG57) to (GLY78) HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY | HYDROLASE (ACID PROTEINASE), ASPARTYL PROTEASE
4ycy:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 218 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4yd4:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 227 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
4yd7:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 255 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
3tto:A (GLN2491) to (ASN2518) CRYSTAL STRUCTURE OF LEUCONOSTOC MESENTEROIDES NRRL B-1299 N- TERMINALLY TRUNCATED DEXTRANSUCRASE DSR-E IN TRICLINIC FORM | (BETA/ALPHA)8 BARREL, SUCROSE/DEXTRAN/GLUCO-OLIGOSACCHARIDE BINDING, ALPHA-1,2 BRANCHING DEXTRANSUCRASE, TRANSFERASE
3tto:D (GLN2491) to (ASN2518) CRYSTAL STRUCTURE OF LEUCONOSTOC MESENTEROIDES NRRL B-1299 N- TERMINALLY TRUNCATED DEXTRANSUCRASE DSR-E IN TRICLINIC FORM | (BETA/ALPHA)8 BARREL, SUCROSE/DEXTRAN/GLUCO-OLIGOSACCHARIDE BINDING, ALPHA-1,2 BRANCHING DEXTRANSUCRASE, TRANSFERASE
1epr:E (ASP83) to (ALA104) ENDOTHIA ASPARTIC PROTEINASE (ENDOTHIAPEPSIN) COMPLEXED WITH PD-135, 040 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ACID PROTEINASE
3twj:A (GLU77) to (SER97) RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH RKI1447 | KINASE, DIMER, DIMERIZATION, MYOSIN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
2eac:A (LEU779) to (LEU801) CRYSTAL STRUCTURE OF 1,2-A-L-FUCOSIDASE FROM BIFIDOBACTERIUM BIFIDUM IN COMPLEX WITH DEOXYFUCONOJIRIMYCIN | FUCOSIDASE, GLYCOSIDE HYDROLASE
1fd9:A (ASP125) to (GLN154) CRYSTAL STRUCTURE OF THE MACROPHAGE INFECTIVITY POTENTIATOR PROTEIN (MIP) A MAJOR VIRULENCE FACTOR FROM LEGIONELLA PNEUMOPHILA | FKBP DOMAIN, LONG ALPHA HELIX, DIMERISATION VIA HELICAL INTERACTIONS, ISOMERASE
1fkj:A (GLN20) to (PHE48) ATOMIC STRUCTURE OF FKBP12-FK506, AN IMMUNOPHILIN IMMUNOSUPPRESSANT COMPLEX | FK506 BINDING PROTEIN, FKBP12, CIS-TRANS PROLYL-ISOMERASE, ROTAMASE
3ulf:B (THR280) to (SER306) THE LIGHT STATE STRUCTURE OF THE BLUE-LIGHT PHOTORECEPTOR AUREOCHROME1 LOV | PAS/LOV DOMAIN, FMN-BINDING BLUE-LIGHT PHOTORECEPTOR, SIGNALING PROTEIN
4z50:D (ARG157) to (GLY178) CRYSTAL STRUCTURE OF MULTIDRUG RESISTANT HIV-1 PROTEASE CLINICAL ISOLATE PR20D25N WITH TUCKED FLAP | HIV-1 PROTEASE, HYDROLASE
4ze6:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT B39 | FRAGMENT SCREENING, ASPARTIC PROTEASE INHIBITION, HYDROLASE
3v4h:B (LEU75) to (ARG108) CRYSTAL STRUCTURE OF A TYPE VI SECRETION SYSTEM EFFECTOR FROM YERSINIA PESTIS | STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, UNKNOWN FUNCTION
1gnm:B (ARG57) to (GLY78) HIV-1 PROTEASE MUTANT WITH VAL 82 REPLACED BY ASP (V82D) COMPLEXED WITH U89360E (INHIBITOR) | ASPARTIC PROTEASE, HIV, MUTANT, INHIBITOR, U-89360E, HYDROLASE (ACID PROTEASE)
1sgu:B (ARG57) to (GLY78) COMPARING THE ACCUMULATION OF ACTIVE SITE AND NON-ACTIVE SITE MUTATIONS IN THE HIV-1 PROTEASE | ACTIVE SITE MUTATIONS, NON-ACTIVE SITE MUTATIONS, INDINAVIR, HIV-1 PROTEASE, HYDROLASE
1sh9:B (ARG57) to (GLY78) COMPARING THE ACCUMULATION OF ACTIVE SITE AND NON-ACTIVE SITE MUTATIONS IN THE HIV-1 PROTEASE | HIV-1 PROTEASE, NON-ACTIVE SITE MUTATIONS, ACTIVE SITE MUTATIONS, RITONAVIR, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3i2l:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF A CHEMICALLY SYNTHESIZED [ALLO-ILE50/50']HIV-1 PROTEASE MOLECULE COMPLEXED WITH MVT-101 REDUCED ISOSTERE INHIBITOR | BETA-SHEET, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1smh:A (GLN42) to (GLU64) PROTEIN KINASE A VARIANT COMPLEX WITH COMPLETELY ORDERED N- TERMINAL HELIX | PKA; PROTEIN KINASE A; CAMP-DEPENDENT PROTEIN KINASE; PHOSPHORYLATION; SER10; MYRISTOYLATION; POSTTRANSLATIONAL MODIFICATION; SIGNALING; MEMBRANE, ALPHA HELIX, SIGNALING PROTEIN,TRANSFERASE/INHIBITOR COMPLEX
1h4q:A (LEU133) to (ALA166) PROLYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS COMPLEXED WITH TRNAPRO(CGG), ATP AND PROLINOL | AMINOACYL-TRNA SYNTHETASE, ATP + L-PROLINE + TRNA(PRO) AMP + PPI + L-PROLYL-TRNA(PRO), CLASS II AMINOACYL-TRNA SYNTHETASE
1h4q:B (LEU133) to (ALA166) PROLYL-TRNA SYNTHETASE FROM THERMUS THERMOPHILUS COMPLEXED WITH TRNAPRO(CGG), ATP AND PROLINOL | AMINOACYL-TRNA SYNTHETASE, ATP + L-PROLINE + TRNA(PRO) AMP + PPI + L-PROLYL-TRNA(PRO), CLASS II AMINOACYL-TRNA SYNTHETASE
2w1g:A (ASP132) to (GLN154) STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR | CANCER, AURORA, KINASE, INHIBITOR, NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, ATP-BINDING, POLYMORPHISM, PHOSPHOPROTEIN, CELL CYCLE
1t77:A (SER2079) to (THR2100) CRYSTAL STRUCTURE OF THE PH-BEACH DOMAINS OF HUMAN LRBA/BGL | PH-BEACH DOMAINS; VESICLE TRAFFICKING; SIGNAL TRANSDUCTION, SIGNALING PROTEIN
1t77:C (SER2079) to (THR2100) CRYSTAL STRUCTURE OF THE PH-BEACH DOMAINS OF HUMAN LRBA/BGL | PH-BEACH DOMAINS; VESICLE TRAFFICKING; SIGNAL TRANSDUCTION, SIGNALING PROTEIN
3igh:X (SER18) to (SER43) CRYSTAL STRUCTURE OF AN UNCHARACTERIZED METAL-DEPENDENT HYDROLASE FROM PYROCOCCUS HORIKOSHII OT3 | STRUCTURAL GENOMICS, AMIDOHYDROLASE, PSI-2, PROTEIN STRUCTURE INITIATIVE, HYDROLASE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC
1hii:A (LYS57) to (GLY78) COMPARATIVE ANALYSIS OF THE X-RAY STRUCTURES OF HIV-1 AND HIV-2 PROTEASES IN COMPLEX WITH CGP 53820, A NOVEL PSEUDOSYMMETRIC INHIBITOR | ASPARTATE PROTEASE, INHIBITED, HIV, HYDROLASE (ASPARTIC PROTEINASE)
2wd0:A (SER77) to (ASN104) CRYSTAL STRUCTURE OF NONSYNDROMIC DEAFNESS (DFNB12) ASSOCIATED MUTANT D124G OF MOUSE CADHERIN-23 EC1-2 | CELL ADHESION, HEARING
3vnt:A (GLY846) to (MET869) CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN VEGFR2 WITH A [1, 3]THIAZOLO[5,4-B]PYRIDINE DERIVATIVE | VEGFR2, KINASE DOMAIN, TYROSIN-PROTEIN KINASE, TRANSFERASE- TRANSFERASE INHIBITOR COMPLEX
1hpo:B (ARG57) to (GLY78) HIV-1 PROTEASE TRIPLE MUTANT/U103265 COMPLEX | HYDROLASE, ACID PROTEASE, ASPARTYL PROTEASE
2wed:A (ASN84) to (ALA105) ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE MACROCYCLIC INHIBITOR:METHYL[CYCLO-7[(2R)- ((N-VALYL)AMINO)-2-(HYDROXYL-(1S)-1-METHYOXYCARBONYL-2- PHENYLETHOXY)PHOSPHINYLOXY-ETHYL]-1-NAPHTHALENEACETAMIDE], SODIUM SALT | PENICILLOPEPSIN, MACROCYCLIC INHIBITOR, HYDROLASE
1hvl:B (ARG57) to (GLY78) INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C2 SYMMETRY-BASED DIOL INHIBITORS OF HIV-1 PROTEASE | HYDROLASE(ACID PROTEASE)
1hxb:B (ARG57) to (GLY78) HIV-1 PROTEINASE COMPLEXED WITH RO 31-8959 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ASPARTYL PROTEASE
1u3u:A (LYS5) to (PRO30) CRYSTAL STRUCTURE OF HUMAN ALCOHOL DEHYDROGENASE BETA-1- BETA-1 ISOFORM COMPLEXED WITH N-BENZYLFORMAMIDE DETERMINED TO 1.6 ANGSTROM RESOLUTION | OXIDOREDUCTASE
1u46:B (GLY138) to (CYS159) CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED KINASE DOMAIN OF THE TYROSINE KINASE ACK1 | TYROSINE KINASE, TRANSFERASE
2i1a:C (ILE259) to (ASP282) A RETROVIRAL PROTEASE-LIKE DOMAIN IN THE EUKARYOTIC PROTEIN DDI1 | ACID PROTEASE FOLD, DIMER, RETROVIRAL PROTEASE DOMAIN, PROTEIN TURNOVER
1ifr:A (GLU460) to (LYS490) STRUCTURE OF LAMIN A/C GLOBULAR DOMAIN | IMMUNOGLOBULIN, IMMUNE SYSTEM
2idb:B (ALA156) to (LEU183) CRYSTAL STRUCTURE OF 3-OCTAPRENYL-4-HYDROXYBENZOATE DECARBOXYLASE (UBID) FROM ESCHERICHIA COLI, NORTHEAST STRUCTURAL GENOMICS TARGET ER459. | ALPHA-BETA PROTEIN, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, LYASE
2idb:C (ALA156) to (LEU183) CRYSTAL STRUCTURE OF 3-OCTAPRENYL-4-HYDROXYBENZOATE DECARBOXYLASE (UBID) FROM ESCHERICHIA COLI, NORTHEAST STRUCTURAL GENOMICS TARGET ER459. | ALPHA-BETA PROTEIN, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, LYASE
2wyi:B (GLU464) to (PRO501) STRUCTURE OF THE STREPTOCOCCUS PYOGENES FAMILY GH38 ALPHA- MANNOSIDASE COMPLEXED WITH SWAINSONINE | HYDROLASE, GLYCOSIDASE, GLYCOSIDE HYDROLASE
2ihp:A (TRP52) to (VAL80) YEAST INORGANIC PYROPHOSPHATASE WITH MAGNESIUM AND PHOSPHATE | INORGANIC PYROPHOSPHATASE, MECHANISM, X-RAY CRYSTALLOGRAPHY, STRUCTURE-FUNCTION, MUTAGENESIS, HYDROLASE
2ihp:B (TRP52) to (VAL80) YEAST INORGANIC PYROPHOSPHATASE WITH MAGNESIUM AND PHOSPHATE | INORGANIC PYROPHOSPHATASE, MECHANISM, X-RAY CRYSTALLOGRAPHY, STRUCTURE-FUNCTION, MUTAGENESIS, HYDROLASE
2ik7:B (TRP52) to (VAL80) YEAST INORGANIC PYROPHOSPHATASE VARIANT D120N WITH MAGNESIUM AND PHOSPHATE | INORGANIC PYROPHOSPHATASE, MECHANISM, X-RAY CRYSTALLOGRAPHY, STRUCTURE-FUNCTION, MUTAGENESIS, HYDROLASE
1izd:A (TRP191) to (THR215) CRYSTAL STRUCTURE OF ASPERGILLUS ORYZAE ASPARTIC PROTEINASE | SUGAR BINDING, ACID PROTEASE, HYDROLASE
2x3n:A (GLY70) to (PRO104) CRYSTAL STRUCTURE OF PQSL, A PROBABLE FAD-DEPENDENT MONOOXYGENASE FROM PSEUDOMONAS AERUGINOSA | MONOOXYGENASE, OXIDOREDUCTASE
1v3m:B (ASP585) to (PRO643) CRYSTAL STRUCTURE OF F283Y MUTANT CYCLODEXTRIN GLYCOSYLTRANSFERASE COMPLEXED WITH A PSEUDO-TETRAOSE DERIVED FROM ACARBOSE | CGTASE, CYCLODEXTRIN, ACARBOSE, TRANSFERASE
3wmf:A (GLY442) to (ASN470) CRYSTAL STRUCTURE OF AN INWARD-FACING EUKARYOTIC ABC MULTITRUG TRANSPORTER G277V/A278V/A279V MUTANT | REC FOLD, MULTI DRUG TRANSPORTER, TRANSPORT PROTEIN
1jqh:A (MET1012) to (VAL1035) IGF-1 RECEPTOR KINASE DOMAIN | PROTEIN KINASE FOLD, TRANSFERASE
1jqh:B (MET1012) to (VAL1035) IGF-1 RECEPTOR KINASE DOMAIN | PROTEIN KINASE FOLD, TRANSFERASE
1jqh:C (MET1012) to (VAL1035) IGF-1 RECEPTOR KINASE DOMAIN | PROTEIN KINASE FOLD, TRANSFERASE
3j9b:A (CYS541) to (SER571) ELECTRON CRYO-MICROSCOPY OF AN RNA POLYMERASE | INFLUENZA RDRP, SINGLE PARTICLE RECONSTITUTION, REPLICATION, RNA BINDING PROTEIN-TRANSFERASE-RNA COMPLEX
3j9b:H (CYS541) to (SER571) ELECTRON CRYO-MICROSCOPY OF AN RNA POLYMERASE | INFLUENZA RDRP, SINGLE PARTICLE RECONSTITUTION, REPLICATION, RNA BINDING PROTEIN-TRANSFERASE-RNA COMPLEX
5bqc:A (MET40) to (CYS65) CRYSTAL STRUCTURE OF NORRIN IN COMPLEX WITH THE CYSTEINE-RICH DOMAIN OF FRIZZLED 4 AND SUCROSE OCTASULFATE | WNT SIGNALLING PATHWAY, NORRIE DISEASE PROTEIN, GLYCOPROTEIN, G PROTEIN COUPLED RECEPTOR, SIGNALING PROTEIN
2jjj:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH A GEM-DIOL INHIBITOR. | ACID PROTEINASE, ASPARTYL PROTEASE, ZYMOGEN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4njs:B (ARG57) to (GLY78) CRYSTAL STRUCTURE OF MULTIDRUG-RESISTANT CLINICAL ISOLATE A02 HIV-1 PROTEASE IN COMPLEX WITH NON-PEPTIDIC INHIBITOR, GRL008 | MULTIDRUG-RESISTANCE, HIV-1 PROTEASE, NON-PEPTIDIC INHIBITOR, PROTEASE INHIBITOR, DARUNAVIR ANALOG, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4njs:D (ARG57) to (GLY78) CRYSTAL STRUCTURE OF MULTIDRUG-RESISTANT CLINICAL ISOLATE A02 HIV-1 PROTEASE IN COMPLEX WITH NON-PEPTIDIC INHIBITOR, GRL008 | MULTIDRUG-RESISTANCE, HIV-1 PROTEASE, NON-PEPTIDIC INHIBITOR, PROTEASE INHIBITOR, DARUNAVIR ANALOG, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
2y7b:A (SER983) to (SER1010) CRYSTAL STRUCTURE OF THE PH DOMAIN OF HUMAN ACTIN-BINDING PROTEIN ANILLIN ANLN | CELL CYCLE
4nnr:B (ASP50) to (PHE78) FKBP13-FK506 COMPLEX | LOOP CROSSING, IMMUNOPHILIN, FKBP, PEPTIDYL-PROLYL ISOMERASE, ISOMERASE, ISOMERASE-ISOMERASE INHIBITOR COMPLEX
1kj4:B (ARG57) to (GLY78) SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES | MARIX-CAPSID, SUBSTRATE RECOGNITION, HYDROLASE
3zqm:A (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 1) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqm:B (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 1) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqm:C (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 1) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqm:E (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 1) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqm:F (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 1) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqm:G (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 1) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqm:H (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 1) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqm:I (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE SMALL TERMINASE OLIGOMERIZATION CORE DOMAIN FROM A SPP1-LIKE BACTERIOPHAGE (CRYSTAL FORM 1) | DNA-BINDING PROTEIN, MOLECULAR MOTOR, DNA PACKAGING
3zqq:A (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE FULL-LENGTH SMALL TERMINASE FROM A SPP1-LIKE BACTERIOPHAGE | DNA-BINDING PROTEIN, DNA PACKAGING
3zqq:B (GLN84) to (GLU104) CRYSTAL STRUCTURE OF THE FULL-LENGTH SMALL TERMINASE FROM A SPP1-LIKE BACTERIOPHAGE | DNA-BINDING PROTEIN, DNA PACKAGING
2ltd:A (LYS21) to (SER45) SOLUTION NMR STRUCTURE OF APO YDBC FROM LACTOCOCCUS LACTIS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET KR150 | STRUCTURAL GENOMICS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, PSI-BIOLOGY, PROTEIN STRUCTURE INITIATIVE, UNKNOWN FUNCTION
5c5z:A (GLY83) to (GLU103) CRYSTAL STRUCTURE ANALYSIS OF C4763, A UROPATHOGENIC E. COLI-SPECIFIC PROTEIN | GGCT-LIKE DOMAIN, UREA, UROPATHOGENIC E. COLI, HYDROLASE
1kun:A (ARG15) to (GLY37) SOLUTION STRUCTURE OF THE HUMAN ALPHA3-CHAIN TYPE VI COLLAGEN C-TERMINAL KUNITZ DOMAIN, NMR, 20 STRUCTURES | COLLAGEN TYPE VI FRAGMENT, KUNITZ-TYPE DOMAIN, EXTRACELLULAR MATRIX, CONNECTIVE TISSUE
2nr4:A (GLY28) to (GLY52) CRYSTAL STRUCTURE OF FMN-BOUND PROTEIN MM1853 FROM METHANOSARCINA MAZEI, PFAM DUF447 | STRUCTURAL GENOMICS, UNKNOWN FUNCTION, FLAVOPROTEIN, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC
2nr4:B (GLY28) to (GLY52) CRYSTAL STRUCTURE OF FMN-BOUND PROTEIN MM1853 FROM METHANOSARCINA MAZEI, PFAM DUF447 | STRUCTURAL GENOMICS, UNKNOWN FUNCTION, FLAVOPROTEIN, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC
1xh5:A (GLU44) to (GLU64) CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS | PKA, KINASE-INHIBITOR-COMPLEX, SERINE/THREONINE-PROTEIN KINASE, BALANOL DERIVATIVE, TRANSFERASE/TRANSFERASE INHIBITOR COMPLEX
1lde:A (LYS5) to (ALA29) HORSE LIVER ALCOHOL DEHYDROGENASE COMPLEXED TO NADH AND N-FORMYL PIPERDINE | DEHYDROGENASE, ALCOHOL, NICOTINAMIDE COENZYME, FORMAMIDES, OXIDOREDUCTASE
1lde:B (LYS5) to (ALA29) HORSE LIVER ALCOHOL DEHYDROGENASE COMPLEXED TO NADH AND N-FORMYL PIPERDINE | DEHYDROGENASE, ALCOHOL, NICOTINAMIDE COENZYME, FORMAMIDES, OXIDOREDUCTASE
1lde:C (LYS5) to (PRO30) HORSE LIVER ALCOHOL DEHYDROGENASE COMPLEXED TO NADH AND N-FORMYL PIPERDINE | DEHYDROGENASE, ALCOHOL, NICOTINAMIDE COENZYME, FORMAMIDES, OXIDOREDUCTASE
1lde:D (LYS5) to (PRO30) HORSE LIVER ALCOHOL DEHYDROGENASE COMPLEXED TO NADH AND N-FORMYL PIPERDINE | DEHYDROGENASE, ALCOHOL, NICOTINAMIDE COENZYME, FORMAMIDES, OXIDOREDUCTASE
1lee:A (TRP193) to (SER215) CRYSTAL STRUCTURE OF PLASMEPSIN FROM P. FALCIPARUM IN COMPLEX WITH INHIBITOR RS367 | PLASMEPSIN, ASPARTIC PROTEASE, PLASMODIUM FALCIPARUM, HYDROLASE
4a5k:A (ILE470) to (PRO494) STRUCTURAL ANALYSES OF SLM1-PH DOMAIN DEMONSTRATE LIGAND BINDING IN THE NON-CANONICAL SITE | SIGNALING PROTEIN, NON-CANONICAL BINDING SITE, INOSITOL PHOSPHATE, PHOSPHOSERINE
4a5k:B (ILE470) to (PRO494) STRUCTURAL ANALYSES OF SLM1-PH DOMAIN DEMONSTRATE LIGAND BINDING IN THE NON-CANONICAL SITE | SIGNALING PROTEIN, NON-CANONICAL BINDING SITE, INOSITOL PHOSPHATE, PHOSPHOSERINE
4a5k:C (ILE470) to (PRO494) STRUCTURAL ANALYSES OF SLM1-PH DOMAIN DEMONSTRATE LIGAND BINDING IN THE NON-CANONICAL SITE | SIGNALING PROTEIN, NON-CANONICAL BINDING SITE, INOSITOL PHOSPHATE, PHOSPHOSERINE
4a5k:D (ILE470) to (PRO494) STRUCTURAL ANALYSES OF SLM1-PH DOMAIN DEMONSTRATE LIGAND BINDING IN THE NON-CANONICAL SITE | SIGNALING PROTEIN, NON-CANONICAL BINDING SITE, INOSITOL PHOSPHATE, PHOSPHOSERINE
1xmx:A (GLN271) to (VAL297) CRYSTAL STRUCTURE OF PROTEIN VC1899 FROM VIBRIO CHOLERAE | ALPHA-BETA, MCSG, PROTEIN STRUCTURE INITIATIVE, STRUCTURAL GENOMICS, PSI, MIDWEST CENTER FOR STRUCTURAL GENOMICS, UNKNOWN FUNCTION
3ka2:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF CHEMICALLY SYNTHESIZED 203 AMINO ACID 'COVALENT DIMER' [L-ALA;GLY51']HIV-1 PROTEASE MOLECULE COMPLEXED WITH MVT-101 REDUCED ISOSTERE INHIBITOR AT 1.4 A RESOLUTION | BETA-BARREL, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3kdc:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K, L33I, L63I) IN COMPLEX WITH KNI-10074 | VIRAL PROTEIN, HYDROLASE, PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3kfp:A (GLY52) to (GLY78) HIV PROTEASE (PR) WITH INHIBITOR TL-3 BOUND, AND DMSOS IN EXO SITE | HIV-1, PROTEASE, EXO SITE, ASPARTYL PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1mg0:B (LYS5) to (PRO30) HORSE LIVER ALCOHOL DEHYDROGENASE COMPLEXED WITH NAD+ AND 2, 3-DIFLUOROBENZYL ALCOHOL | DEHYDROGENASE, ALCOHOL, NICOTINAMIDE COENZYME, ALTERNATIVE CONFORMATION, OXIDOREDUCTASE
1mg0:C (LYS5) to (PRO30) HORSE LIVER ALCOHOL DEHYDROGENASE COMPLEXED WITH NAD+ AND 2, 3-DIFLUOROBENZYL ALCOHOL | DEHYDROGENASE, ALCOHOL, NICOTINAMIDE COENZYME, ALTERNATIVE CONFORMATION, OXIDOREDUCTASE
5d0f:A (ALA807) to (GLU832) CRYSTAL STRUCTURE OF THE CANDIDA GLABRATA GLYCOGEN DEBRANCHING ENZYME (E564Q) IN COMPLEX WITH MALTOPENTAOSE | TIM BARREL, (ALPHA/ALPHA)6 BARREL, HYDROLASE, SUGAR BINDING PROTEIN
5d0f:B (ALA807) to (GLU832) CRYSTAL STRUCTURE OF THE CANDIDA GLABRATA GLYCOGEN DEBRANCHING ENZYME (E564Q) IN COMPLEX WITH MALTOPENTAOSE | TIM BARREL, (ALPHA/ALPHA)6 BARREL, HYDROLASE, SUGAR BINDING PROTEIN
1y20:A (LYS40) to (GLY65) CRYSTAL STRUCTURE OF THE NR1 LIGAND-BINDING CORE IN COMPLEX WITH ACPC | PROTEIN-LIGAND COMPLEX; LIGAND-BINDING COMPLEX, LIGAND BINDING PROTEIN
1y7x:A (ASN10) to (GLY39) SOLUTION STRUCTURE OF A TWO-REPEAT FRAGMENT OF MAJOR VAULT PROTEIN | STRUCTURAL REPEATS, BETA-SHEET MODULES, STRUCTURAL PROTEIN, PROTEIN BINDING
1y9e:A (PHE5) to (SER25) CRYSTAL STRUCTURE OF BACILLUS SUBTILIS PROTEIN YHFP WITH NAD BOUND | HYPOTHETICAL PROTEIN YHFP, BACILLUS SUBTILIS, ALCOHOL DEHYDROGENASE ACTIVITY, ZINC-DEPENDENT, STRUCTURAL GENOMICS, PROTEIN STRUCTURE INITIATIVE, PSI, NEW YORK SGX RESEARCH CENTER FOR STRUCTURAL GENOMICS, NYSGXRC, UNKNOWN FUNCTION
1yh5:A (VAL4) to (ALA41) SOLUTION NMR STRUCTURE OF PROTEIN YGGU FROM ESCHERICHIA COLI. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET ER14. | ALPHA+BETA; NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, PSI, PROTEIN STRUCTURE INITIATIVE, NESG, STRUCTURAL GENOMICS, UNKNOWN FUNCTION
1mwp:A (GLN90) to (VAL112) N-TERMINAL DOMAIN OF THE AMYLOID PRECURSOR PROTEIN | HEPARIN BINDING, SUGAR BINDING PROTEIN
1yti:A (GLY52) to (GLY78) SIV PROTEASE CRYSTALLIZED WITH PEPTIDE PRODUCT | COMPLEX (HYDROLASE/PEPTIDE,) AIDS, POLYPROTEIN, HYDROLASE, ASPARTYL PROTEASE, ENDONUCLEASE, RNA-DIRECTED DNA POLYMERASE, COMPLEX (HYDROLASE/PEPTIDE) COMPLEX
1z4w:A (GLU481) to (ASN505) PARAINFLUENZA VIRUS 5 (SV5) HEMAGGLUTININ-NEURAMINIDASE (HN) WITH LIGAND DANA (SOAKED WITH DANA, PH8.0) | HEMAGGLUTININ,NEURAMINIDASE,FUSION,TETRAMER, HYDROLASE
1z4z:A (GLU481) to (ASN505) PARAINFLUENZA VIRUS 5 (SV5) HEMAGGLUTININ-NEURAMINIDASE (HN) WITH LIGAND DANA(SOAKED WITH SIALIC ACID, PH7.0)) | HEMAGGLUTININ,NEURAMINIDASE,FUSION,TETRAMER, HYDROLASE
5dq2:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 48 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
5dr3:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 333 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
5dr7:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH FRAGMENT 311 | FRAGMENT SCREENING, HYDROLASE, INHIBITION
1zbg:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF A COMPLEX OF MUTANT HIV-1 PROTEASE (A71V, V82T, I84V) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE- PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2 | HIV, PROTEASE, PEPTIDOMIMETIC INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1zbg:B (ARG157) to (GLY178) CRYSTAL STRUCTURE OF A COMPLEX OF MUTANT HIV-1 PROTEASE (A71V, V82T, I84V) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE- PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2 | HIV, PROTEASE, PEPTIDOMIMETIC INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5dvp:B (GLY295) to (ILE328) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS L,D-TRANSPEPTIDASE 2 WITH DORIPENEM ADDUCT | PEPTIDOGLYCAN SYNTHESIS ENZYME, CELL WALL ENZYME, TRANSFERASE
4asd:A (GLY846) to (MET869) CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH SORAFENIB (BAY 43-9006) | ANGIOGENESIS, NUCLEOTIDE-BINDING, INHIBITOR, PHOSPHORYLATION, RECEPTOR, TRANSFERASE, KDR
1zpk:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF THE COMPLEX OF MUTANT HIV-1 PROTEASE (A71V, V82T, I84V) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE- PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2 | HIV, PROTEASE, PEPTIDOMIMETIC INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1zpk:B (ARG157) to (GLY178) CRYSTAL STRUCTURE OF THE COMPLEX OF MUTANT HIV-1 PROTEASE (A71V, V82T, I84V) WITH A HYDROXYETHYLAMINE PEPTIDOMIMETIC INHIBITOR BOC-PHE- PSI[R-CH(OH)CH2NH]-PHE-GLU-PHE-NH2 | HIV, PROTEASE, PEPTIDOMIMETIC INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3aos:B (PRO42) to (GLY69) CRYSTAL STRUCTURE OF JUVENILE HORMONE BINDING PROTEIN FROM SILKWORM IN COMPLEX WITH JH II | BETA-BARREL, JUVENILE HORMONE, HEMOLYMPH, HORMONE BINDING PROTEIN
3aot:A (PRO42) to (GLY69) CRYSTAL STRUCTURE OF JUVENILE HORMONE BINDING PROTEIN FROM SILKWORM IN ITS APO FORM | BETA-BARREL, JUVENILE HORMONE, HEMOLYMPH, HORMONE BINDING PROTEIN
4q63:A (TYR7) to (SER32) CRYSTAL STRUCTURE OF LEGIONELLA UNCHARACTERIZED PROTEIN LPG0364 | STRUCTURAL GENOMICS, PSI-BIOLOGY, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, ALPHA-BETA, BETA-BARREL, UNKNOWN FUNCTION
1zyi:A (GLN27) to (GLU50) SOLUTION STRUCTURE OF ICLN, A MULTIFUNCTIONAL PROTEIN INVOLVED IN REGULATORY MECHANISMS AS DIFFERENT AS CELL VOLUME REGULATION AND RNA SPLICING | PH DOMAIN; ICLN; CELL VOLUME REGULATION; RNA SPLICING, TRANSLATION
3lvp:A (MET1012) to (VAL1035) CRYSTAL STRUCTURE OF BISPHOSPHORYLATED IGF1-R KINASE DOMAIN (2P) IN COMPLEX WITH A BIS-AZAINDOLE INHIBITOR | PROTEIN KINASE, TYROSINE KINASE, TYROSINE PHOSPHORYLATION, PROTEIN- SUBSTRATE COMPLEX, TRANSFERASE
3lvp:B (GLY1011) to (VAL1035) CRYSTAL STRUCTURE OF BISPHOSPHORYLATED IGF1-R KINASE DOMAIN (2P) IN COMPLEX WITH A BIS-AZAINDOLE INHIBITOR | PROTEIN KINASE, TYROSINE KINASE, TYROSINE PHOSPHORYLATION, PROTEIN- SUBSTRATE COMPLEX, TRANSFERASE
4qaf:D (THR71) to (LEU97) CRYSTAL STRUCTURE OF AN ENGINEERED LIPOCALIN (ANTICALIN) IN COMPLEX WITH VEGF(8-109) | BETA-BARREL, BINDING PROTEIN, ENGINEERED LIPOCALIN, TRANSPORT PROTEIN-SIGNALING PROTEIN COMPLEX
5er1:E (GLY82) to (ALA104) A RATIONAL APPROACH TO THE DESIGN OF ANTIHYPERTENSIVES. X-RAY STUDIES OF COMPLEXES BETWEEN ASPARTIC PROTEINASES AND AMINOALCOHOL RENIN INHIBITORS | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5er2:E (ASP83) to (ALA104) HIGH-RESOLUTION X-RAY DIFFRACTION STUDY OF THE COMPLEX BETWEEN ENDOTHIAPEPSIN AND AN OLIGOPEPTIDE INHIBITOR. THE ANALYSIS OF THE INHIBITOR BINDING AND DESCRIPTION OF THE RIGID BODY SHIFT IN THE ENZYME | ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3bu5:A (GLY1008) to (VAL1032) CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH IRS2 KRLB PEPTIDE AND ATP | IRK, KRLB, IRS2, ATP, INSULIN RECEPTOR, PEPTIDE, SUBSTRATE, ALTERNATIVE SPLICING, ATP-BINDING, CARBOHYDRATE METABOLISM, CLEAVAGE ON PAIR OF BASIC RESIDUES, DIABETES MELLITUS, DISEASE MUTATION, GLYCOPROTEIN, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE, TRANSDUCER
3buk:A (LYS80) to (ASP105) CRYSTAL STRUCTURE OF THE NEUROTROPHIN-3 AND P75NTR SYMMETRICAL COMPLEX | LIGAND-RECEPTOR COMPLEX, BETA-SHEET, NEUROTROPHIN-3, P75NTR, CLEAVAGE ON PAIR OF BASIC RESIDUES, GLYCOPROTEIN, GROWTH FACTOR, SECRETED, APOPTOSIS, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, MEMBRANE, NEUROGENESIS, TRANSMEMBRANE, SIGNALING PROTEIN
3buk:B (LYS80) to (ASP105) CRYSTAL STRUCTURE OF THE NEUROTROPHIN-3 AND P75NTR SYMMETRICAL COMPLEX | LIGAND-RECEPTOR COMPLEX, BETA-SHEET, NEUROTROPHIN-3, P75NTR, CLEAVAGE ON PAIR OF BASIC RESIDUES, GLYCOPROTEIN, GROWTH FACTOR, SECRETED, APOPTOSIS, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, MEMBRANE, NEUROGENESIS, TRANSMEMBRANE, SIGNALING PROTEIN
4r0j:A (VAL166) to (ASN198) THE CRYSTAL STRUCTURE OF A FUNCTIONALLY UNCHARACTERIZED PROTEIN SMU1763C FROM STREPTOCOCCUS MUTANS | STRUCTURAL GENOMICS, PSI-BIOLOGY, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG, UNKNOWN FUNCTION
5fu6:E (THR493) to (GLU517) NOT MODULE OF THE HUMAN CCR4-NOT COMPLEX (CRYSTALLIZATION MUTANT) | GENE REGULATION, DEADENYLATION, MRNA DECAY, CCR4-NOT, TRANSCRIPTION, TRANSLATIONAL REPRESSION
5fu6:F (PHE719) to (GLU743) NOT MODULE OF THE HUMAN CCR4-NOT COMPLEX (CRYSTALLIZATION MUTANT) | GENE REGULATION, DEADENYLATION, MRNA DECAY, CCR4-NOT, TRANSCRIPTION, TRANSLATIONAL REPRESSION
3cqw:A (GLU149) to (ALA171) CRYSTAL STRUCTURE OF AKT-1 COMPLEXED WITH SUBSTRATE PEPTIDE AND INHIBITOR | KINASE, APOPTOSIS, ATP-BINDING, CARBOHYDRATE METABOLISM, CYTOPLASM, GLUCOSE METABOLISM, GLYCOGEN BIOSYNTHESIS, GLYCOGEN METABOLISM, MEMBRANE, NUCLEOTIDE-BINDING, NUCLEUS, PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, SUGAR TRANSPORT, TRANSFERASE, TRANSLATION REGULATION, TRANSPORT, ALTERNATIVE SPLICING, WNT SIGNALING PATHWAY
3nyg:B (ARG57) to (GLY78) X-RAY STRUCTURE OF ESTER CHEMICAL ANALOGUE [O-GLY51,O-GLY51']HIV-1 PROTEASE COMPLEXED WITH MVT-101 INHIBITOR | BETA-BARREL, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3czv:B (VAL93) to (ASN124) CRYSTAL STRUCTURE OF THE HUMAN CARBONIC ANHYDRASE XIII IN COMPLEX WITH ACETAZOLAMIDE | CARBONIC ANHYDRASE, PROTEIN-INHIBITOR COMPLEX, LYASE, METAL-BINDING
4cq7:B (LYS81) to (THR107) THE CRYSTAL STRUCTURE OF THE ALLENE OXIDE CYCLASE 2 FROM ARABIDOPSIS THALIANA WITH BOUND PRODUCT - OPDA | ISOMERASE, JASMONATES, CYCLIZATION, ALLENE OXIDE, OXYLIPINS
3d94:A (GLY981) to (VAL1005) CRYSTAL STRUCTURE OF THE INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE IN COMPLEX WITH PQIP | IGF1RK, RECEPTOR TYROSINE KINASE, PQIP, INHIBITOR, ATP- BINDING, GLYCOPROTEIN, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, TRANSFERASE, TRANSMEMBRANE, TYROSINE- PROTEIN KINASE
3dck:B (ARG57) to (GLY78) X-RAY STRUCTURE OF D25N CHEMICAL ANALOGUE OF HIV-1 PROTEASE COMPLEXED WITH KETOMETHYLENE ISOSTERE INHIBITOR | HIV-1 PROTEASE, HOMODIMER, BETA-TURNS, BETA-STRAND, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4twl:B (ALA174) to (MET196) CRYSTAL STRUCTURE OF DIOSCORIN COMPLEXED WITH ASCORBATE | DIOSCORIN, ASCORBATE, CARBONIC ANHYDRASE, DEHYDROASCORBATE REDUCTASE, PLANT PROTEIN
5h8i:C (ILE90) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) IN COMPLEX WITH N-(DIHYDROXYMETHYL)PUTRESCINE | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, INTERMEDIATE, HYDROLASE
5h8i:H (VAL89) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) IN COMPLEX WITH N-(DIHYDROXYMETHYL)PUTRESCINE | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, INTERMEDIATE, HYDROLASE
5h8i:I (VAL89) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) IN COMPLEX WITH N-(DIHYDROXYMETHYL)PUTRESCINE | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, INTERMEDIATE, HYDROLASE
5h8i:N (VAL89) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) IN COMPLEX WITH N-(DIHYDROXYMETHYL)PUTRESCINE | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, INTERMEDIATE, HYDROLASE
5h8k:C (ILE90) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) C158S MUTANT | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, HYDROLASE
5h8k:D (ILE90) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) C158S MUTANT | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, HYDROLASE
5h8k:E (ILE90) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) C158S MUTANT | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, HYDROLASE
5h8k:G (ILE90) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) C158S MUTANT | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, HYDROLASE
5h8k:I (VAL89) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) C158S MUTANT | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, HYDROLASE
5h8k:J (ILE90) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) C158S MUTANT | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, HYDROLASE
5h8k:L (ILE90) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) C158S MUTANT | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, HYDROLASE
5h8k:M (ILE90) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) C158S MUTANT | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, HYDROLASE
5h8k:N (VAL89) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) C158S MUTANT | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, HYDROLASE
5h8k:P (VAL89) to (ASP110) CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA N-CARBAMOYLPUTRESCINE AMIDOHYDROLASE (MTCPA) C158S MUTANT | AMIDASE, HELICAL OCTAMER, ALPHA-BETA-BETA-ALPHA SANDWICH FOLD, HYDROLASE
5he3:A (ILE560) to (PRO585) BOVINE GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND CCG224411 | RGS, KINASE, PH, WD-40, INHIBITOR COMPLEX, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
3pco:B (ARG566) to (GLY598) CRYSTAL STRUCTURE OF E. COLI PHENYLALANINE-TRNA SYNTHETASE COMPLEXED WITH PHENYLALANINE AND AMP | AMINOACYLATION, TRNA-BINDING, DNA-BINDING DOMAIN, FOUR-HELIX BUNDLE, AMINOACYL-TRNA SYNTHETASE, ATP-BINDING, LIGASE, NUCLEOTIDE-BINDING, PROTEIN BIOSYNTHESIS
3pco:D (ARG568) to (GLY598) CRYSTAL STRUCTURE OF E. COLI PHENYLALANINE-TRNA SYNTHETASE COMPLEXED WITH PHENYLALANINE AND AMP | AMINOACYLATION, TRNA-BINDING, DNA-BINDING DOMAIN, FOUR-HELIX BUNDLE, AMINOACYL-TRNA SYNTHETASE, ATP-BINDING, LIGASE, NUCLEOTIDE-BINDING, PROTEIN BIOSYNTHESIS
4um8:C (TYR290) to (ALA322) CRYSTAL STRUCTURE OF ALPHA V BETA 6 | IMMUNE SYSTEM, CELL SURFACE RECEPTOR
3pll:A (ASP88) to (ALA109) ENDOTHIAPEPSIN IN COMPLEX WITH A FRAGMENT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5id8:B (GLY102) to (LYS141) CRYSTAL STRUCTURE OF CGL1 FROM CRASSOSTREA GIGAS, LIGAND FREE FORM (CGL1/FREE) | CGL1, LECTIN, N-TYPE, CRASSOSTREA GIGAS, UNKNOWN FUNCTION, SUGAR BINDING PROTEIN
5id8:D (GLY102) to (LYS141) CRYSTAL STRUCTURE OF CGL1 FROM CRASSOSTREA GIGAS, LIGAND FREE FORM (CGL1/FREE) | CGL1, LECTIN, N-TYPE, CRASSOSTREA GIGAS, UNKNOWN FUNCTION, SUGAR BINDING PROTEIN
5idb:B (GLY102) to (LYS141) CRYSTAL STRUCTURE OF CGL1 FROM CRASSOSTREA GIGAS, MANNOSE-BOUND FORM (CGL1/MAN2) | CGL1, LECTIN, CRASSOSTREA GIGAS, N-TYPE, MANNOSE, SUGAR BINDING PROTEIN
5idb:A (GLY102) to (LYS141) CRYSTAL STRUCTURE OF CGL1 FROM CRASSOSTREA GIGAS, MANNOSE-BOUND FORM (CGL1/MAN2) | CGL1, LECTIN, CRASSOSTREA GIGAS, N-TYPE, MANNOSE, SUGAR BINDING PROTEIN
4ehc:A (ILE57) to (SER76) CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF RV0977 OF MYCOBACTERIUM TUBERCULOSIS | ASPARTIC PROTEINASE, HYDROLASE
4ep3:A (ARG57) to (GLY78) CRYSTAL STRUCTURE OF INACTIVE SINGLE CHAIN WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH THE SUBSTRATE CA-P2 | HIV-1 PROTEASE, SPECIFICITY DESIGN, DRUG DESIGN, PROTEASE INHIBITORS, AIDS, ASPARTYL PROTEASE, HYDROLASE, HYDROLASE-HYDROLASE SUBSTRATE COMPLEX
4f0p:B (GLU185) to (VAL211) MSPJI RESTRICTION ENDONUCLEASE - P31 FORM | ENDONUCLEASE, DNA METHYLATION DEPENDENT, SRA DOMAIN, EPIGENETICS TOOL, CYTOSINE METHYLATION-DEPENDENT ENDONUCLEASE, HYDROLASE
4fae:B (ARG57) to (GLY78) SUBSTRATE P2/NC IN COMPLEX WITH A HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE VARIANT | PROTEASE, VIRAL PROTEIN
4fc2:A (GLY778) to (ASP800) CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN | MOUSE, PARG, POLY(ADP-RIBOSE) GLYCOHYDROLASE, HYDROLASE
4fc2:B (GLY778) to (ASP800) CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN | MOUSE, PARG, POLY(ADP-RIBOSE) GLYCOHYDROLASE, HYDROLASE
4fc2:C (GLY778) to (ASP800) CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN | MOUSE, PARG, POLY(ADP-RIBOSE) GLYCOHYDROLASE, HYDROLASE
4fc2:D (GLY778) to (ASP800) CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN | MOUSE, PARG, POLY(ADP-RIBOSE) GLYCOHYDROLASE, HYDROLASE
3qtk:B (THR64) to (LEU90) THE CRYSTAL STRUCTURE OF CHEMICALLY SYNTHESIZED VEGF-A | COVALENT DIMER, CYSTEINE KNOT PROTEIN, GROWTH FACTOR, X-RAY CRYSTAL STRUCTURE, HUMAN VEGF-A, HORMONE
3qtk:E (THR64) to (LEU90) THE CRYSTAL STRUCTURE OF CHEMICALLY SYNTHESIZED VEGF-A | COVALENT DIMER, CYSTEINE KNOT PROTEIN, GROWTH FACTOR, X-RAY CRYSTAL STRUCTURE, HUMAN VEGF-A, HORMONE
4ght:B (ASP118) to (ASN139) CRYSTAL STRUCTURE OF EV71 3C PROTEINASE IN COMPLEX WITH AG7088 | HYDROLASE, CYSTEINE PROTEINASE, INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5kjb:D (LYS314) to (ASP353) SYNECHOCYSTIS APOCAROTENOID OXYGENASE (ACO) MUTANT - GLU150ASP | IRON-COORDINATION, ACTIVE SITE, CAROTENOID BINDING, LIGAND INTERACTION, NON-HEME IRON, MUTAGENESIS, OXIDOREDUCTASE
5ozj:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 30 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p01:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 48 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p05:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 52 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0e:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 61 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p0w:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 79 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p13:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 86 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1c:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 95 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1h:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 100 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1n:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 106 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1o:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 107 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1q:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 109 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1t:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 112 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p1v:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 114 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2a:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 128 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2c:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 130 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2e:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 132 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2i:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 136 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2j:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 137 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2s:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 145 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p2y:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 151 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p39:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 162 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3a:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 163 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3f:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 168 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p3h:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 170 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4n:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 212 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4u:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 219 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p4x:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 222 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p50:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 225 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p51:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 226 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p52:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 227 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p57:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 232 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5b:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 236 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p5p:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 250 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p60:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 261 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p67:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 268 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p69:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 270 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6b:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 272 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p6f:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 276 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p73:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 300 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p74:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 301 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p79:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 306 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7f:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 312 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7g:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 313 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7h:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 314 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7k:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 317 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7l:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 318 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p7s:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 325 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8g:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 349 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8i:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 351 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
5p8q:A (ASP88) to (ALA109) AUTOMATED REFINEMENT OF DIFFRACTION DATA OBTAINED FROM AN ENDOTHIAPEPSIN CRYSTAL TREATED WITH FRAGMENT 359 | FRAGMENT SCREENING, METHOD DEVELOPMENT, ASPARTIC PROTEASE, HYDROLASE
7adh:A (LYS5) to (ALA29) THREE-DIMENSIONAL STRUCTURE OF ISONICOTINIMIDYLATED LIVER ALCOHOL DEHYDROGENASE | OXIDOREDUCTASE (NAD(A)-CHOH(D))
7lpr:A (THR163) to (ASN184) STRUCTURAL BASIS FOR BROAD SPECIFICITY IN ALPHA-LYTIC PROTEASE MUTANTS | SERINE PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX